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Summary 
 
Mycobacterium tuberculosis is a major human pathogen, infecting approximately one 
third of the world’s population. The majority of infected individuals are asymptomatic, 
and in these cases M. tuberculosis is present in a non-replicating persistent state. 
Mycobacterium tuberculosis is capable of emerging from this persistent state and 
causing active disease. Extensive gene regulation facilitates the entry into and 
emergence from the persistent state, and understanding this reprogramming of genes 
may help provide novel methods of treatment. The cAMP receptor protein Rv3676 is a 
global gene regulator in M. tuberculosis that is required for virulence, regulating ~100 
genes including whiB1. The whiB1 gene encodes a member of the Wbl family of 
proteins, which are iron-sulphur cluster-containing transcription factors associated with 
a role in developmental processes in the actinomycetes. WhiB1, one of seven Wbl 
proteins encoded by M. tuberculosis, was the focus of this study. The whiB1 gene was 
identified as being essential for M. tuberculosis survival. The WhiB1 protein 
incorporated a [4Fe-4S] cluster, ligated by four essential cysteine residues, which was 
stable in the presence of oxygen but reacted rapidly with nitric oxide in a multiphasic 
reaction forming an unusual octa-nitrosylated cluster. The reduced and oxidised apo-
WhiB1 bound both the whiB1 and groEL2 promoter regions, but the [4Fe-4S] 
containing form of WhiB1 (holo-WhiB1) was unable to bind DNA. Treatment of holo-
WhiB1 with nitric oxide led to restoration of DNA-binding. The DNA-binding 
capabilities of WhiB1 were found to be, in part, due to specific amino acid residues in 
the helix-turn-helix region of the protein. Transcription of whiB1 is negatively-regulated 
by apo-WhiB1 in both the presence and absence of Rv3676, which has been identified 
as activating whiB1 expression. Thus whiB1 expression is regulated by two important 
infection signals viz. nitric oxide and cAMP, suggesting a role for WhiB1 in 
tuberculosis pathogenesis.  
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1.0 Introduction 
 
1.1 The lifestyle of Mycobacterium tuberculosis 
 
1.1.1  Mycobacterium tuberculosis as the causative agent of tuberculosis 
 
Mycobacterium tuberculosis is a member of the Mycobacterium genus within the 
actinomycetes, and is a Gram positive rod-shaped bacterium. Mycobacterium 
tuberculosis is slow growing with a doubling time of 15-20 hours, forming colonies on 
Petri dishes after 3-4 weeks. In 1882 Robert Koch isolated M. tuberculosis for the first 
time, and demonstrated that it was the causative agent of tuberculosis in humans 
(Daniel, 2006 and references therein). Mycobacterium tuberculosis is an obligate aerobe 
with a highly impermeable cell envelope containing a variety of unusual lipids that 
contribute to virulence; these include, mycolic acids (conferring the property of acid-
fastness associated with Mycobacteria); glycolipids (including the inflammatory 
molecule lipoarabinomannan); and polyketides (including phenolphthiocerol, which 
forms a complex with mycocerosic acid to give the virulence factor phenolphthiocerol-
dimycocerosate - PDIM) (Daffé and Draper, 1998). The properties of the M. 
tuberculosis bacillus and its resistance to a wide variety of antibiotics contribute to its 
virulence and continued presence as one of the world’s biggest killers. 
 
1.1.2 Prevalence of tuberculosis 
 
Tuberculosis has been a strain on society for thousands of years, and remains a huge 
problem throughout the world today. The World Health Organisation estimated there 
were 8.8 million cases of tuberculosis in 2010 leading to 1.45 million deaths (WHO, 
2011). It is also estimated that one third of the world’s population (~ 2 billion) is 
infected with tuberculosis, creating a huge reservoir of M. tuberculosis (WHO, 2011). 
Of this infected population, individuals have a 5-10% risk of developing active 
tuberculosis. This risk is highly dependent on a number of factors, most significantly 
that of socio-economic and regional variation that is also impacted by the extent of HIV 
infection (Dye, 2006; Figure 1.1). Susceptibility to tuberculosis infection is 
considerably increased by HIV infection and diabetes. Co-infection of tuberculosis and  
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Figure 1.1: Global distribution of the estimated incidence rates of tuberculosis. 
Map shows the distribution of estimated new cases of tuberculosis in 2010. Numbers 
are based on cases per 100,000 of the population according to World Health 
organisation estimates. Map is from the WHO global tuberculosis report 2011 (WHO, 
2011). 
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HIV in sub-Saharan Africa is a particular problem, while the increasing rates of diabetes 
in rapidly growing economies is also causing an increase in tuberculosis cases (Comas 
and Gagneux, 2009). Thus tuberculosis is a global problem and due to the increase in 
multidrug resistant strains continues to be so. Research into M. tuberculosis and new 
methods of treatment are therefore a necessity. 
   
1.1.3 Control of tuberculosis 
 
The continued presence of tuberculosis as a worldwide health problem is in part due to 
the current inadequate methods of diagnosis, treatment and prevention (Young et al., 
2008). Diagnosis for both latent and active tuberculosis relies on methods derived in the 
19
th
 century with low sensitivity; the skin test for latent infections and sputum-smear 
microscopy for active tuberculosis infections (Daniel 2006 and references therein; 
Ehrlich, 1882). Prevention comes in the form of the BCG (bacillus Calmette-Guérin) 
vaccine derived from Mycobacterium bovis. Despite widespread use however, it is 
largely ineffective at preventing adult pulmonary disease (Young et al., 2008).  
 
Mycobacteria are naturally resistant to the majority of antibiotics and chemotherapeutic 
agents. This is likely due to their highly hydrophobic cell envelope, which acts as an 
efficient permeability barrier (Nikaido et al., 2011). This offers a limited choice for 
tuberculosis treatment. The current treatment for tuberculosis infections, devised in the 
1960s, involves the administration of four drugs over a period of 6-9 months. 
Chemotherapy comprises of an initial intensive phase of treatment with four drugs for 
two months, as discussed by Heym and Cole (1997). Here the mycobacteria specific 
drugs of isoniazid, pyrazinamide and ethambutol as well as the general antibiotic 
rifampicin, are administered to kill M. tuberculosis and prevent the emergence of 
resistant mutants. The second continuation phase involves treatment for four months 
with isoniazid and rifampicin to ensure full sterilisation of bacterial cells and the lesions 
infected by M. tuberculosis (Heym and Cole, 1997).  
 
There are a number of problems associated with the current treatment of tuberculosis, 
including the need for drugs in forms which can be safely administered to children, and 
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that can be administered in combination with antiretroviral therapy for patients co-
infected with tuberculosis and HIV (Swindells, 2012). The current method of treatment 
is also associated with a number of side effects, which can cause poor patient 
compliance. This, along with patients stopping their treatment when they begin to feel 
better, incorrect prescription and unreliable drug sources, leads to a worrying level of 
drug-resistant tuberculosis (Swindells, 2012). Drug-resistant tuberculosis is harder to 
treat, requiring a departure from the standard course often taking up to 30 months to 
administer (Matteelli et al., 2007). This treatment involves the use of second-line drugs 
which have limited efficacy, cause more severe side effects and are more expensive 
(Heym and Cole, 1997). The emergence of strains of M. tuberculosis resistant to several 
prescribed drugs highlights the problem further. Multidrug-resistant tuberculosis (MDR-
TB), defined as strains resistant to isoniazid and rifampicin, is an increasing problem 
with 400,000 new cases per year (Matteelli et al., 2007). More worryingly, extensively 
resistant tuberculosis (XDR-TB), defined as MDR-TB plus resistance to a quinolone 
and one of the second-line anti-tuberculosis injectable drugs, for example kanamycin, is 
an emerging issue (Young et al., 2008). 
 
It is clear that further research is required to find new methods of diagnosis, prevention 
and cure for tuberculosis as the current methods are insufficient. Drugs that can 
specifically target dormant M. tuberculosis cells for example, would not only help in 
preventing relapses, but may also help eliminate the organism from the huge latently 
infected population, which in turn would reduce the reservoir of disease (Heym and 
Cole, 1997). 
 
1.1.4 Infection process of tuberculosis 
 
Infection with M. tuberculosis begins with inhalation of the infectious bacilli as droplet 
nuclei from the atmosphere (Russell, 2001; 2007; Russell et al., 2010). These bacilli are 
known to remain airborne for several hours, and the minimum infectious dose is 
estimated at a single bacterium (Russell, 2007). Of those infected, between 5-10% 
develop primary tuberculosis. These individuals are usually children and those who are 
immunocomprimised (often due to co-infection with HIV), and primary tuberculosis is 
associated with the disseminated form of the disease (Bloom and Murray, 1992; Stewart 
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et al., 2003). The majority of people do however control this initial infection by 
mounting a cell-mediated response. The inhaled bacilli are phagocytosed by alveolar 
macrophages and are either killed directly or grow intracellularly to a limited extent in a 
localised lesion, the tubercle (Bloom and Murray, 1992). The formation of this lesion 
defining the disease and referred to as a granuloma, follows a set chain of events and is 
summarised here and in Figure 1.2 (Russell, 2001; 2007; Russell et al., 2010). The 
activated alveolar macrophages invade the subtending epithelial layer entering the blood 
vessels of the lungs. This then induces a localised inflammatory response characterised 
by the recruitment of mononuclear cells from neighbouring blood vessels, which 
provide fresh host cells for the expanding bacterial population. These cells become the 
building blocks of the granuloma, which appears as an unordered mass of monocytes, 
neutrophils and macrophages. The macrophages differentiate into specialised cell types 
including foamy macrophages, epithelioid macrophages and multinucleated giant cells. 
Development of the acquired immune response results in the arrival of lymphocytes, 
which in turn causes the granuloma to become more structured and organised. This in 
part is due to the production of tumour necrosis factor (TNF) by macrophages and T 
cells, which is believed to aid chemokine and adhesion-molecule regulation (Tufariello 
et al., 2003).  The macrophage rich centre is surrounded by lymphocytes, and is often 
enclosed by a fibrous cuff (Russell, 2001; 2007; Russell et al., 2010). At this stage the 
granuloma has reduced blood supply and is generally thought to be hypoxic (Via et al., 
2008). The arrival of the M. tuberculosis-specific lymphocytes 2-6 weeks post infection 
causes the end of rapid bacterial replication and the killing of some bacilli, resulting in a 
containment phase (Bloom and Murray, 1992; Russell et al., 2010). These lymphocytes 
are in the form of CD4 and CD8 T cells and B cells. The CD4 and CD8 T cells produce 
interferon γ, which activates the macrophages in the granuloma. The CD8 T cells can 
lyse the infected activated macrophages and kill intracellular bacteria (Tufariello et al., 
2003). This prevents active disease, often with no symptoms being noticed, but can 
leave a residual population of viable bacteria in the walled-off lesion (Stewart et al., 
2003). Hypoxia, as seen in the granulomas, has been shown to induce a non-replicative 
persistence state in M. tuberculosis cultures, which explains how a residual population 
remains (Russell et al., 2010; Via et al., 2008). 
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Figure 1.2: Infection process of tuberculosis. The inhaled M. tuberculosis (Mtb) 
bacilli are engulfed by alveolar macrophages (green cells), resulting in a local 
inflammatory response. Fresh macrophages arrive for the expanding bacterial 
population, forming the building blocks of the granuloma, which is serviced by 
numerous blood vessels (red lines). This core is surrounded by differentiated 
macrophages (blue cells) including foamy macrophages, giant multinucleated cell and 
epithelioid macrophages. Development of the acquired immune response leads to the 
arrival of lymphocytes (red cells). This results in a more ordered structure and 
containment of the infection. The granuloma becomes walled-off by a fibrous cuff and 
is no longer serviced by blood vessels, thus becoming hypoxic. Depletion of 
lymphocytes as a result of immunocomprimisation causes the granuloma to no longer 
be able to contain the infection. Reactivation of Mtb causes rapid replication and the 
failure of the granuloma. The lesion ruptures spilling infectious bacilli into the airway 
and the effective transmission of Mtb. 
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Due to the presence of viable bacteria in the granuloma, post-primary tuberculosis can 
develop in later life by the reactivation of these bacterial cells or failure to control a 
second infection (Stewart et al., 2003). This occurrence is usually a result of the 
individual becoming immunocomprimised, causing a reduction in CD4 T cells. 
Depletion of these T cells results in a reduced ability of the granuloma to contain the 
bacilli. There is a decrease in the production of interferon γ, which leads to decreased 
activation of macrophages. This in turn allows M. tuberculosis cells to multiply, leading 
to reactivation of the disease (Tufariello et al., 2003). Neutralisation of TNF can also 
have an effect as it leads to disorder of the granuloma, possibly by deregulating 
chemokine and adhesion molecule production (Tufariello et al., 2003). The granuloma 
can no longer contain the infection and ruptures releasing thousands of viable bacilli 
into the airways, creating the characteristic productive cough associated with 
tuberculosis and efficient aerosol transmission of infectious bacilli (Figure 1.2). This 
form of tuberculosis is predominately a pulmonary disease, which causes extensive lung 
damage (Stewart et al., 2003). 
 
1.1.5 The role of Mycobacterium tuberculosis during infection 
 
In Section 1.1.4, the role of the immune system in controlling M. tuberculosis infections 
is discussed. The bacillus itself however, plays an important role in establishing an 
infection by its ability to evade the immune response and set up a persistent infection. In 
doing this, it can survive for extended periods of time in a non-replicating dormant state 
until conditions are favourable for replication. This then leads to successful 
transmission, which is the ultimate aim. Mycobacterium tuberculosis experiences a 
variety of hostile environments in its life-cycle of infection and has adopted a number of 
methods of evasion and survival. Once the M. tuberculosis bacilli are engulfed by 
macrophages, they have the ability to survive and grow intracellularly within a safe 
niche. They do this by employing a number of methods to prevent being killed by the 
macrophage itself and evading detection by lymphocytes, which in turn kill the infected 
macrophage. 
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Mycobacterium tuberculosis evades two of the major antimicrobial mechanisms of the 
macrophages; generation of nitric oxide and reactive nitrogen intermediates (RNIs), and 
the fusion of the phagosomes and lysosomes (Tufariello et al., 2003). RNIs are 
produced by the nitric oxide synthase NOS2, and are essential for controlling M. 
tuberculosis infection in humans (Rich et al., 1997). As the host is often unable to 
eliminate the bacteria, M. tuberculosis must express a number of genes to cope with the 
bactericidal and bacteriostatic effects of these RNIs and persist in the host. This ability 
will be discussed in detail in Section 1.2. Macrophages engulf bacteria into a 
compartment referred to as the phagosome. To kill the bacilli the phagosome must 
mature by fusion with a lysosome forming the phagolysosome, an acidic compartment 
with bactericidal activity (reviewed in Vieira et al., 2002). Mycobacterium tuberculosis 
is capable of interfering with this fusion to form the phagolysosome, thus avoiding the 
bactericidal activity of the reactive oxygen and nitrogen intermediates, lysozymal 
enzymes, toxic peptides and the acidic pH (reviewed in Deretic et al., 2006; Rohde et 
al., 2007b; Russell, 2001; Smith, 2003; Tufariello et al., 2003). As well as this, M. 
tuberculosis also prevents the acidification of the phagosome, restricting it to pH 6.4 not 
pH 4.8 (Russell, 2007). 
 
As mentioned, M. tuberculosis can evade intracellular killing by the macrophages it 
occupies. The bacilli also produce a number of molecules, including a 19 kDa 
lipoprotein and a 25 kDa glycolipoprotein, which can interfere with the pathway for 
processing and presenting of MHC class II antigens by infected macrophages (Noss et 
al., 2001; Wadee et al., 1995). Successful presentation of antigens in this manner alerts 
CD4 T cells, and is thus essential for the priming and effector functions of these 
lymphocytes (Tufariello et al., 2003). Mycobacterium tuberculosis is therefore capable 
of preventing this and can remain safe in the macrophage and evades killing by the 
acquired immune response, which in turn aids in its persistence (Tufariello et al., 2003). 
 
In addition to the evasion of the immune system by occupying a safe niche in the 
macrophage, M. tuberculosis can survive for years in the hypoxic walled-off lesion 
described in Section 1.1.4. The bacilli do not replicate in this lesion due to its acidic 
nature, low oxygen levels and the presence of toxic fatty acids, but persist in a non-
replicating dormant-like state (Smith, 2003). To remain in the granuloma without being 
cleared by the immune system, it is thought that the infection is sustained by this 
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population of non-replicating bacilli and that the immune response mainly targets 
antigens produced by a small population of actively growing M. tuberculosis cells 
(Russell et al., 2009). As well as avoiding the immune response, non-replicating cells 
avoid the anti-tuberculosis drugs administered. This dormant state of M. tuberculosis, 
bought on by the stress conditions in the granuloma, confers innate immunity to the 
drugs which target actively growing cells (Russell et al., 2009). To survive in the 
granuloma in the non-replicating state, M. tuberculosis must employ mechanisms to 
cope with the environmental stresses and lack of nutrients. Changes in gene expression 
are key to this ability. To cope with nutrient starvation for example, genes are induced 
by M. tuberculosis to oxidise fatty acids, which are then used as the main carbon and 
energy source (Sassetti and Rubin, 2003). There are also sophisticated genetic 
mechanisms employed to sense and cope with the environmental stresses of hypoxia, 
nitric oxide and changes in redox potential, which will be discussed in more detail in 
Section 1.2 (Talaat et al., 2004).  
 
It is clear that M. tuberculosis is a highly successful pathogen, capable of setting up a 
persistent infection for extended periods of time. Its ability to evade killing by 
macrophages and switch from active growth to a non-replicating latent state is key in its 
success. To do this it must transmit the signals associated with infection, including 
hypoxia and nitric oxide, to alter its gene expression. 
 
1.2 Transcriptional regulation in M. tuberculosis during infection 
 
Following initial infection, M. tuberculosis can persist in a non-replicating state from 
which it may emerge when conditions are more favourable (e.g. in periods of 
immunosuppression) (Stewart et al., 2003). Understanding the persistent state may be 
key in finding novel ways of controlling tuberculosis. Extensive and appropriate gene 
regulation is necessary for establishing the non-replicating state (dormancy) and for 
emerging from it, and a number of studies have explored the expression profiles of M. 
tuberculosis genes associated with infection (Rengarajan et al., 2005; Rohde et al., 
2007a; Sassetti and Rubin, 2003; Schnappinger et al., 2003; Talaat et al., 2004). Some 
of the transcriptional regulation mechanisms employed by M. tuberculosis in response 
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to the signals associated with infection, namely hypoxia, nitric oxide and cAMP, will be 
discussed here. 
 
1.2.1 The transcriptional regulatory network in M. tuberculosis 
 
The M. tuberculosis genome has over 140 genes encoding regulatory proteins and signal 
transduction pathways that control gene expression, which are essential for adaption to 
the variety of stressful environments the bacteria encounters (Cole et al., 1998). In 
addition, M. tuberculosis encodes 13 sigma factors that govern gene expression at the 
transcriptional level, 11 pairs of sensor histidine kinases and response regulators, and 6 
serine-threonine protein kinases, all involved in gene regulation (Cole et al., 1998). 
Characterising the function of these regulatory proteins will provide insights into how 
M. tuberculosis relays environmental signals into altered gene expression. What is 
known currently about a number of the key regulators is discussed below. 
 
1.2.2 Gene regulation in response to hypoxia and nitric oxide 
 
Mycobacterium tuberculosis experiences both hypoxia and the presence of nitric oxide 
during the infection process. These two important signals of infection need to be relayed 
to changes in gene expression to allow survival and entrance into the dormant state. 
Adaption in response to these signals is mediated by the DosR/S/T (dormancy survival 
regulator) regulon. The dormancy regulon responds to hypoxia, and controls the 
expression of about 50 genes (Boon and Dick, 2002; Park et al., 2003; Voskuil et al., 
2004). The DosR/S/T regulon controls the shift from aerobic to anaerobic metabolism 
during M. tuberculosis infection, allowing the bacilli to survive during hypoxia-induced 
dormancy, and facilitates the reversal to replication upon re-exposure to oxygen 
(Gengenbacher and Kaufmann, 2012; Leistikow et al., 2010; Rustad et al., 2009). The 
two sensor kinases of the three component system, DosS (redox sensor) and DosT 
(hypoxia sensor), have been shown to bind nitric oxide, carbon monoxide and oxygen 
(Kumar et al., 2007). These signals are then relayed to alter gene expression through the 
DosR regulator. Non-toxic concentrations of nitric oxide induce a 48 gene regulon, via 
the response regulator DosR, to inhibit aerobic respiration and slow the replication of 
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cells (Voskuil et al., 2003). The individual contributions of the genes induced by the 
DosR/S/T regulon in aiding M. tuberculosis survival in the dormant state are unknown. 
The DosR/S/T regulon is also thought to be under the control of a number of different 
transcription factors which, like Dos R/S/T, may respond to the infection signals of 
hypoxia and nitric oxide as well as oxidative stress and carbon monoxide, both in 
macrophages and the granuloma. 
 
The role of DosR in response to the infection signal of hypoxia appears to be key in 
controlling a large network of genes to aid M. tuberculosis survival within the host. One 
study has suggested that there is another response to hypoxia that is independent of 
DosR. This enduring hypoxic response (EHR) showed a change in 230 genes, including 
30 transcriptional regulators, which were significantly induced at four and seven days of 
hypoxia (Rustad et al., 2008). This paper suggests that the EHR may have an important 
role in controlling bacteriostasis, and that the importance of DosR may not be as 
significant as previously thought. Identification of the genes regulated by EHR may 
help shed more light on the changes in gene expression in response to hypoxia. 
 
PhoPR is a two-component system with a role in transcriptional regulation, whereby the 
PhoR sensor histidine kinase relays yet unidentified stimuli to the PhoP regulator 
(Gonzalo-Asensio et al., 2006). Inactivation of the phoP regulator leads to attenuation 
of M. tuberculosis, with impaired growth in macrophages and mice models, and reduced 
virulence due to reduced secretion of the major T-cell antigen ESAT-6 (Frigui et al., 
2008; Pérez et al., 2001). Transcriptome analysis has identified PhoP to, in part, control 
the DosR regulon (Gonzalo-Asensio et al., 2008). This was further confirmed as the 
phoP mutant showed downregulation of the DosR regulated α-crystallin protein, which 
is involved in protecting partially folded proteins during long periods of non-replicative 
growth (Gonzalo-Asensio et al., 2008; Sherman et al., 2001; Voskuil et al., 2003). PhoP 
is therefore believed to regulate dormancy through cross talk with DosR. Regulation of 
a subset of genes in the EHR by PhoP also suggests an important role in linking both the 
initial and enduring hypoxic responses. In addition to its regulation of genes involved in 
the response to hypoxia, PhoP was also identified as regulating genes encoding proteins 
with a role in the general stress response, persistence, respiratory metabolism, synthesis 
of lipids and virulence. These were differentially expressed in response to macrophage 
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infection, thus PhoP is believed to control many key functions for intracellular survival 
(Gonzalo-Asensio et al., 2008). 
 
It is clear that gene regulation in response to nitric oxide and hypoxia is extremely 
complex involving an overlapping and vast transcriptional network. It is likely that there 
are many other regulators involved which are yet to be identified. 
 
1.2.3 Gene regulation in response to cAMP 
 
Cyclic AMP is a universal second messenger, which relays external environmental 
signals from membrane receptors to effectors within the cell (McDonough and 
Rodriguez, 2011). The regulatory effects of cAMP in bacteria are through interactions 
with cAMP receptor proteins. This results in changes in the DNA-binding properties of 
the regulators and thus alterations in gene expression (McDonough and Rodriguez, 
2011). Cyclic AMP is considered as an important signalling molecule in M. tuberculosis 
as suggested by the presence of 15-17 genes encoding adenylyl cyclases, the generators 
of cAMP (Cole et al., 1998). Cyclic AMP is believed to play an important role in the 
infection process because concentrations increase 50-fold upon M. tuberculosis 
infection of macrophages (Bai et al., 2009). This increase upon infection occurs through 
a mycobacterial-derived cAMP burst, and has been shown to promote bacterial survival 
by interfering with host signalling pathways (Agarwal et al., 2009). The adenylyl 
cyclases that produce the cAMP show increased activity upon exposure to the infection 
signals of pH and fatty acids (as seen in the macrophages), and hypoxia and nutrient 
starvation (as seen in the granuloma) (Bai et al., 2011). The production of cAMP by the 
adenylyl cyclase, Rv0386, has been shown to have a direct link to survival and 
virulence as deletion of the gene leads to decreased pathology and attenuated virulence 
in mouse models of infection (Agarwal et al., 2009). Furthermore, the importance of 
cAMP as a signalling molecule to affect gene regulation in promoting survival and 
virulence has been demonstrated (Gazdik and McDonough, 2005; Rickman et al., 2005; 
Stapleton et al., 2010).  
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This gene regulation is mediated by two members of the cAMP receptor protein (CRP) 
family of transcription factors, encoded in the M. tuberculosis genome (Cole et al., 
1998). The best characterised is Rv3676, referred to as CRP
MT
, and has been shown to 
be a DNA-binding transcriptional regulator of more than 100 genes (Agarwal et al., 
2006; Bai et al., 2005; Rickman et al., 2005; Stapleton et al., 2010). Rv3676 is 
necessary for virulence, whereby deletion of the Rv3676 gene resulted in attenuated 
growth in macrophages and mice, as well as reduced virulence in mice (Rickman et al., 
2005). Transcriptome analysis in the form of whole genome microarrays of the H37Rv 
strain of M. tuberculosis revealed that there were significant changes in the Rv3676 
mutant strain compared to the wild-type. Eight genes were identified with a >2.4 fold 
increase in the abundance of their transcripts in the wild-type compared to the Rv3676 
mutant, and eight genes identified with a >2.4 fold increase in the abundance of their 
transcripts in the mutant (Rickman et al., 2005). Two genes of particular interest were 
rpfA and whiB1. The rpfA gene encodes resuscitation promoting factor A (RpfA), a 
member of a group of Rpf proteins that may be involved in the regulation of persistent 
infection and in the reactivation process (Mukamolova et al., 2002). The whiB1 
transcript, encoded by Rv3219, was 3.41 fold more abundant in the wild-type strain 
(Rickman et al., 2005). WhiB1 is a member of the Wbl family of proteins. The Wbl 
family are thought to function as transcription factors, with a role in regulating 
developmental processes and survival within the host (den Hengst and Buttner, 2008). 
Thus, Rv3676, in complex with cAMP, regulates genes involved in the formation of M. 
tuberculosis’ persistent state and emergence from dormancy (Stapleton et al., 2010). 
Previous studies have shown that whiB1 is transcribed under the control of Rv3676 and 
that it is regulated by varying cAMP levels (Agarwal et al., 2006). They showed how 
cAMP-activated Rv3676 directly binds a consensus site adjacent to the whiB1 promoter, 
leading to whiB1 transcription. Further studies by Stapleton et al. (2010) have shown 
that the Rv3676 dimer can bind two molecules of cAMP and that it binds at two 
adjacent sites in the whiB1 promoter. At low cAMP concentrations, only the upstream 
binding site is occupied by Rv3676 causing activation. At high cAMP concentrations, 
both sites are occupied leading to repression of whiB1 transcription (Stapleton et al., 
2010). The role of WhiB1 will be further analysed in this thesis.  
 
Mycobacterium tuberculosis possesses a second member of the cAMP receptor protein 
family, Rv1675c (Cmr – cAMP and macrophage regulator) (McCue et al., 2000). 
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Rv1675c has not been as well characterised as Rv3676, but it has been identified as a 
cAMP-responsive transcription factor, regulating four cAMP-induced genes (Gazdik 
and McDonough, 2005; Gazdik et al., 2009). Of these four genes, Rv1675c bound the 
promoters of mdh (encoding a malate dehydrogenase), groEL2 and Rv1265 (a gene of 
unknown function) (Gazdik et al., 2009), suggesting direct regulation similar to that 
seen for Rv3676 of whiB1. Gazdik et al. (2009) suggest that Rv1675c is a transcription 
factor that regulates cAMP-induced genes within the macrophage and may be important 
in M. tuberculosis pathogenesis. The role of Rv1675c will be further analysed in this 
thesis. 
 
1.3 The Wbl family of proteins  
 
WhiB1 is a member of the Wbl (WhiB-like) family of proteins. They are found 
exclusively in the actinomycetes and play an important role in developmental processes, 
where they are thought to act as transcription factors (den Hengst and Buttner, 2008). 
The first member of the family to be identified and characterised was encoded by the 
whiB gene from Streptomyces coelicolor, whereby a mutant showed white colonies (the 
‘whi’ phenotype) opposed to the grey colour associated with the wild-type (Chater, 
1972). It was identified in a screen for mutants that abolished sporulation, and thus the 
grey polyketide pigment associated with it, showing abnormally long, tightly-coiled 
aerial hyphae that were unable to form septa (Chater, 1972; Davis and Chater, 1992). 
Genome sequencing has revealed 270 Wbl homologues in the actinomycetes. In S. 
coelicolor there are 14 wbl genes, 11 encoded in the chromosome and 3 on the giant 
linear plasmid, SCP1 (Bentley et al., 2002; Bentley et al., 2004). Of these, 5 (WhiB, 
WhiD, WblA, WblC and WblE) are conserved in the actinomycetes. Mycobacterium 
tuberculosis encodes seven Wbl proteins (WhiB1-7) (Cole et al., 1998; Soliveri et al., 
2000). Here the current literature available on the roles of Wbl proteins, as well as their 
structural and functional characteristics, is discussed.  
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1.3.1 Structural features of the Wbl proteins 
 
The Wbl family of proteins are characterised by their small size, ranging from 81-122 
amino acid residues in length, with the exception of WblP σ factor fusion protein from 
S. coelicolor (den Hengst and Buttner, 2008). The Wbl family have four highly 
conserved cysteine residues in the N-terminal domain with the central two forming a 
CXXC motif and a general alignment of Cys-X14-22-Cys-X2-Cys-X5-Cys (Soliveri et al., 
2000). The only exception to this is WhiB5 of M. tuberculosis, which has a Cys-X3-Cys 
motif (Soliveri et al., 2000). The role of the four cysteine residues is considered to be in 
the binding of a metal co-factor. Another interesting feature of the Wbl proteins, first 
identified for WhiB from S. coelicolor, is the presence of a weakly predicted helix-turn-
helix structure in the C-terminal domain (Davis and Chater, 1992). The loop region 
between the two helices has a conserved GV/IWGG motif, which may be exposed and 
play a role in interaction with RNA polymerase (Soliveri et al., 2000). The predicted 
helix-turn-helix feature suggests that Wbl proteins function as DNA-binding 
transcription factors, although there is no strong DNA-binding motif. Wbl proteins all 
have a high overall hydrophilicity, suggesting a cytoplasmic location. They also have an 
overall negative charge, but with a positively charged carboxy-region, again 
highlighting a possible role for them as DNA-binding proteins (Davis and Chater, 1992; 
Soliveri et al., 2000). The function of Wbl proteins, and the role of these structural 
features, will be discussed in Sections 1.3.2 and 1.3.3. 
 
The presence of four highly conserved cysteine residues in the Wbl proteins suggest that 
they coordinate a metal co-factor, which is a feature of some DNA-binding proteins. A 
number of members of the Wbl family from S. coelicolor and M. tuberculosis have been 
shown to bind iron-sulphur clusters (Alam et al., 2007; 2009; Jakimowicz et al., 2005; 
Rybniker et al., 2010; Singh et al., 2007). The seven Wbl proteins from M. tuberculosis 
were shown to bind [2Fe-2S] clusters when aerobically expressed and purified, but 
following anaerobic reconstitution bound [4Fe-4S] clusters (Alam et al., 2009). Similar 
observations were made for WhiD from S. coelicolor (Jakimowicz et al., 2005). The 
iron-sulphur clusters, bound by the four cysteine residues, have been shown to be redox 
sensitive and react with oxygen and nitric oxide (Alam et al., 2009; den Hengst and 
Buttner, 2008; Jakimowicz et al., 2005). It is believed that the presence of the iron-
sulphur cluster in the Wbl proteins will prove to be essential in controlling function, as 
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seen for the DNA-binding proteins SoxR and FNR of Escherichia coli (summarised by 
Crack et al. (2012)). 
 
1.3.2 Roles of Wbl proteins in Streptomyces 
 
As mentioned, the Wbl proteins from the actinomycetes are believed to play a role in 
developmental processes. The Streptomycetes, of which S. coelicolor is a member, are 
soil-dwelling, spore-forming bacteria which are an important source of antibiotics. 
Sporulation occurs when conditions are unfavourable for growth, and members of the 
Wbl family (WhiB and WhiD) have been shown to be important in this process (Chater, 
1972; Davis and Chater, 1992; Flärdh et al., 1999; McVittie, 1974; Molle et al., 2000). 
WhiB, as discussed in Section 1.3, is essential for the proper septation of spores 
(Chater, 1972). WhiD is required for the later stages of sporulation, and whiD mutants 
produce spores that are heat-sensitive, prone to lysis and show size and shape 
irregularities (McVittie, 1974; Molle et al., 2000). Other Wbl proteins in S. coelicolor, 
have been shown to have roles in antibiotic production (WblA) and resistance (WblC). 
WblC was shown to control multidrug resistance in S. coelicolor as well as 
Streptomyces lividans, whereby a wblC mutant in S. lividans was sensitive to a wide 
variety of antibiotics (Morris et al., 2005). WblA was seen to act as a pleiotropic 
regulator of antibiotic biosynthesis in Streptomyces peucetius, down-regulating the anti-
cancer drug doxorubicin, and in S. coelicolor, down-regulating the synthesis of a 
number of antibiotics including actinorhodin (Kang et al., 2007). Mutants in wblA of S. 
coelicolor also showed an ability to overproduce pigmented antibiotics, which were 
present in the aerial hyphae (Fowler-Goldsworthy et al., 2011). WblA of S. coelicolor, 
like WhiB and WhiD, was also shown to have a role in sporulation and development. A 
detailed study described a wblA mutant strain as having a delay in shutting off rapid 
growth as nutrients approached starvation levels (Fowler-Goldsworthy et al., 2011). 
This is similar to the findings by Flärdh et al. (1999), whereby a whiB mutant strain 
lacked controlled growth cessation. The role of WblE, the remaining conserved member 
in S. coelicolor, remains unknown as a wblE mutant strain showed no obvious 
phenotype (Homerová et al., 2003). It is clear that the Wbl proteins in the Streptomyces 
species have diverse roles, but are essential in developmental processes. The importance 
of WhiB, WhiD and WblA in stopping rapid growth when conditions are unfavourable 
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and in sporulation, indicates a regulatory role, potentially by acting as transcriptional 
regulators. 
 
There is little direct evidence for the Wbl proteins in the Streptomyces species acting as 
transcription factors. The diverse phenotypes seen in Wbl mutants, as well as 
information on their structural features (Section 1.3.1), does however suggest a role in 
gene regulation. In addition, the unusual WblP σ factor fusion protein from S. coelicolor 
encodes an RNA polymerase sigma factor at its C-terminus as well as the conserved 
Wbl features at the N-terminus (Bentley et al., 2004). Detailed biochemical knowledge 
of these proteins in Streptomyces is limited, with WhiD being the most studied. As 
mentioned in Section 1.3.1, WhiD from S. coelicolor binds a [4Fe-4S] cluster which is 
sensitive to oxygen (Crack et al., 2009; Jakimowicz et al., 2005). It is thought that the 
Wbl proteins act as transcription factors and that the presence, absence or state of the 
cluster may play a vital role in their regulatory ability, possibly by relaying signals 
associated with changing environments (e.g. low oxygen conditions). Studies to identify 
possible genes regulated by WhiD, as well as the other members of the Wbl family in S. 
coelicolor, and whether this regulation is direct, will provide new insights to the 
biochemical function of these proteins. 
 
1.3.3 Roles of Wbl proteins in Mycobacterium species 
 
Mycobacterium tuberculosis, as discussed in Section 1.1.5, experiences a persistent 
state in its life-cycle of infection, whereby the bacilli undergo huge changes in gene 
expression to survive in this non-replicating latent state. The Wbl family of proteins 
have been implicated in the ability of M. tuberculosis to persist within the host for 
extended periods of time in the granuloma, despite the low oxygen and nutrient 
conditions, and survive within the macrophages, despite the presence of nitric oxide 
(Banaiee et al., 2006; Rohde et al., 2007a). The bacilli also have a substantial tolerance 
to a wide variety of antibiotics, and the Wbl proteins have also been implicated in this 
(Morris et al., 2005). The seven Wbl proteins therefore appear to be important in the 
remarkable ability of M. tuberculosis to survive in the harsh environment of the host, 
and moreover have been shown to be expressed under stress conditions (Geiman et al., 
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2006; Larsson et al., 2012). Here, what is known of the roles of the seven Wbl proteins 
in M. tuberculosis is summarised. 
 
WhiB1, the focus of this study, is regulated by CRP
MT
 (Rv3676) and studies on whiB1 
expression have shown it to be induced by cAMP (Agarwal et al., 2006; Larsson et al., 
2012; Rickman et al., 2005; Stapleton et al., 2010). Although WhiB1 binds an iron-
sulphur cluster (Alam et al., 2009), there is little detailed knowledge about its 
biochemical properties and function. Interestingly, an alternative role for WhiB1 has 
been suggested rather than it acting as a transcription factor. A group has presented 
evidence that the Wbl proteins in M. tuberculosis (with the exception of WhiB2), act as 
general protein disulphide reductases, reducing the substrate insulin (Alam et al., 2007; 
2009; Garg et al., 2007). WhiB1 was also shown to interact with the α (1,4)-glucan 
branching enzyme (GlgB) reducing its intra-molecular disulphide bond (Garg et al., 
2009). 
 
WhiB2 is homologous to both WhiB from S. coelicolor and WhmD from M. smegmatis 
(den Hengst and Buttner, 2008). Both whiB2 and whmD are essential genes and have 
been shown to be functionally equivalent (Gomez and Bishai, 2000; Raghunand and 
Bishai, 2006a; 2006b). Controlled depletion experiments have shown an essential role 
for them in proper septation and cell division of Mycobaterium (Gomez and Bishai, 
2000; Raghunand and Bishai, 2006a). The whmD conditional mutant in M. smegmatis 
showed filamentous and branched growth with diminished septum formation, whereas 
when whmD was overexpressed there was growth retardation and hyperseptation 
(Gomez and Bishai, 2000). Similar observations were seen for whiB2 of M. tuberculosis 
(Raghunand and Bishai, 2006a). These studies show the importance of WhiB2 and 
WhmD in Mycobacterium growth, and their similar roles to that of WhiB in S. 
coelicolor. The whiB2 gene has been shown to be expressed during nutrient starvation, 
in macrophages and in the presence of cAMP, indicating its essential role during the 
infection process (Betts et al., 2002; Keiser et al., 2011; Larsson et al., 2012). There is 
direct evidence that WhiB2 from M. tuberculosis acts as a DNA-binding protein from 
the Rybniker group (2010). WhiB2 was shown to bind its own promoter region, 
regulating its own synthesis. This binding was affected by the presence of the iron-
sulphur cluster, whereby the apo-form of the protein bound the promoter DNA 
(Rybniker et al., 2010). Interestingly, the Mycobacteriophage TM4 encodes a Wbl 
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protein (WhiBTM4), which acts a transcriptional inhibitor of WhiB2. WhiBTM4 is 
capable of binding to the WhiB2 promoter, and expression of whiBTM4 led to hindered 
septation, similar to that of a whiB2 mutant (Rybniker et al., 2010). It has recently been 
suggested that WhiB2 has properties similar to that of a chaperone, suppressing the 
aggregation of several model substrates including luciferase (Konar et al., 2012). This 
paper suggests that, although having the same features as the other Wbl proteins, 
WhiB2 has evolved differently to the other members and serves a very different 
function (Konar et al., 2012). This contradicts the findings of others that WhiB2 is a 
transcriptional regulator (Raghunand and Bishai, 2006a; Rybniker et al., 2010). 
 
WhiB3 from M. tuberculosis is the best studied of the Wbl proteins and has been 
identified as a DNA-binding protein, which can sense redox and control several aspects 
of virulence (Guo et al., 2009; Saini et al., 2012; Singh et al., 2007; 2009; Steyn et al., 
2002). Expression of whiB3 is induced in macrophages and the mouse lung, indicating 
that M. tuberculosis regulates whiB3 expression in response to environmental signals 
associated with infection (Banaiee et al., 2006). This idea has been supported by the 
findings whereby acid stress, hypoxia and nitric oxide induced whiB3 expression 
(Geiman et al., 2006; Larsson et al., 2012). WhiB3 has also been shown to play a role in 
virulence, as mice infected with a whiB3 null mutant showed increased survival (Steyn 
et al., 2002). WhiB3 incorporates a [4Fe-4S] cluster, which reacts with the dormancy 
signals oxygen and nitric oxide, suggesting it acts as a sensor of these physiologically 
significant gases (Singh et al., 2007). This study also demonstrated the role of WhiB3 in 
regulating the intermediary metabolism of M. tuberculosis, as it was essential for 
survival during nutrient starvation. This indicates that WhiB3 acts as an intracellular 
redox sensor, relaying signals through its iron-sulphur cluster to the regulation of 
metabolism (Singh et al., 2007). A number of studies have demonstrated that during 
exposure to hypoxia and nitric oxide, M. tuberculosis responds by accumulating the 
fatty acid triacylglycerol (Daniel et al., 2004; Sirakova et al., 2006). WhiB3 has been 
identified as regulating lipid and polyketide biosynthesis, including triacylglycerol and 
the virulence factor PDIM (Section 1.1.1), in response to activated macrophages (Guo et 
al., 2009; Singh et al., 2007; 2009). Thus WhiB3 has been implicated in M. tuberculosis 
survival and virulence. This is achieved by regulating lipid anabolism in response to 
oxido-reductive stress associated with infection, thus maintaining redox balance (Singh 
et al., 2009). Triacylglycerol has previously been identified as being under the control 
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of the DosR/S/T regulon (Daniel et al., 2004; Reed et al., 2007), and the finding that 
WhiB3 also regulates triacylglycerol production highlights a link between the dormancy 
regulon and this redox-sensing transcription factor (Singh et al., 2009). WhiB3 acts as a 
direct DNA-binding protein at the pks2 and pks3 promoter regions, encoding genes 
necessary for polyketide biosynthesis (Singh et al., 2009). It has also been shown to 
interact with the RpoV sigma factor, further confirming its role as a transcription factor 
(Steyn et al., 2002). Its DNA binding is independent of the presence or redox state of 
the iron-sulphur cluster, but reduction of apo-WhiB1 abolished DNA binding whereas 
oxidation encouraged it (Singh et al., 2009). This confirmed that WhiB3 regulation of 
fatty acid metabolism was redox-dependent. In summary, WhiB3 has been identified as 
a transcriptional regulator of fatty acid synthesis and thus accumulation, which is an 
essential virulence feature of M. tuberculosis during latent infection of the host. 
 
Further evidence for the role of the Wbl proteins in the infection life-cycle of M. 
tuberculosis has come from recent work on WhiB5. A whiB5 mutant showed attenuated 
infection abilities in the mouse lung with lower bacilli numbers and was unable to 
resume growth after reactivation from a chronic infection (Casonato et al., 2012). This 
is of significant interest, suggesting WhiB5 controls the expression of genes involved in 
reactivation from the latent state (Casonato et al., 2012). WhiB5 was also shown to 
influence the expression of a number of genes including sigM, encoding an alternative 
sigma factor, and genes encoding constituents for the ESX-2 and ESX-4 secretion 
systems, highlighting the role of WhiB5 in virulence (Casonato et al., 2012). 
 
WhiB7 from M. tuberculosis, like WblC from S. coelicolor, has been linked with a role 
in antibiotic resistance (Morris et al., 2005). WhiB7 is induced by treatment with sub-
inhibitory levels of antibiotics (erythromycin, tetracycline and streptomycin), and a 
number of stress conditions associated with infection (Geiman et al., 2006; Larsson et 
al., 2012; Morris et al., 2005). WhiB7 expression is also induced by fatty acids that M. 
tuberculosis accumulates and encounters during infection (Morris et al., 2005). A 
whiB7 null mutant is hyper-sensitive to antibiotics, whereas overexpression of whiB7 
led to increased resistance (Morris et al., 2005). Morris and co-workers (2005) showed 
that WhiB7 provided this drug resistance by activating the expression of a regulon of 
genes involved in ribosomal protection and drug efflux. These data taken together 
suggest that whiB7 is expressed during infection of the host and plays a role as a 
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transcriptional activator to help M. tuberculosis survive antibiotic treatment. WhiB7, as 
has been demonstrated for WhiB2, autoregulates its own transcription in response to 
antibiotics and changes in redox homeostasis (Burian et al., 2012). WhiB7 therefore 
appears to act as a transcription factor regulating antibiotic resistance, possibly by the 
iron-sulphur centre sensing redox changes. 
 
There is little known about WhiB4 and WhiB6 of M. tuberculosis. They have both been 
shown to bind an iron-sulphur cluster similar to that of the other Wbl proteins (Alam et 
al., 2009), and have been implicated in having protein disulphide activity (Alam et al., 
2007; 2009). They are also induced by cAMP and expressed during stress conditions 
(Geiman et al., 2006; Larsson et al., 2012).  
 
1.4 Aims of the project 
 
The information provided above clearly shows that M. tuberculosis is a major 
worldwide healthcare problem. Its ability to enter a persistent state, resulting in an 
enormous reservoir of infection, and to subsequently emerge from this state are key 
features of tuberculosis pathogenesis. This transition and the ability to survive the harsh 
environment within macrophages and the tubercle requires significant reprogramming 
of gene expression. As discussed, hypoxia, nitric oxide, carbon monoxide and cAMP 
signals all play major roles in bringing about this reprogramming through the actions of 
the DosR/S/T, PhoPR, CRP
MT
 and Cmr regulators. It is likely however, that we only 
have a partial picture of the signals and regulators involved in these complex processes. 
Wbl proteins play roles in developmental processes in actinomycetes but they are 
largely uncharacterised. The general properties of Wbl proteins and the regulation of M. 
tuberculosis whiB1 by the cAMP-Rv3676 complex suggests however, that WhiB1 could 
play a role in development (transitions between replicating and persistent states). Based 
on current evidence, the hypothesis is that M. tuberculosis WhiB1 is an iron-sulphur 
cluster containing transcription factor that regulates gene expression in response to a 
redox signal. The experiments described in this thesis were carried out to test this 
hypothesis using a range of molecular biology and biochemical approaches.  
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2.0 Materials and Methods 
 
2.1 Strains and plasmids 
 
The strains of Escherichia coli used in this study are listed in Table 2.1 and the plasmids 
in Table 2.2. 
 
Table 2.1: Strains of Escherichia coli used in this study 
 
Strain Relevant characteristics Source or reference 
BL21 λ(DE3) Escherichia coli BL21 λ(DE3) lysogen 
carrying a copy of the T7 RNA 
polymerase under the control of the 
IPTG-inducible lacUV5 promoter 
Novagen 
JRG2357 DH5α ∆lacZYA-argF, lacZ∆M15 Invitrogen 
JRG5923 DH5α /pGS2164 This work 
JRG6050 BL21 λ(DE3)/pGS2164 This work 
JRG5652 DH5α /p2060 This work 
JRG5733 DH5α /pGS2103 This work 
JRG5871 DH5α /p2126 This work 
JRG6494 DH5α /p2365 This work 
JRG6495 DH5α /p2366 This work 
JRG6496 DH5α /p2367 This work 
JRG6439 DH5α /p2344 This work 
JRG6221 DH5α /pGS2300 This work 
JRG6222 DH5α /pGS2301 This work 
JRG6223 DH5α /pGS2302 This work 
JRG6224 DH5α /pGS2303 This work 
JRG6225 DH5α /pGS2304 This work 
JRG6226 DH5α /pGS2305 This work 
JRG6227 DH5α /pGS2306 This work 
JRG6228 DH5α /pGS2307 This work 
JRG6229 DH5α /pGS2308 This work 
33 
 
JRG6230 DH5α /pGS2309 This work 
JRG6232 DH5α /pGS2311 This work 
JRG6233 DH5α /pGS2312 This work 
JRG6234 DH5α /pGS2313 This work 
JRG6481 DH5α /pGS2358 This work 
JRG6482 DH5α /pGS2359 This work 
JRG6483 DH5α /pGS2360 This work 
JRG6484 DH5α /pGS2361 This work 
JRG6485 DH5α /pGS2362 This work 
JRG6486 DH5α /pGS2363 This work 
JRG6487 DH5α /pGS2364 This work 
   
 
Table 2.2: Plasmids used in this study 
 
Plasmid Relevant characteristics Source or reference 
pET28a His6-tag overexpression vector; Kan
R
 Novagen 
pGS2164 pET28a-WhiB1; Kan
R
 This work 
pGS2103 pET28a-Rv1675c; Kan
R
 This work 
pCR4Blunt-TOPO Cloning Vector; Kan
R
 and Amp
R
 Invitrogen 
p2060 pCR4Blunt-TOPO-PwhiB1; Kan
R
 and 
Amp
R
 
Buxton, NIMR 
p2126 pCR4Blunt-TOPO-PgroEL2; Kan
R
 and 
Amp
R
 
Buxton, NIMR 
p2365 pCR4Blunt-TOPO-Prv2007c; Kan
R
 Buxton, NIMR 
p2366 pCR4Blunt-TOPO-Prv2032; Kan
R
 Buxton, NIMR 
p2367 pCR4Blunt-TOPO-Prv3133c; Kan
R
 Buxton, NIMR 
p2344 pCR4Blunt-TOPO-Prv3134c; Kan
R
 Buxton, NIMR 
pGS2300 pGS2164 with C9A mutation This work 
pGS2301 pGS2164 with C37A mutation This work 
pGS2302 pGS2164 with C40A mutation This work 
pGS2303 pGS2164 with C46A mutation This work 
pGS2304 pGS2164 with P41S mutation This work 
pGS2305 pGS2164 with E45L mutation This work 
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pGS2306 pGS2164 with P41S/E45L mutation This work 
pGS2307 pGS2164 with K72E mutation This work 
pGS2308 pGS2164 with R73E mutation This work 
pGS2309 pGS2164 with R74E mutation This work 
pGS2311 pGS2164 with R77E mutation This work 
pGS2312 pGS2164 with K79E mutation This work 
pGS2313 pGS2164 with R81E mutation This work 
pGS2358 pGS2164 with S57E mutation This work 
pGS2359 pGS2164 with G58E mutation This work 
pGS2360 pGS2164 with V59E mutation This work 
pGS2361 pGS2164 with W60E mutation This work 
pGS2362 pGS2164 with G61E mutation This work 
pGS2363 pGS2164 with G62E mutation This work 
pGS2364 pGS2164 with D13A mutation This work 
   
 
2.2 Media and chemical suppliers 
 
Bacterial growth media components were sourced from Oxoid Ltd. Chemicals were 
supplied by BDH Chemicals Ltd., Fisher Scientific, Melford Laboratories Ltd. and 
Sigma. Kits for DNA purification were purchased from Qiagen. Restriction enzymes 
were sourced from Roche, Fermentas and Promega. DNase enzyme was supplied from 
Promega and Klenow enzyme from Fermentas. HiTrap columns were from GE 
Healthcare. Kanamycin antibiotic was sourced from Melford Laboratories Ltd. Proli 
NONOate was sourced from Alexis Biochemicals and Cayman Chemicals. Protein 
assay reagent was obtained from Bio-Rad. Isotopes were sourced from Perkin Elmer. 
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2.3 Growth media and conditions 
 
2.3.1 Rich media 
 
Escherichia coli was cultured in Lennox broth (LB) medium. 
 
    LB (g/l)  LB Agar (g/l) 
Tryptone   10   10 
Yeast extract   5   5 
NaCl    5   5 
Agar bacteriological  -   15 
 
These ingredients were made up to 1 litre with distilled water and autoclaved (121°C, 
15 psi) to sterilise. 
 
Once the LB medium was cooled to 50°C the appropriate antibiotics were added. 
Molten agar was poured into petri dishes (25 ml/dish) and allowed to cool and set. 
Plates were stored at 4°C for up to 1 month. 
 
2.3.2 Growth of Escherichia coli 
 
Escherichia coli was typically cultured in LB with the appropriate antibiotics at 37°C 
with shaking (250 rpm), until the desired optical density at 600 nm (OD600) was 
reached. Overnight cultures (5 ml) were prepared by inoculating a single colony from a 
LB agar plate and were either used directly or to inoculate larger cultures. 
 
2.3.3 Measurement of bacterial growth 
 
Escherichia coli growth was estimated by measuring the OD600 of 1 ml of the culture 
using the Eppendorf Biophotometer, with LB as a blank. 
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2.3.4 Supplementation of growth media 
 
Media were supplemented as indicated with kanamycin, 20 µg/ml. IPTG was added to a 
final concentration of 120 µg/ml for protein overexpression. 
 
2.3.5 Storage of strains 
 
Strains were stored on solid media at 4°C for up to one month. For long term storage 
strains were kept in the form of glycerol stocks, made as follows; 5 ml overnight 
cultures were centrifuged and cell pellets were resuspended in 1.25 ml LB, 1 ml sterile 
80% (v/v) glycerol and the appropriate antibiotics. These were stored at -20°C. 
 
2.3.6 Production of chemically competent cells 
 
A single colony of the appropriate strain from a LB agar plate was inoculated in 0.25 ml 
of LB and incubated overnight at 37°C with rocking. This was then used to inoculate 
25 ml LB containing MgSO4 (final concentration of 20 mM) at 37°C with shaking 
(250 rpm). Once the OD600 reached 0.4, the cells were pelleted by centrifugation at 
4500 xg for 5 minutes at 4°C. The pellet was then gently resuspended in 10 ml of 
chilled filter sterilised TFB1 (pH 5.8), i.e. 2/5 volume of original culture. 
 
Cells were kept on ice for the following steps and all pipettes, Eppendorf tubes and 
flasks were chilled. The cells were incubated on ice for 5 minutes and pelleted at 
4500 xg for 5 minutes at 4°C. Cells were then resuspended in 1 ml chilled filter 
sterilised TFB2 (pH 6.5), i.e. 1/25 of original culture volume. 
 
TFB1 (pH 5.8):    TFB2 (pH 6.5) 
Potassium acetate 30 mM  MOPS  10 mM 
CaCl2   10 mM  CaCl2  75 mM 
MnCl2   50 mM  RbCl  10 mM 
RbCl   100 mM  Glycerol 15% (v/v) 
Glycerol  15% (v/v) 
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Cells were incubated on ice for 30 minutes, then aliquoted as 200 µl samples for storage 
at -70°C. 
 
2.3.7 Transformation of chemically competent cells 
 
Chemically competent cells were thawed on ice and 50 µl was placed into a chilled 
eppendorf tube. The desired plasmid (up to 1 µg) was added and chilled on ice for 
30 minutes. Cells were subjected to heat shock at 42°C for 90 seconds and returned to 
ice for 2 minutes. LB (1 ml) was added and incubated at 37°C for 1 hour. Cells were 
then centrifuged for 30 seconds at 16060 xg in a bench-top centrifuge. The pellet was 
resuspended in a small volume of LB (~100 µl) and spread on a LB agar plate with the 
correct antibiotic. 
 
2.3.8 Production of electrically competent cells 
 
LB (100 ml) was inoculated with an overnight culture (1%) and grown at 37°C with 
shaking (250 rpm) until the OD600 reached 0.6. Cells were pelleted at 4°C (4500 xg for 
15 minutes) and washed three times in sterile ice-cold water. The cell pellet was then 
resuspended in 300 µl of 10% (v/v) glycerol, and stored as 50 µl aliquots at -70°C. 
 
2.3.9 Transformation of electrically competent cells 
 
Plasmid DNA (up to 1 µg) was added directly to 50 µl aliquots of electrically competent 
cells. The mixtures were kept on ice for 30 minutes and then transformed by 
electroporation using a Hybaid Cell Shock unit (1800 V, 1 mm path length) and a 
chilled cuvette. LB (1 ml) was added and the cells were incubated at 37°C for 1 hour. 
Cells were plated onto LB agar containing the correct antibiotic. 
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2.4 Nucleic acid methods 
 
2.4.1 Storage 
 
Purified plasmids and genomic DNA were stored in either Qiagen EB buffer (10 mM 
Tris-HCl, pH 8.5) or deionised water at -20°C. 
 
2.4.2 Measurement of DNA concentration 
 
DNA concentration was measured using the double stranded DNA programme on an 
Eppendorf Biophotometer with dH2O as a blank. 
 
2.4.3 Plasmid purification 
 
Plasmid DNA was typically purified from 5 ml overnight cultures of E. coli using the 
Qiagen QIAprep
® Spin Miniprep kit, in accordance with the manufacturer’s 
instructions. 
 
2.4.4 Digestion of DNA with restriction endonucleases 
 
Restriction enzymes were used in conjunction with the appropriate 10X buffer in 
accordance with manufacturer’s instructions. Digests were usually performed in 
10-100 µl reaction volumes containing DNA and the enzyme(s) at 1:10 of the reaction 
volume. Reactions were incubated at 37°C usually for 2 hours. The desired DNA 
fragments were purified by PCR purification (Section 2.4.9) and analysed by agarose 
gel electrophoresis (Section 2.4.5). 
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2.4.5 Agarose gel electrophoresis 
 
Agarose gel electrophoresis was used for visualising DNA fragments. Agarose 
(1% (w/v)) was added to 1X TAE buffer and dissolved by heating in a microwave oven. 
Once sufficiently cooled, GelRed™ solution, provided by Biotium, was added to the gel 
at a 1:10000 dilution before casting. Prior to loading, DNA samples were mixed with 
6X loading dye provided by Fermentas. A 1 kb ladder ‘Generuler™’ was used for size 
calibration supplied by MBI Fermentas. Gels were electrophoresed in 1X TAE buffer at 
100 V for 1 hour. DNA fragments were visualised using a UVItech photodocumentation 
system. 
 
50X TAE Buffer: 
Tris   242 g 
Glacial acetic acid 57.1 ml 
EDTA (0.5 M, pH 8) 100 ml 
dH2O to 1 litre 
 
2.4.6 Gel Extraction 
 
When required, specific DNA fragments were removed from agarose gels (Section 
2.4.5) and purified using the QIAquick
®
 Gel Extraction Kit from Qiagen according to 
the manufacturer’s instructions. 
 
2.4.7 Primer Design 
 
Primers were designed for site-directed mutagenesis (Section 2.4.10) and are listed in 
Table 2.3 below, with the altered bases indicated in red. They were between 30-45 base 
pairs in length with a GC content of >70% and ideally with a Tm of 75ºC. Primers 
were produced by Eurofins MWG Synthesis GmbH. 
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Table 2.3: Primers used for site-directed mutagenesis 
 
Primer Mutation Sequence Direction 
    
LS1 C9A GCCACAAGGCGGTCGCTCGTGA
CGAGGATCC 
Forward 
LS2 C9A GGATCCTCGTCACGAGCGACCG
CCTTGTGGC 
Reverse 
    
LS3 C37A GCGAAACTGGTCGCTAATCGGT
GCCCGGTC 
Forward 
LS4 C37A GACCGGGCACCGATTAGCGAC
CAGTTTCGC 
Reverse 
    
LS5 C40A GGTCTGTAATCGGGCCCCGGTC
ACCACAGAG 
Forward 
LS6 C40A CTCTGTGGTGACCGGGGCCCGA
TTACAGACC 
Reverse 
    
LS7 C46A GGTCACCACAGAGGCCCTCAGC
TGGGCACTG 
Forward 
LS8 C46A CAGTGCCCAGCTGAGGGCCTCT
GTGGTGACC 
Reverse 
    
LS9 P41S GGTCTGTAATCGGTGCTCGGTC
ACCACAGAG 
Forward 
LS10 P41S CTCTGTGGTGACCGAGCACCGA
TTACAGACC 
Reverse 
    
LS11 E45L GCCCGGTCACCACACTGTGCCT
CAGCTGGG 
Forward 
LS12 E45L CCCAGCTGAGGCACAGTGTGGT
GACCGGGC 
Reverse 
    
LS15 K72E GCGGCGCGCGCTGGAGCGTCG
CAACGCCCGC 
Forward 
LS16 K72E GCGGGCGTTGCGACGCTCCAGC
GCGCGCCGC 
Reverse 
    
LS17 R73E GCGGCGCGCGCTGAAGGAACG
CAACGCCCGC 
Forward 
LS18 R73E GCGGGCGTTGCGTTCCTTCAGC
GCGCGCCGC 
Reverse 
    
LS19 R74E GCGCGCTGAAGCGTGAAAACG
CCCGCACGAAAG 
Forward 
LS20 R74E CTTTCGTGCGGGCGTTTTCACG
CTTCAGCGCGC 
Reverse 
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LS23 R77E GAAGCGTCGCAACGCCGAAA
CGAAAGCCCG 
Forward 
LS24 R77E CGGGCTTTCGTTTCGGCGTTG
CGACGCTTC 
Reverse 
    
LS25 K79E GCAACGCCCGCACGGAAGCC
CGTACCGGG 
Forward 
LS26 K79E CCCGGTACGGGCTTCCGTGCG
GGCGTTGC 
Reverse 
    
LS27 R81E GCCCGCACGAAAGCCGAAAC
CGGGGTCTG 
Forward 
LS28 R81E CAGACCCCGGTTTCGGCTTTC
GTGCGGGC 
Reverse 
    
LS29 P41S/E45L GGTCTGTAATCGGTGCTCGGT
CACCACACTGTGCCTCAGCTG
GG 
Forward 
LS30 P41S/E45L CCCAGCTGAGGCACAGTGTG
GTGACCGAGCACCGATTACA
GACC 
Reverse 
    
LS31 S57E GAATACCGGCCAGGACGAGG
GCGTCTGGGG 
Forward 
LS32 S57E CCCCAGACGCCCTCGTCCTGG
CCGGTATTC 
Reverse 
    
LS33 G58E GGCCAGGACTCGGAGGTCTG
GGGAGGCATG 
Forward 
LS34 G58E CATGCCTCCCCAGACCTCCGA
GTCCTGGCC 
Reverse 
    
LS35 V59E GGCCAGGACTCGGGCGAGTG
GGGAGGCATG 
Forward 
LS36 V59E CATGCCTCCCCACTCGCCCGA
GTCCTGGCC 
Reverse 
    
LS37 W60E GGACTCGGGCGTCGAGGGAG
GCATGAGCGAAG 
Forward 
LS38 W60E CTTCGCTCATGCCTCCCTCGA
CGCCCGAGTCC 
Reverse 
    
LS39 G61E GGACTCGGGCGTCTGGGAAG
GCATGAGCGAAG 
Forward 
LS40 G61E CTTCGCTCATGCCTTCCCAGA
CGCCCGAGTCC 
Reverse 
    
LS41 G62E GGGCGTCTGGGGAGAGATGA
GCGAAGACGAG 
Forward 
LS42 G62E CTCGTCTTCGCTCATCTCTCCC
CAGACGCCC 
Reverse 
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LS43 D13A GTCTGTCGTGACGAGGCTCCG
GAACTGTTC 
Forward 
LS44 D13A GAACAGTTCCGGAGCCTCGTC
ACGACAGAC 
Reverse 
    
 
2.4.8 Polymerase Chain Reaction (PCR) 
 
Reactions for analytical PCR typically contained (unless stated otherwise): 
 
Plasmid DNA (~0.1  g/ l)    1 l 
Primer 1 (100 pmol/ l)    1 l 
Primer 2 (100 pmol/ l)    1 l 
Extensor PCR Master Mix 1 (Thermo Scientific) 25 l 
dH2O       22 l 
 
PCR was carried out using a Techne TC-3000 with the following typical reaction 
profile, unless stated otherwise. Samples were then run on agarose gel electrophoresis 
for analysis (Section 2.4.5) or purified (Section 2.4.9). 
 
Initial denaturation 95ºC – 5 minutes 
Denaturation  95ºC – 30 seconds 
Annealing  50ºC – 30 seconds  25 Cycles 
Extension  72ºC – 1 minutes 
Final extension 72ºC – 5 minutes 
 
2.4.9 DNA purification 
 
DNA was typically purified using the Qiagen QIAquick
® 
Purification kit, in accordance 
with the manufacturer’s instructions. 
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2.4.10 Site-Directed Mutagenesis (SDM) 
 
SDM was carried out using QuikChange® II XL Site-Directed Mutagenesis Kit from 
Stratagene. The manufacturer’s instructions were followed. 
 
2.5 Protein Methods 
 
2.5.1 Measurement of protein concentration 
 
Protein concentration was typically calculated using the Bio-Rad reagent (Bradford, 
1976). A protein assay standard curve for a 5 ml reaction volume was used. Absorbance 
was measured at 595 nm using a Unicam HEλIOS spectrophotometer. 
 
2.5.2 Denaturing gel electrophoresis (SDS-PAGE) 
 
SDS-PAGE was performed as described by (Laemmli, 1970). Analysis was completed 
using 15% (w/v) resolving gel, and 5% (w/v) stacking gel as detailed below. 
 
15% Resolving gel (ml): 5% Stacking gel (ml): 
30% (w/v) Acrylamide 3.8    1.7 
3 M Tris-HCl (pH 8.3) 0.95    - 
0.5 M Tris-HCl (pH 6.8) -    1.25 
dH2O    2.7    6.95 
10% (w/v) SDS  0.075    0.1 
10% (w/v) APS  0.1    0.1 
TEMED   0.02    0.02 
 
The glass plates and spacers were set up in the clamps ready for pouring the gel. The 
resolving gel was poured, leaving space for the stacking gel to be added on top. Water-
saturated butanol was applied to the top of the gel. Once the gel had set, the butanol was 
rinsed off with dH2O. The stacking gel was then poured and a comb inserted to form the 
wells. The comb was removed once the gel had set. The gel, sandwiched between the 
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glass casting plates, was placed in the tank with 1X SDS running buffer. Samples were 
mixed with loading buffer at a 1:1 ratio and boiled for 10 minutes at 95°C before 
loading. 
 
Protein size markers (Precision Plus Protein™ Standards from Bio-Rad) were also 
loaded to allow determination of molecular weight. Electrophoresis was carried out at 
200 V for 45 minutes, until the dye front reached the base of the gel. 
 
2X SDS loading buffer:    1X SDS running buffer: 
Glycerol   20% (v/v)  Tris  3 g 
Tris-HCl (0.5 M pH 6.8) 100 mM  SDS  1 g 
SDS    4% (v/v)  Glycine 14.4 g 
Bromophenol blue  0.02% (v/v)  dH2O to 1 litre 
2-Mercaptoethanol  200 mM   
 
After electrophoresis, the gel was removed from its glass plate and immersed in 
Coomasie Blue stain for 30 minutes followed by destain overnight. 
 
     Coomassie Blue stain: Destain: 
Coomassie Brilliant Blue (R250) 1.15 g/l   - 
Methanol    400 ml    400 ml 
Acetic acid    100 ml    100 ml 
dH2O to 1 litre 
 
2.5.3 Overproduction of WhiB1 and Rv1675c 
 
WhiB1 and Rv1675c were typically overproduced by culturing the host strain in a 
2 litre flask containing 500 ml of LB and kanamycin, inoculated at 1:100 from an 
overnight culture. The culture was grown aerobically at 37°C with shaking (250 rpm) 
until an OD600 of 0.6-0.9 was reached. IPTG was added to a final concentration of 
120 µg/ml. Cultures were then grown at 25°C with shaking (250 rpm), post induction, 
for 2 hours. Cells were then pelleted by centrifugation at 11900 xg for 30 minutes at 
4°C. Pellets were either frozen overnight at -20°C or used immediately to produce cell-
free extracts (Section 2.5.4). 
45 
 
2.5.4 Production of cell-free extracts 
 
Cell pellets were typically resuspended in 10 ml of binding buffer A (Section 2.5.5). 
Resuspended cells were lysed by two passages through a French pressure cell at 
16000 psi. The soluble and insoluble fractions were separated by centrifugation at 
39190 xg for 15 minutes at 4°C. The soluble fraction was used immediately for 
purification of proteins. 
 
2.5.5 Purification of recombinant WhiB1 and Rv1675c by affinity 
chromatography 
 
WhiB1 and Rv1675c were purified using the engineered histidine tag. Purification used 
the soluble fractions after the French press step. Purification was carried out using the 
His-tag purification programme on the AKTA™ prime machine (GE Healthcare), and 
either a 1 or 5 ml HiTrap™ chelating column (GE Healthcare). The appropriate reagents 
were prepared and the machine was configured according to the manufacturer’s 
instructions. The cell-free extracts (10 ml for the 1 ml column or 20 ml for the 5 ml 
column) were injected and the fractions (1 ml) eluting from the column were collected. 
The fractions which corresponded to the second absorption peak (280 nm) after addition 
of the elution buffer were collected and samples were separated by SDS-PAGE to locate 
the target protein. Fractions were stored at -20°C, with 1 mM DTT for WhiB1, until 
required. 
 
Binding buffer A (pH 7.4):   Elution buffer A (pH 7.4): 
Sodium phosphate 20 mM  Sodium phosphate 20 mM 
NaCl   0.5 M   NaCl   0.5 M 
      Imidazole  0.5 M 
dH2O to 1 litre    dH2O to 1 litre 
 
Ni-Loading eluent: 
NiSO4   100 mM 
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2.5.6 Refolding 
 
Protein refolding was necessary for WhiB1 mutant proteins which were in the insoluble 
pellet after preparation of cell-free extracts. This was achieved using the refolding 
programme on the AKTA™ prime machine and a 1 ml HiTrap™ chelating column. The 
appropriate reagents were prepared and the machine was configured according to the 
manufacturer’s instructions. The insoluble pellet was resuspended in 10 ml binding 
buffer B (recipe below) and agitated at 4˚C overnight to solubilise the proteins. The 
sample was then centrifuged at 39190 xg for 15 minutes at 4°C to separate soluble and 
insoluble fractions. The soluble sample was then applied to the column and the fractions 
(1 ml) collected. The fractions which corresponded to the absorption peak (280 nm) 
after addition of the elution buffer were collected and samples separated on SDS-PAGE 
to locate the protein. Fractions were stored at -20°C with 1 mM DTT until required. 
 
Binding buffer B (pH 8):   Solubilisation buffer (pH 8): 
Guanidine hydrochloride 6 M  Urea    6 M 
Tris-HCl   20 mM Tris-HCl   20 mM 
NaCl    0.5 M  NaCl    0.5 M 
Imidazole   5 mM  Imidazole   5 mM 
2-Mercaptoethanol  1 mM  2-Mercaptoethanol  1 mM 
dH2O to 1 litre    dH2O to 1 litre 
 
Elution buffer B (pH 8):   Refolding buffer (pH 8): 
Tris-HCl   20 mM Tris-HCl   20 mM 
NaCl    0.5 M  NaCl    0.5 M 
Imidazole   0.5 M  Imidazole   5 mM 
2-Mercaptoethanol  1 mM  2-Mercaptoethanol  1 mM 
dH2O to 1 litre    dH2O to 1 litre 
 
Ni-Loading eluent: 
NiSO4    100 mM 
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2.5.7 Transfer of proteins onto Immuno-Blot
TM
 PVDF membrane 
 
Proteins were first separated using SDS-PAGE (Section 2.5.2), before blotting onto the 
Immuno-Blot
TM
 PVDF membrane (BioRad). The membrane was soaked in methanol 
for a few seconds and then transferred to electroblotting buffer (10 mM CAPS in 
10% (v/v) methanol; pH 11). The gel was removed from the electrophoresis cell and 
soaked in electroblotting buffer for 5 minutes. The transblotting sandwich was 
assembled and electroblotted at 50 V for 30 minutes at room temperature, using a 
BioRad Mini Trans-Blot Electrophoretic Transfer Cell. 
 
2.5.8 N-Terminal sequencing 
 
The Immuno-Blot
TM
 PVDF membrane was removed from the transblotting sandwich 
(Section 2.5.7) and briefly rinsed with dH2O. It was then submerged in 100% methanol 
for a few seconds prior to staining with Coomassie brilliant blue R250 (0.1% (w/v) in 
40% (v/v) methanol and 1% (v/v) acetic acid) for 1 minute. The membrane was then 
destained in 50% (v/v) methanol and extensively rinsed in dH2O before being allowed 
to dry at room temperature. The polypeptides of interest were excised from the 
membrane and sequences were determined by Dr A. J. G. Moir (Krebs sequencing and 
synthesis facility) using the Applied Biosystems protein sequencer.  
 
2.5.9 Total amino acid analysis 
 
Amino acid analysis was carried out by Alta Bioscience (University of Birmingham, 
UK) by complete acid hydrolysis for 24 h at 110ºC of aliquots of WhiB1 that had been 
previously assayed for protein concentration (Section 2.5.1). 
 
2.5.10 Estimation of molecular mass by gel filtration 
 
A calibrated Shodex KW805 column, equilibrated with 50 mM sodium phosphate 
buffer (pH 6.0) containing 150 mM NaCl was used. Both apo- and holo-WhiB1 samples 
(50 μM) were prepared and purified using heparin chromatography, eluted into 20 mM 
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sodium phosphate buffer, pH 7.4 with 0.5 M NaCl, and treated with the indicated 
reagents. Samples were compared to a standard curve using proteins of known 
molecular mass. 
 
2.5.11 Estimation of reactive sulphydryl groups 
 
The method described by Thelander (1973) was used. The reaction was performed in a 
1 ml volume containing 700 l 0.1 M Tris-HCl and 0.01 M EDTA (pH 7.6) and 200 l 
of a solution containing 0.2 ml 0.4% 5,5’-dithiobis(2-nitrobenzoic acid) (DTNB) in 
ethanol and 1.8 ml of 1 M Tris-HCl (pH 8). WhiB1 (50 g) in 100 l of 25 mM Tris-
HCl, pH 7.4 was added and the absorbance measured at 412 nm immediately. Protein 
samples were treated with 1% SDS where indicated. Buffer (25 mM Tris-HCl, pH 7.4) 
was used as the control. The reactive sulphydryl groups were then determined using the 
following formula. 
 
A = E412c1 A = Absorbance at 412 nm 
  E = Molar coefficient of NTB: 13,600 M
-1
cm
-1
 
  c = Concentration of NTB (M) 
  1 = Path length (cm) 
 
Reactive sulphydryl groups =  Concentration of NTB (M) 
     Concentration of WhiB1 (M) 
 
2.5.12 Protein disulphide reductase activity assay 
 
The protein disulphide reductase activity of WhiB1 was determined using the assay first 
described by Holmgren (1979). The assay relies on the ability of protein disulphide 
reductases to reduce the disulphide bonds that covalently hold the two chains of insulin 
together in a DTT-mediated manner. Release of the insoluble β-chain of insulin can be 
measured at 600 nm. 
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Insulin was prepared to a final concentration of 1.3 mM by the addition of 50 mM Tris-
HCl (pH 8), adjusting the pH to 2-3 with 1 M HCl and then rapidly titrating back to 
pH 8. Aliquots were stored at -20°C until required.  
 
The assay was carried out with varying concentrations of WhiB1 (apo-, holo- and NO-
treated), or E. coli thioredoxin as a bone fide general protein disulphide reductase. 
Reactions were completed in 100 µl reaction volumes, in quadruplet in 50 mM Tris 
(pH 8) with 1 mM DTT and 100 mM NaCl. The 96 well plates containing the reactions 
and the insulin were pre-incubated separately for 1 hour at 25°C prior to addition of the 
insulin. Precipitation was monitored at OD600 using a plate reader maintained at 25°C, 
every 30 seconds for 115 minutes. 
 
Enzyme activity was calculated by dividing the slope of the linear phase of the curve by 
the time required to reach the onset of precipitation (defined as an increase in 
absorbance ≥ 0.05).  
 
2.6 Iron-sulphur cluster methods 
 
2.6.1 Reconstitution of the iron-sulphur cluster of WhiB1 
 
Purified WhiB1 (Section 2.5.5) was used for iron-sulphur cluster reconstitution. 
Reconstitution was carried out in a MK3 anaerobic workstation from Don Whitley 
Scientific Limited using anaerobic buffers and all solutions were allowed to become 
anaerobic before use. The typical reaction composition is listed below. 
 
Purified WhiB1 (~50-600 µM)    1000 µl 
Tris-HCl buffer (25 mM, pH 7.4)    1000 µl 
Solution 1 (2.5 mM DTT and 1 mM L-cysteine)  20 µl  
Solution 2 (100 mM ammonium ferrous sulphate)  10X Protein concentration  
NifS (22.5 µM)      20 µl 
 
50 
 
Reactions were typically left to reconstitute in the cabinet overnight. Reconstituted 
WhiB1 was then cleaned-up to remove any non-integrated iron as detailed in Section 
2.6.2. 
 
2.6.2 Clean-up of reconstituted protein 
 
Reconstituted WhiB1 was cleaned-up using either a 1 ml or 5 ml HiTrap™ heparin HP 
column. The reconstituted protein sample was loaded onto the column, washed with the 
anaerobic Tris buffer (25 mM, pH 7.4) and eluted with Tris buffer (25 mM, pH 7.4) 
containing 0.5 M NaCl into clean tubes. 
 
2.6.3 Preparation of Proli NONOate 
 
Proli NONOate (Cayman Chemicals or Alexis Biochemicals) was regularly used as a 
NO donor for sensitivity experiments. It was dissolved in 1 M NaOH and stored in 50 µl 
aliquots at a concentration of 22.8 mM at -20°C until required (unless otherwise stated). 
 
2.6.4 Scanning spectroscopy 
 
A Cary 50 Bio UV Vis Spectrophotometer was used. Protein samples were typically 
scanned in a Hellma
®
 10 mm cuvette, made of either special optical glass or quartz with 
a screw-cap lid to maintain anaerobic conditions. A baseline was created using the 
appropriate buffers, depending on the protein sample to be scanned. The absorption 
spectrum of the protein was obtained by scanning between wavelengths 200-800 nm. 
Stress reagents were added by injection into the cuvette through the Hellma
®
 silicone 
seal in the lid with a Hamilton syringe. 
 
2.6.5 Kinetic spectroscopy 
 
Rapid rate kinetics was carried out at the University of East Anglia with Dr Jason Crack 
as described in Crack et al. (2011). The reaction of WhiB1 with NO was measured 
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using a Bio-sequential DX.17 MV UV-Vis Stopped-flow spectrometer with a 1 cm path 
length (Applied Photophysics). Absorption changes were detected with a 
photomultiplier set at a single wavelength. Reactions were carried out in 25 mM Tris, 
0.5 M NaCl, 10 % (v/v) glycerol (pH 7.4), using gas-tight syringes (Hamilton). The 
stopped-flow system was flushed with anaerobic buffer prior to use. All solutions used 
for stopped-flow experiments were stored and manipulated inside an anaerobic cabinet 
(Belle Tech). The Proli NONOate used for NO generation was stored in 25 mM NaOH 
and quantified optically (ε252 nm 8400 M/cm). An aliquot was combined with the assay 
buffer and allowed to decompose in a gastight syringe to achieve the desired 
concentration. The change in absorbance at 364 nm and 420 nm was measured at 24°C 
as a function of time. Absorbance data were fitted using Origin (Microcal) and Dynafit 
to the exponential function y=y0 + (ymax-y0) (1-e
[-kobs. x]
), where y = absorbance at any 
given time, y0 = initial absorbance, ymax = maximum absorbance, and kobs = the observed 
rate constant. 
 
2.6.6 Electron paramagnetic resonance spectroscopy 
 
Electron paramagnetic spectroscopy (EPR) was carried out by Dr Jason Crack at the 
University of East Anglia on samples prepared in Sheffield, as described in Smith et al. 
(2010). WhiB1 samples (17 µM) were prepared in 25 mM Tris buffer (pH 7.4) 
containing 1 mM DTT. Where indicated, a 27-fold molar excess of Proli NONOate was 
added. Samples were transferred to EPR tubes and frozen in liquid nitrogen before 
analysis. EPR spectra were recorded with a Bruker EMX spectrometer equipped with a 
TE-102 microwave cavity and an ESR-900 helium flow cryostat (Oxford Instruments). 
Spectra were recorded at both 20 K and 77 K. The microwave power was 2 mW with a 
frequency of 9.68 GHz, and the field modulation amplitude was 1 mT. Spectra were 
normalised to the same receiver gain. Spin intensities of paramagnetic samples were 
estimated by double integration of EPR spectra using 1 mM Cu(II) and 10 mM EDTA 
as the standard (Smith et al., 2010). 
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2.6.7 Circular Dichroism (CD) Spectroscopy 
 
Circular dichroism (CD) spectroscopy was carried out at the University of East Anglia 
with Dr Jason Crack. CD measurements were made using a Jasco J810 
spectropolarimeter and holo-WhiB1 (196 µM) in 20 mM sodium phosphate buffer 
(pH 7.4). 
 
2.6.8 Iron assay 
 
Protein samples post iron-sulphur reconstitution and clean-up using heparin 
chromatography (Section 2.6.2) were boiled in 1% (w/v) trichloroacetic acid (TCA) and 
dH2O for 5 minutes. Samples were then centrifuged at 16060 xg in a bench-top 
centrifuge for 1 minute and the supernatant retained. The supernatant was then used in 
the following reaction: 
 
Sample and dH2O     480 µl 
Saturated sodium acetate    400 µl 
10% (w/v) Bathophenanthroline sulphonic acid 30 µl 
20% (w/v) Fresh sodium ascorbate   90 µl 
 
Once the sample had turned red after the addition of sodium ascorbate, the samples 
were centrifuged for 15 minutes and the absorbance measured at 535 nm and compared 
to a standard curve prepared with an iron standard solution (BDH) at 18 mM. The 
number of moles of iron in the sample was then calculated. 
 
2.7 DNA-Protein Interactions 
 
2.7.1 Radiolabelling of DNA 
 
DNA fragments from PCR amplification (Section 2.4.8) were digested with the relevant 
restriction endonucleases (Section 2.4.4). The reaction mix was then purified (Section 
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2.4.9) and the DNA concentration measured (Section 2.4.2). A typical labelling reaction 
is detailed below and reactions were left for 1-2 hours at room temperature to complete. 
 
DNA    150-600 ng 
dNTPs (if required) 2.5 mM 
Klenow buffer  1X 
Klenow enzyme 1 μl (10 units) 
[α-32P]dNTP  1 μl (10 mCi/ml) 
dH2O to 30 μl 
 
Reactions were purified (Section 2.4.9) and the labelled DNA was eluted into EB buffer 
and stored at –20˚C until required. Variations in purification methods are stated where 
differences occurred. 
 
2.7.2 Phenol extraction and ethanol precipitation 
 
Phenol extraction was used to remove protein contaminants from DNA samples. An 
equal volume of phenol (pH 7-8) was added to samples, mixed thoroughly then 
centrifuged to separate the aqueous and phenolic phases. The aqueous phase was 
recovered and used for ethanol precipitation. 
 
Sodium acetate (0.1 volume; 3 M, pH 5.2) was added to the DNA sample, followed by 
glycogen (1 µl; 20 mg/ml) and 2 volumes of 100% ethanol at -20°C. This was then 
centrifuged at 16060 xg for 30 minutes at 4°C. The supernatant was carefully removed 
and the resulting pellet washed with 70% ethanol before further centrifugation for 10 
minutes. The supernatant was again removed and the pellet dried under vacuum in a 
Hetovac for ~30 minutes. The DNA was then resuspended as required.  
 
2.7.3 Electromobility shift assays 
 
Electromobility shift assays (EMSAs) were carried out with WhiB1 and Rv1675c. DNA 
fragments to be examined were restriction digested and radiolabelled (Sections 2.4.4 
and 2.7.1). Labelled fragments (~3 ng) were incubated with varying concentrations of 
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the DNA-binding protein for 10 minutes on ice (WhiB1) or 10 minutes at room 
temperature (Rv1675c) in a total reaction volume of 10 µl. Reactions also contained 
100 mM NaCl, 40 mM Tris (pH 8), 10 mM MgCl2, 0.1 mM EDTA, 1 mM DTT, 0.25 
mg/ml BSA, and ~1 µg calf thymus DNA. Reactions with WhiB1 also contained a 
further 1 mM EDTA. 
 
Loading buffer (2 µl of 50% glycerol, bromophenol blue) was added to the samples 
immediately prior to loading onto a 6% polyacrylamide gel. EMSAs for WhiB1 were 
carried out using TBE gels and 0.5X TBE running buffer. EMSAs for Rv1675c were 
carried out using Tris-glycine gels with corresponding running buffer. Electrophoresis 
was at 30 mA for ~30 minutes. Gels were dried and visualised by autoradiography 
(Section 2.7.6). 
 
6% TBE gel     6% Tris gel 
30% (w/v) Acrylamide 1.5 ml  30% (w/v) Acrylamide 1.5 ml 
10X TBE buffer  0.375 ml 3 M Tris (pH 8.3)  0.95 ml 
dH2O    5.625 ml dH2O    5 ml 
10% (w/v) APS  75 µl  10% (w/v) APS  75 µl 
TEMED   7.5 µl  TEMED   7.5 µl 
 
10X TBE     Running Buffer 
Tris   108 g   Tris  3 g 
Boric acid  55 g   Glycine 14.4 g 
0.5 M EDTA (pH 8) 40 ml   dH2O to 1 litre 
dH2O to 1 litre 
 
2.7.4 DNaseI Footprinting 
 
The promoter DNA fragments of interest were restriction digested and one strand was  
labelled (Section 2.7.1). DNA was purified using phenol extraction and ethanol 
precipitation (Section 2.7.2). Approximately ~50 ng of DNA and 5-20 µM apo-WhiB1 
were incubated in the presence of 40 mM Tris (pH 8), 75 mM KCl, 10 mM MgCl2, 
0.5 mM EDTA, 5 % (v/v) glycerol, 1 mM DTT and 250 µg/ml BSA.  
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Complexes were then digested with one unit of DNaseI for 7-60 seconds at 25°C. 
Reactions were stopped with 50 mM EDTA (pH 8), followed by phenol extraction and 
the DNA was ethanol precipitated (Section 2.7.2). The resulting DNA pellet was 
resuspended in 10 µl footprinting loading buffer and heated to 90°C for 30 seconds 
prior to electrophoretic fractionation on a polyacrylamide-urea gel in 1X TBE running 
buffer. Electrophoresis was carried out at 50 W for 2 hours before drying and 
visualisation using autoradiography (Section 2.7.6). 
 
Polyacrylamide-urea gel 
Gel solution (6% acrylamide, 7M urea, 1X TBE; Severn Biotech Limited)  60 ml 
10% (w/v) APS         600 µl  
TEMED           60 µl  
 
Footprinting Loading Dye 
Formamide   80% (v/v) 
SDS    0.1% (w/v) 
Glycerol   10% (v/v) 
EDTA (pH 8)   8 mM 
Bromophenol blue  0.1% (w/v) 
Xylene cyanol  0.1% (w/v) 
 
2.7.5 DMS methylation 
 
Dimethylsulphate (DMS) methylation was used to prepare Maxam and Gilbert G tracks 
of DNA fragments, to provide a calibration for DNase I footprints (Maxam and Gilbert, 
1980). Approximately ~50 ng radiolabelled DNA was incubated with 0.2% (v/v) fresh 
DMS (from BDH) at 25°C for 2-10 minutes. The reaction was stopped by adding 0.5 
volume of DMS stop solution, followed by ethanol precipitation (Section 2.7.2) and 
then dried under vacuum. The resulting pellet was resuspended in 20 µl piperidine-
EDTA and incubated at 90°C for 30 minutes. The sample was dried under vacuum and 
the resulting pellets resuspended in 10 µl footprinting loading buffer and heated to 90°C 
for 30 seconds before loading onto the gel (Section 2.7.4). 
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DMS Stop Solution     Piperidine-EDTA 
Sodium acetate (pH 7)  1.5 M   Piperidine (BDH)  10 % (v/v) 
EDTA (pH 8)   15 mM  EDTA (pH 8)   10 mM 
Calf thymus DNA  100 µg/ml 
2-Mercaptoethanol  1 M 
 
2.7.6 Autoradiography 
 
After electrophoresis, EMSA and footprinting gels were transferred to Whatman
®
 3MM 
filter paper and dried at 80°C under vacuum. The dried gels were then exposed to 
Kodak medical X-ray film at -70°C. After the required exposure time, the 
autoradiographs were developed in Kodak Industrex developer (~2 minutes), fixed in 
Kodak Industrex fixer (~2 minutes) and washed in water before air-drying. 
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3.0 Isolation, biochemical and biophysical characterisation of 
WhiB1 
 
3.1 Introduction 
 
Members of the Wbl family of proteins, with few exceptions, are small proteins varying 
in length from 81-122 amino acids residues (den Hengst and Buttner, 2009). They have 
four highly conserved cysteine residues with a central CXXC motif which suggests that 
they act as ligands for a metal cofactor, and indeed a number of members of the Wbl 
family have been shown to bind iron-sulphur clusters (Alam et al., 2007; 2009; 
Jakimowicz et al., 2005; Rybniker et al., 2010; Singh et al., 2007; Smith et al., 2010). 
The seven Wbl proteins from Mycobacterium tuberculosis were shown to bind [2Fe-2S] 
clusters when aerobically expressed and purified, but following anaerobic reconstitution 
bound [4Fe-4S] clusters (Alam et al., 2009). Similar observations were made for WhiD 
from Streptomyces coelicolor (Jakimowicz et al., 2005). This chapter aims to 
characterise WhiB1 from M. tuberculosis and understand the nature of its iron-sulphur 
cluster.  
 
3.2 Overproduction and purification of WhiB1 
 
3.2.1 Optimisation of WhiB1 overproduction 
 
Electrically competent Escherichia coli BL21 λ(DE3) cells were transformed with 
pGS2164, encoding recombinant His-WhiB1. 
 
Trials to discover the best conditions for overproduction of His-WhiB1 were completed 
in 10 ml cultures. To first determine the optimum time for induction, 100 µl of an 
overnight culture was added to a 10 ml volume of LB containing kanamycin. The 
culture was grown at 37°C with shaking (250 rpm) until an OD600 of ~0.8 was reached. 
IPTG was added to a final concentration of 30 µg/ml and the culture was incubated at 
37°C with shaking. Whole cell samples were taken before induction and at 60, 90, 120, 
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150, 180 and 210 minutes post induction for analysis by SDS-PAGE as described in 
section 2.5.2 (Figure 3.1A). There was an obvious polypeptide at ~13 kDa in all post-
induction fractions, corresponding to His-WhiB1 (12.876 kDa). There was little 
difference in the relative abundance of His-WhiB1 as judged by SDS-PAGE, and a 
2 hour induction period was chosen as it offered a good level of overproduction. 
Secondly, the ideal concentration of IPTG to use was determined. Growth was carried 
out as above and cultures were then induced with 30, 60, 120, 240 and 480 µg/ml of 
IPTG for 2 hours. Whole cell samples were taken for SDS-PAGE analysis (Figure 
3.1B). The final concentration of 120 µg/ml of IPTG was chosen as it offered good 
overproduction, but all IPTG concentrations were effective. The use of different 
induction temperatures was the final condition tested in optimising His-WhiB1 
overproduction. Growth was again carried out as described above and cultures were 
then induced with 120 µg/ml IPTG and moved to 25, 30 or 37°C for 2 hours. Whole cell 
samples were taken and analysed using SDS-PAGE (Figure 3.1C). There was good 
overproduction of WhiB1 at 25°C, which was chosen as it was hoped that the lower 
temperature would assist protein folding and solubility. 
 
Upon finding the optimum overproduction conditions (induction with 120 µg/ml IPTG 
for 2 hours at 25 °C), WhiB1 was purified by affinity chromatography. 
 
3.2.2 Purification of His-WhiB1 
 
Cell pellets from the overproduction of WhiB1 (1-5 litres of culture) (Section 2.5.3) 
were resuspended in binding buffer (10 ml) and lysed in a French pressure cell 
according to the method detailed in Section 2.5.4. Figure 3.2B shows an SDS-PAGE gel 
with a clear species corresponding to His-WhiB1 at ~13 kDa in the whole cell pellet 
(lane 2) as well as in the soluble (lane 3) and insoluble (lane 4) fractions after lysis. It 
was judged that there was sufficient WhiB1 in the soluble fraction, which was therefore 
subsequently used for affinity purification as described in Section 2.5.5. Figure 3.2A 
shows the elution profile from the HiTrap chelating column. Proteins containing high 
levels of histidine and the protein of interest only, should bind to the column. Once the 
elution buffer was applied, the imidazole competes with the His-tag for the nickel 
column and the bound proteins are released. The first peak after the imidazole gradient 
usually corresponds to proteins with high histidine content, and the second peak is the  
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Figure 3.1: Optimisation of overexpression of recombinant WhiB1 in BL21 
λ(DE3). (A) Comparison of different induction times. Lane 1, Precision plus protein 
standards (molecular weights indicated in kDa); Lane 2, Whole cell extract before IPTG 
induction; Lanes 3-8, Cell extracts with 30 g/ml IPTG induction for 60, 90, 120, 150, 
180 or 210 minutes. (B) Comparison of different IPTG concentrations. Lane 1, 
Precision plus protein standards (molecular weights indicated in kDa); Lane 2, Whole 
cell extract before IPTG induction; Lanes 3-7, Cell extracts after 2 hours induction with 
30, 60, 120, 240 or 480 g/ml IPTG. (C) Comparison of different induction 
temperatures. Lane 1, Precision plus protein standards (molecular weights indicated in 
kDa); Lane 2, Whole cell extract before IPTG induction; Lanes 3-5, Whole cell extracts 
after 120 g/ml IPTG induction for 2 hours at 25, 30 and 37 C. The location of the 
WhiB1 polypeptide is indicated. 
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Figure 3.2: (A) Elution profile from HiTrap chelating chromatography of cell-free 
extract containing His-WhiB1. Supernatant (20 ml) was applied to a Hi-Trap chelating 
column (5 ml) and fractionated with a linear gradient of imidazole (0-0.5 M). The traces 
show protein (A280: blue line) and imidazole gradient (red line). The expected location 
of the WhiB1 is indicated (Peaks 1 and 2). (B) Histidine-tagged purification of His-
WhiB1. Coomassie Blue-stained SDS-PAGE gel: Lane 1, Precision plus protein 
standards (molecular weights indicated in kDa); Lane 2, Cell extract after induction 
(120 g/ml IPTG for 2 hours at 25 C); Lane 3, Cell pellet after clarification of French 
pressure cell extract; Lane 4, Cell-free extract after clarification of French pressure cell 
extract. Lanes 5-11, Fractions collected after application of the imidazole gradient 
corresponding to the peak indicated in Figure 3.2A. 
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protein of interest. These peaks were clearly visible on the elution profile and the 
fractions corresponding to the second peak were analysed by SDS-PAGE. This 
confirmed the presence of WhiB1 at ~13 kDa (Figure 3.2B). The purification shown in 
Figure 3.2 was completed using a 5 ml nickel affinity column. This provided a very 
good level of WhiB1 from the soluble fraction (~20 mg from 5 litres of culture). The 
conditions described in Section 3.2.1 for overproduction, and this method of 
purification, have thus provided a successful way of purifying WhiB1 using the 
engineered histidine tag. 
 
3.2.3 Amino acid analysis 
 
To determine the concentration of purified WhiB1, the Bradford assay was used as 
described in Section 2.5.1 (Bradford, 1976). This assay can overestimate or 
underestimate the concentration of some proteins, which can have downstream effects 
on analytical experiments for which an accurate measure of WhiB1 concentration is 
important. Amino acid analysis gives a much more accurate measure of the protein 
concentration and can provide a correction factor which can be applied to all Bradford 
assay results for future experiments. Samples of WhiB1 were used in a Bradford assay 
to determine the protein concentration. They were then sent to Alta Bioscience for total 
amino acid analysis. Results showed that the Bradford assay was overestimating WhiB1 
concentration and a correction factor of 0.86 was calculated and applied to protein 
concentration determination throughout the project. Furthermore this analysis confirmed 
the integrity of the WhiB1 protein, yielding the expected relative amounts of each 
amino acid. 
 
3.3 Characterisation of the iron-sulphur cluster of WhiB1 
 
3.3.1 Reconstitution of the cluster 
 
Purification of large quantities of His-WhiB1 yielded some protein fractions which were 
colourless, some red-brown in colour and a high proportion which were straw-yellow in 
colour, indicating the possible presence of iron-sulphur clusters. Colour was lost upon 
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prolonged exposure to air. Figure 3.3 shows the UV-visible spectroscopic analysis 
(Section 2.6.4) of two coloured fractions from the purification depicted in Figure 3.2. 
The fractions corresponding to Peak 1 were straw-yellow in colour and those from Peak 
2 were red-brown. These observations, along with the spectroscopy indicate the 
presence of a [4Fe-4S] cluster for Peak 1 (strong feature at 420 nm) and a [2Fe-2S] 
cluster for Peak 2 (shoulders at 420, 460 and 550 nm) (Reviewed in Orme-Johnson, 
1973; Sweeney, 1980). To fully determine whether WhiB1 could incorporate an iron-
sulphur cluster and what form it took, reconstitution reactions were carried out (Section 
2.6.1). The concentration of the protein sample was measured and then moved to an 
anaerobic cabinet, where it was incubated with a source of iron, sulphur and the enzyme 
NifS. All samples were allowed to become anaerobic before setting up the reaction. As 
it proceeded, the reaction turned straw-yellow in colour which suggests the 
incorporation of a [4Fe-4S] cluster. To confirm this observation, spectroscopy was 
carried out as described in the following sections. 
 
3.3.2 Purification of holo-WhiB1 using heparin 
 
Heparin has a very high negative charge and can be used in the purification of 
DNA-binding proteins. As WhiB1 is a predicted transcription factor, it was hoped that 
using a HiTrap Heparin HP column (GE healthcare) would help purify the holo-WhiB1 
from unincorporated components after the reconstitution reaction. Figure 3.4 shows the 
purification of apo-WhiB1 using heparin. A 1 ml fraction was diluted 1 in 2 with 
25 mM Tris buffer (pH 7.4) to reduce the salt concentration (0.5 to 0.25 M). The diluted 
fraction was loaded onto the heparin column which was then washed with 25 mM Tris 
(pH 7.4) to remove any unbound contaminants. WhiB1 was eluted by application of 
25 mM Tris buffer (pH 7.4) containing 0.5 M salt. Fractions (1 ml) were collected 
throughout the procedure. Samples were analysed using the Bradford assay and 
SDS-PAGE. Figure 3.3 shows that the protein bound to the column and was eluted by 
the increased salt concentration. The low molecular weight species below WhiB1 
(~13 kDa) did not bind to the column. In this example 1.44 mg of apo-WhiB1 was 
applied to the heparin column (2 ml of sample shown in Figure 3.4, lane 3). This 
yielded 1.2 mg apo-WhiB1 in a 1 ml fraction after elution with the high salt buffer 
(Figure 3.4, lane 10), equivalent to a yield of 83%. Therefore, heparin chromatography 
offers a convenient method of concentrating the WhiB1 protein.  
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Figure 3.3: UV-visible Spectroscopy of WhiB1 fractions after His-tagged 
purification. Fractions corresponding to the WhiB1 main peak (Peak 1) and the 
shoulder (Peak 2) seen in Figure 3.2A were analysed using UV-Visible spectroscopy. 
There is a peak at 420 nm for Peak 1, indicative of a [4Fe-4S] cluster. The spectrum of 
Peak 2 shows shoulders at 420, 460 and 550 nm, indicative of a [2Fe-2S] cluster. 
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Figure 3.4: Purification of recombinant WhiB1 using a HiTrap Heparin column, 
following Histidine-tagged purification. Lane 1, Precision plus protein standards 
(molecular weights indicated in kDa); Lane 2, fraction collected after Histidine-tagged 
purification; Lane 3, fraction diluted with Tris buffer (25 mM, pH 7.4) before 
application to the heparin column; Lanes 4-6, fractions collected after protein addition 
(wash through); Lanes 7-9, fractions collected after column was washed with Tris buffer 
(25 mM, pH 7.4); Lanes 10-13, fractions collected after elution of protein with 25 mM 
Tris buffer (pH 7.4) containing 0.5 M salt. 
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This method was adopted to purify holo-WhiB1 post reconstitution, therefore allowing 
WhiB1 to be used for further assays with no contaminating unincorporated iron, sulphur 
and NifS. It also allows buffer exchange, removing imidazole which interferes with 
some spectroscopic analyses. 
 
3.3.3 Characterisation of WhiB1 iron-sulphur clusters by UV-visible 
spectroscopy 
 
As described (Section 3.3.1), WhiB1 was reconstituted under anaerobic conditions and 
the resulting sample was straw-yellow in colour. This suggested the presence of a 
[4Fe-4S] cluster; iron-sulphur clusters of this type have a characteristic absorbance peak 
at 420 nm in UV-visible spectroscopy. Accordingly, reconstitution of the iron-sulphur 
cluster was accompanied by an increase in absorbance at ~420 nm (Figure 3.5A). 
Reconstituted WhiB1 was exposed to the reductant sodium dithionite (0.2 mM for 15 
minutes at 20ºC). This caused the absorbance peak at 420 nm to be partially bleached 
(Figure 3.5B). This suggests the [4Fe-4S] cluster can be reduced, by this strong 
reductant, probably from the 2+ to the 1+ state. Thus UV-visible spectroscopy has 
confirmed the presence of a [4Fe-4S] iron-sulphur cluster in holo-WhiB1. 
 
3.3.4 Characterisation of the WhiB1 cluster using EPR 
 
Electron paramagnetic spectroscopy was carried out on both apo-WhiB1 and 
holo-WhiB1 as described in Section 2.6.6 by Dr Jason Crack. Apo-WhiB1 was diluted 
with 25 mM Tris buffer (pH 7.4) containing 1 mM DTT to a final concentration of 
~17 µM. Holo-WhiB1 was purified from the reconstitution reaction components using 
heparin chromatography and diluted with 25 mM Tris buffer (pH 7.4) containing 1 mM 
DTT to a final concentration of ~17 µM. Samples (200 µl) were frozen in liquid 
nitrogen in EPR tubes before analysis. Apo-WhiB1 was EPR silent, as was holo-
WhiB1. This is consistent with the presence of a diamagnetic [4Fe-4S]
2+
 cluster in holo-
WhiB1 (Sweeney, 1980). 
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Figure 3.5: UV-visible spectroscopic analysis of reconstituted WhiB1. (A) WhiB1 
(250 µM) reconstitution reaction under anaerobic conditions. The spectra shown are 
before (blue line) and after (red line) reconstitution. The arrow indicates the increase in 
absorbance at 420 nm with time. (B) Dithionite reduction of WhiB1 (25 µM cluster). 
The spectra shown are before (red line) and after (blue line) treatment with sodium 
dithionite (0.2 mM for 15 minutes at 20ºC). The arrow indicates the decrease in 
absorbance at 420 nm. (Smith et al., 2010).  
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3.3.5 Confirmation of WhiB1 cluster stoichiometry 
 
Reconstitution of WhiB1 yields a protein sample straw-yellow in colour, and UV-
visible and EPR spectroscopy indicate that it contains a [4Fe-4S]
2+
 cluster. To confirm 
these observations, an iron assay was carried out as described in Section 2.6.8 to 
determine the ratio of iron atoms to WhiB1 monomers. A standard curve was created 
using a standard iron solution (Figure 3.6A). Protein samples were then prepared in 
triplicate by reconstituting WhiB1 and then purifying the holo-protein from the 
unincorporated reagents using heparin chromatography (Section 3.3.2). The protein 
concentration was measured using the Bradford assay and adjusted using the correction 
factor calculated from amino acid analysis (Section 3.2.3). The molar ratio of protein to 
iron was then calculated and the results are shown in Figure 3.6B. The average of the 
three repeats was 3.57 moles of iron to each WhiB1 monomer. This result is consistent 
with spectroscopic observations that WhiB1 binds a [4Fe-4S]
2+
 cluster. 
 
3.3.6 CD spectroscopy 
 
Circular dichroism (CD) spectroscopy was carried out on holo-WhiB1 (196 µM) to 
further characterise the structure of WhiB1 as described in Section 2.6.7, in 
collaboration with Dr Jason Crack. The spectrum showed positive features at 427 nm 
and 509 nm (Figure 3.7A), similar to that of WhiD from S. coelicolor (Figure 3.7A) 
(Crack et al., 2009). The spectrum was different however, to that of the oxygen sensor 
FNR from E. coli, which lacked these positive features (Figure 3.7B), highlighting a 
difference in iron-sulphur cluster environment of the Wbl proteins compared to FNR. 
 
3.4 Characterisation of the oligomeric state of WhiB1 
 
3.4.1 Analysis by SDS-PAGE 
 
Large scale purification of His-WhiB1 yielded ~20 mg WhiB1 from 5 litres culture. 
Analysis of concentrated samples by SDS-PAGE often showed the presence of species 
of higher and lower molecular weights, than expected of a WhiB1 monomer  
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Figure 3.6: Determination of iron content in holo-WhiB1. (A) Standardisation of 
iron assay. Different concentrations of iron (Iron standard solution, BDH) were assayed 
(Section 2.6.8). (B) Ratio of iron atoms to WhiB1. The absorbance measured for each 
protein sample was used to determine the concentration of iron in the sample and the 
ratio subsequently calculated. 
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Figure 3.7: CD Spectroscopic analysis of WhiB1. (A) CD spectrum of WhiB1. 
Reconstituted WhiB1 (196 µM) was scanned and the spectrum (red line) is compared to 
that of another Wbl protein, WhiD (396 µM cluster; blue line). (B) CD spectrum of 
FNR. FNR (24 µM cluster) spectrum from Green et al. (1996), showing different 
features to the Wbl proteins. 
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(Figure 3.8A). To identify these species, N-terminal amino acid sequencing was carried 
out by Dr A.J.G. Moir (Sections 2.5.7 and 2.5.8). The four species indicated on the gel 
in Figure 3.8A were sequenced and the results are shown in Figure 3.8B. As shown, all 
four species had the same sequence, which corresponded to that of His-WhiB1. Due to 
the higher concentration of protein in the fractions, the cysteine residues appear to be 
forming inter- and intramolecular disulphide bonds, despite the presence of 100 mM 
β-mercaptoethanol. Addition of further fresh reducing agent to the loading dye and 
storage of fractions in buffer containing 1 mM DTT at -20°C prevented formation of 
disulphide linked oligomers. Furthermore, addition of the components of the 
reconstitution reaction to the protein fractions converted WhiB1 to a monomer 
containing a [4Fe-4S] cluster. The formation of oligomers appears to be a consequence 
of high concentrations of WhiB1 and the absence of the [4Fe-4S] cluster.  
 
3.4.2 Determination of sulphydryl groups in WhiB1 
 
The presence of disulphide bonds in apo-WhiB1, suggested by the N-terminal amino 
acid sequencing and SDS-PAGE analysis, was confirmed by measuring the amount of 
reactive thiol using DTNB as described by Thelander (1973). Assays were carried out in 
the absence of reducing agents under native conditions and denaturing conditions 
(treatment with 1% SDS). WhiB1 samples were prepared at 3.88 µM and the assay was 
as described in Section 2.5.11. Results revealed the presence of two (1.88 ± 0.27, n = 9) 
reactive thiols in the native soluble apo-protein, implying the presence, on average, of 
one disulphide bridge per apo-WhiB1 because WhiB1 has four cysteine residues. The 
number of reactive thiols per apo-WhiB1 decreased to 1.15 ± 0.15 (n = 9) after 
treatment with SDS, implying that unfolding the protein promoted additional disulphide 
bridge formation (on average 1.5 per monomer) (Smith et al., 2010). This propensity to 
form disulphide bonds accounts for the protein pattern seen on the SDS-PAGE gel and 
the N-terminal amino acid sequencing results. 
 
3.4.3 Analysis by gel filtration 
 
The oligomeric state of native WhiB1 was assessed by gel filtration chromatography 
(Section 2.5.10). A standard curve was produced using a set of proteins of known  
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Figure 3.8: WhiB1 can form disulphide linked oligomers. A) SDS-PAGE analysis 
of His-WhiB1. Lane 1, Precision plus protein standards (molecular weights indicated in 
kDa); Lanes 2-15, fractions collected after imidazole elution of WhiB1 from a 5 ml Hi-
trap chelating column. The SDS-PAGE was blotted and used for N-terminal amino acid 
sequencing to identify the four species indicated. B) Results from N-terminal amino 
acid sequencing. Table shows the sequence of the four species analysed. The six amino 
acids given correspond to the histidine tag on the WhiB1 protein. The predicted proteins 
corresponding to the species are shown. 
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molecular weights (Figure 3.9). As shown earlier (Section 3.4.1), apo-WhiB1 has a 
tendency to form oligomers in high concentrations or under insufficiently reducing 
conditions. Apo-WhiB1 (50 µM) was purified using heparin chromatography and eluted 
in 20 mM sodium phosphate buffer, pH 7.4 with 0.5 M NaCl, treated with 1 mM DTT 
(for reducing conditions) or 1 mM diamide (for oxidising conditions) and applied to the 
calibrated Shodex KW805 column. Due to the aggregation of apo-WhiB1 (as has been 
shown previously on SDS-PAGE gels, Section 3.4.1), the elution profile was difficult to 
interpret due to the formation of many large oligomers (data not shown). Holo-WhiB1 
(50 µM) was reconstituted and the reaction purified using heparin chromatography. 
Holo-WhiB1 samples were treated with 1 mM DTT and 1 mM diamide also, where 
indicated. The results for Holo-WhiB1 are shown in Figure 3.10. The trace shows a 
peak at ~715 seconds (Figure 3.10). When used to determine the molecular weight 
using the standard curve (Figure 3.9B), a value of ~12.5 kDa was obtained. This 
corresponds to a WhiB1 monomer (actual molecular weight 12.876 kDa). There was no 
effect of adding diamide or DTT to these samples. These data indicate that holo-WhiB1 
is a monomer with a [4Fe-4S] cluster, but in high concentrations the apo- form has a 
tendency to form oligomers through the formation of disulphide bridges. 
 
3.5 Discussion 
 
Work undertaken in this chapter has characterised the apo-form of WhiB1 and the 
nature of the iron-sulphur cluster in the holo-form of WhiB1. As suggested in the 
literature, the presence of four highly conserved cysteine residues in the Wbl proteins 
are expected to bind iron-sulphur clusters (den Hengst and Buttner, 2008). Here we 
show that WhiB1 can incorporate both a [2Fe-2S] and a [4Fe-4S] cluster. Aerobic 
overproduction and purification of WhiB1 yielded protein in its apo-form, containing no 
cluster, as well as holo- protein containing either a [2Fe-2S] or a [4Fe-4S] cluster 
(Section 3.3.1 and Figure 3.3). The observation that aerobically purified WhiB1 could 
contain a [2Fe-2S] cluster is consistent with findings for the other WhiB proteins of M. 
tuberculosis and WhiD from S. coelicolor (Alam et al., 2007; 2009; Jakimowicz et al., 
2005; Singh et al., 2007). Streptomyces coelicolor WhiD, after overexpression, was 
found in coloured inclusion bodies and following solubilisation the resulting protein 
was red-brown in colour. UV-visible spectroscopic analysis showed features at 420, 450 
and 550 nm indicating the presence of a [2Fe-2S] cluster (Jakimowicz et al., 2005). 
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Figure 3.9: Molecular weight standard curve for gel filtration. (A) Peaks of the 
molecular weight standards.  Standards were prepared (5 mg/ml of vitamin B12, 1.38 
kDa; cytochrome C, 12.385 kDa; myoglobin, 18.8 kDa; ovalbumin, 47.2 kDa; BSA, 
66kDa and 132 kDa; blue dextran, 2000 kDa) in 20 mM sodium phosphate pH 7.4 with 
0.5 M NaCl and run on a Shodex KW805 column. (B) Calibration graph. The elution 
time of each protein was plotted against the log of its molecular weight and a standard 
curve produced. 
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Figure 3.10: Gel filtration analysis of holo-WhiB1. Holo-WhiB1 (50 µM initial 
concentration) was analysed in normal conditions (no pre-treatment of holo-WhiB1), 
reducing conditions (holo-WhiB1 pre-treated with 1 mM DTT) and oxidising conditions 
(holo-WhiB1 treated with 1 mM diamide). The peak corresponding to the WhiB1 
monomer is indicated.  
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A similar spectrum with features at 420, 460 and 550 nm was seen for WhiB1 (Figure 
3.3). Calculations showed that there was a 15-37 % occupation of WhiD with a [2Fe-
2S] cluster, and it was expected that the presence of a [2Fe-2S] cluster was a result of 
aerobic purification (Jakimowicz et al., 2005). Similar findings were seen for the seven 
WhiB proteins of M. tuberculosis (Alam et al., 2007; 2009; Singh et al., 2007). To 
determine the true nature of the iron-sulphur cluster of WhiB1, the cluster was 
reconstituted under anaerobic conditions (Section 3.3.1). The resulting protein sample 
was straw yellow in colour and UV-visible spectroscopic analysis showed a spectrum 
with a strong peak at 420 nm, indicative of a [4Fe-4S] cluster (Figure 3.5A). This was 
confirmed by analysis of the stoichiometry providing 3.57 Fe: 1 WhiB1 (Section 3.3.5). 
The [4Fe-4S] cluster underwent reduction with dithionite (Figure 3.5B) and combined 
with the presence of a silent species in EPR analysis (Section 3.3.4), it was concluded 
that WhiB1 incorporates a [4Fe-4S]
2+
 cluster which can undergo one electron reduction. 
Reconstitution under anaerobic conditions for WhiD of S. coelicolor and the other Wbl 
proteins of M. tuberculosis also showed them to bind [4Fe-4S] clusters with UV-visible 
spectroscopy showing strong features at 420 nm and EPR showing silent species (Alam 
et al., 2007; 2009; Jakimowicz et al., 2005; Singh et al., 2007).  
 
CD analysis of holo-WhiB1 showed positive features at 427 nm and 509 nm, similar to 
those of WhiD (430 nm and 515 nm), and negative features at 335, 375 and 600 nm 
(325, 395 and 600 nm in WhiD) (Section 3.3.6 and Figure 3.7A; Crack et al., 2009). In 
contrast, the well characterised oxygen-sensing transcription factor FNR from E. coli 
has a very different CD spectrum (compare Figure 3.7A to 3.7B) with negative features 
at 300 nm and 500 nm, and a positive feature at 800 nm (Green et al., 1996). This 
suggests that the environment surrounding the [4Fe-4S] clusters of these two Wbl 
proteins is different to that surrounding the [4Fe-4S] cluster of FNR, and the sensitivity 
and function of the cluster of WhiB1 will be analysed in Chapter 4. 
 
As discussed, WhiB1 binds a [4Fe-4S] and this holo-form of WhiB1 is a monomer, 
shown by gel filtration analysis (Section 3.4.3 and Figure 3.10). The iron-sulphur 
cluster-containing form of WhiD from S. coelicolor is also found as a monomer as 
shown by analytical gel filtration (Crack et al., 2009; Jakimowicz et al., 2005). The apo-
form of WhiB1 however, has a tendency to form oligomers especially in the absence of 
reducing conditions or when at high concentrations. Gel filtration analysis of apo-
WhiB1 showed no distinct peak corresponding to a monomer but a heterogeneous 
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spectrum which could not be interpreted due to aggregation forming oligomers (Section 
3.4.3). Similar observations were made for partially iron-loaded WhiD purified from 
inclusion bodies (Jakimowicz et al., 2005). Garg and co-workers, suggested that WhiB1 
forms a homo-dimer under reducing conditions (Garg et al., 2007), with similar reports 
for WhiB3 (Alam and Agrawal, 2008) and WhiB4 (Alam et al., 2007). For WhiB3 
however, the size of the homo-dimer was 26 kDa instead of the expected 32 kDa, which 
was attributed to the globular form of the dimer forming a compact complex (Alam and 
Agrawal, 2008). Interestingly, these groups showed that WhiB1, WhiB3 and WhiB4 
were found as monomers in reducing SDS-PAGE (Alam et al., 2007; Alam and 
Agrawal, 2008; Garg et al., 2007). These findings correspond to our findings for 
WhiB1, whereby in reducing conditions the main species was seen as a monomer 
(Section 3.4.1). In insufficient reducing conditions, oligomers of apo-WhiB1 were seen 
due to the formation of disulphide bonds between monomers (Section 3.4.1 and Figure 
3.8). These observations corroborate the findings of Crack et al. with WhiD, whereby 
dimeric species were lost under reducing conditions (Crack et al., 2009). It was 
concluded that WhiB1 is a monomeric protein when in the holo-form, but the apo-form 
has a tendency to oligomerise through the formation of intermolecular disulphide bonds. 
As well as the formation of intermolecular disulphide bonds, intramolecular disulphide 
bonds are formed in apo-WhiB1, as can be seen by a species on SDS-PAGE which 
migrated faster than the monomer (Figure 3.8). This has also been seen for WhiB2, 
WhiB3, WhiB4 and WhiB5 (Alam et al., 2007; 2009; Alam and Agrawal, 2008; Garg et 
al., 2007). Interestingly, the inability of the intramolecular disulphide form of WhiB1 to 
bind heparin (Figure 3.4) suggested that this is a distinct conformational form of the 
protein that could fulfil a specific biological role. The presence of disulphide bonds was 
further confirmed by the reactive thiol assay (Section 3.4.2). This showed the presence 
of 1 disulphide bond in each apo-WhiB1 monomer, which increased to 1.5 in unfolded 
WhiB1 (Smith et al., 2010). Mass spectroscopy of WhiB1, WhiB3 and WhiB4 indicated 
the presence of 2 disulphide bonds per monomer in apo-WhiB1 (Alam et al., 2007; 
Alam and Agrawal, 2008; Garg et al., 2007). 
 
Work in this chapter has begun to characterise the biochemical and biophysical 
properties of WhiB1. It can incorporate a [4Fe-4S]
2+
 cluster and in this form is seen as a 
monomer. Apo-WhiB1 is also found as a monomer in reducing conditions but has a 
tendency to oligomerise in the absence of reductant, due to the formation of both 
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intermolecular and intramolecular disulphide bonds. Work will now focus on the role of 
the iron-sulphur cluster and function of WhiB1.  
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4.0 Functional characterisation of WhiB1 
 
4.1 Introduction 
 
As shown in Chapter 3, Mycobacterium tuberculosis WhiB1 can be overproduced in 
both its apo- and holo- form (with a [2Fe-2S] or [4Fe-4S] cluster) and upon 
reconstitution incorporates a [4Fe-4S] cluster. Proteins containing iron-sulphur clusters 
can act as sensors of environmental changes, including the presence or absence of 
oxygen and nitric oxide, and relay this information by altering gene expression. This 
process occurs through changes in protein conformation and thus changes in DNA-
binding affinity (Crack et al., 2012). This chapter aims to characterise the sensitivity of 
the WhiB1 iron-sulphur cluster to oxygen and nitric oxide to determine whether holo-
WhiB1 may act as a sensor for either of these physiologically significant gases. The 
[4Fe-4S] cluster of WhiB3 from M. tuberculosis, is slowly degraded in the presence of 
oxygen and also reacts with nitric oxide forming dinitrosyl-iron thiol complexes 
(DNICs) (Singh et al., 2007). The presence of a predicted helix-turn-helix, as well as 
phenotypic studies of mutants, led to the suggestion that Wbl proteins function as DNA-
binding transcription factors (den Hengst and Buttner, 2009). This function has been 
attributed to WhiB3 whereby interaction to promoter DNA of genes known to be 
differentially regulated in a whiB3 mutant, and with the essential sigma factor SigA, has 
been seen (Guo et al., 2009; Singh et al., 2009; Steyn et al., 2002). It has also been 
suggested that Wbl proteins, including WhiB1, function as protein disulphide reductases 
(Alam et al., 2007; 2009; Garg et al., 2007), although WhiD from Streptomyces 
coelicolor was shown to lack such activity (Crack et al., 2009). Here, the role of the 
iron-sulphur cluster on any DNA-binding ability or protein disulphide reductase activity 
will be analysed to determine WhiB1 function. 
 
4.2 Insensitivity of the iron-sulphur cluster of WhiB1 to oxygen 
 
As previously discussed in Chapter 3, WhiB1 can be purified in its holo-form 
containing either a [2Fe-2S] or [4Fe-4S] cluster (Figure 3.3). Upon prolonged exposure 
to air, the cluster of WhiB1 disassembles to give apo-WhiB1. These observations 
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indicate that the iron-sulphur cluster of WhiB1 is relatively stable in air. Upon 
reconstitution, WhiB1 ligates a [4Fe-4S] cluster. To determine how stable this cluster is, 
and whether upon oxygen exposure the cluster disassembles into a [2Fe-2S] form then 
to apo-WhiB1, or [4Fe-4S] to apo-WhiB1, UV-visible spectroscopy was carried out 
(Section 2.6.4). WhiB1 was reconstituted and purified using heparin chromatography as 
described previously (Sections 2.6.1 and 2.6.2). The resulting holo-protein contained 
10 μM of [4Fe-4S] cluster and was exposed to oxygen by the addition of air-saturated 
buffer (25 mM Tris, pH 7.4 containing 0.5 M NaCl, 10% glycerol and 1 mM DTT) 
equivalent to a final concentration of 110 μM oxygen. Spectra were taken at 0 and 
120 minutes (Figure 4.1). There was a minor decrease in absorbance at 420 nm over the 
two hours incubation with oxygen (Figure 4.1). This shows that the [4Fe-4S] cluster of 
WhiB1 is very stable in the presence of oxygen. After prolonged exposure for 
24-72 hours, the cluster disassembled to give apo-WhiB1. There were no signs in the 
spectroscopy to indicate the formation of an intermediate [2Fe-2S] cluster. 
 
4.3 Sensitivity of the iron-sulphur cluster of WhiB1 to nitric oxide 
 
After concluding that the iron-sulphur cluster of WhiB1 was relatively stable in oxygen, 
its stability to nitric oxide was then tested. Proli NONOate (Alexis Biochemicals and 
Cayman Chemicals) was the chosen nitric oxide donor as it reacts immediately, 
releasing two molecules of nitric oxide per molecule (half-life of 1.8 seconds at pH 7.4 
and 37°C). This was used in all the following experiments to determine the sensitivity 
of holo-WhiB1 to nitric oxide. 
 
4.3.1 UV-visible spectroscopic analysis 
 
To test whether the iron-sulphur cluster of WhiB1 is sensitive to nitric oxide, UV-
visible spectroscopy was carried out as described in Section 2.6.4 with holo-WhiB1 and 
Proli NONOate. Reconstituted and heparin purified WhiB1 (22 μM cluster) in 25 mM 
Tris (pH 7.4) containing 0.5 M NaCl was analysed before exposure to Proli NONOate 
(570 µM) for three hours to allow any reaction to run to completion under anaerobic 
conditions. This gave a ratio of 52 nitric oxide: [4Fe-4S]. After exposure for three hours 
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Figure 4.1: UV-visible spectroscopy of the reaction of WhiB1 and oxygen. Spectra 
showing WhiB1 (10 μM cluster) in air-saturated buffer containing 1 mM DTT, 
equivalent to a final concentration of 110 μM oxygen at 0 minutes (red line) and 120 
minutes (blue line). 
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Figure 4.2: UV-visible spectroscopic analysis of the reaction of WhiB1 and nitric 
oxide. The spectra of holo-WhiB1 (22 μM cluster) before (red line) and after (blue line) 
the addition of 570 μM Proli NONOate for 3 hours were measured. This gave a ratio of 
52 nitric oxide:1 [4Fe-4S]. The increase in absorbance at 350-360 nm due to the 
formation of nitrosylated clusters is indicated. 
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the UV-visible spectrum was obtained (Figure 4.2). The absorbance peak at 420 nm, 
indicative of a [4Fe-4S] cluster, was lost after exposure to nitric oxide. A shoulder was 
formed at 350-360 nm as shown in Figure 4.2. This feature is typical of nitrosylated iron 
complexes, which are formed in the reaction of iron-sulphur clusters and nitric oxide. 
These complexes can be found as both dinitrosylated iron complexes (DNICs) and 
tetranitrosylated iron complexes (Roussin’s red esters - RREs), which both contribute to 
the absorbance profile (Figure 4.3; Cruz-Ramos et al., 2002). The reaction of holo-
WhiB1 and nitric oxide was then subjected to further study, as the iron-sulphur cluster 
is more sensitive to nitric oxide than oxygen. 
 
4.3.2 EPR spectroscopic analysis 
 
As described previously (Section 3.3.4), WhiB1 was analysed using EPR spectroscopy 
to determine the nature of the iron-sulphur cluster. Both apo-WhiB1 and holo-WhiB1 
were EPR silent (Figure 4.4A). This indicated the presence of a [4Fe-4S]
2+
 cluster in 
holo-WhiB1 (Section 3.3.4). Holo-WhiB1 (17 μM), post reconstitution and heparin 
purification was then exposed to a 27-fold molar excess of Proli NONOate under 
anaerobic conditions for ten minutes and then two hours. These reactions were in 
25 mM Tris (pH 7.4) containing 1 mM DTT. Samples (200 μl) were frozen in liquid 
nitrogen in EPR tubes before analysis by Dr Jason Crack at the University of East 
Anglia (Section 2.6.6). As shown in Figure 4.3, the nitrosylation of iron-sulphur clusters 
can result in di- and tetra-nitrosylated iron complexes. Dinitrosylated iron complexes 
(DNICs) have characteristic EPR spectra, whereas tetranitrosylated iron complexes are 
EPR silent. After treatment of holo-WhiB1 with Proli NONOate for ten minutes, an 
axial EPR spectrum (g = 2.048, 2.03 and 2.022) was detected (Figure 4.4A and B). This 
indicated the presence of 6 µM DNIC from 17 μM iron-sulphur cluster, i.e. ~10% of the 
total iron was present as an EPR-detectable DNIC. Due to the presence of DTT in the 
reaction buffer, some of this intensity may have arisen from a DTT co-ordinated DNIC 
species. The intensity of the signal at 2.03 decreased upon longer incubation of holo-
WhiB1 and Proli NONOate for two hours (Figure 4.4A and B). This decrease was 
equivalent to 2.8 µM DNIC, i.e. ~4% of the total iron (Smith et al., 2010). The EPR 
analysis of the reaction of holo-WhiB1 with nitric oxide combined with the UV-visible 
spectroscopy suggests a formation of a mixture of EPR active DNICs and EPR silent  
  
83 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Diagram showing two forms of nitrosylated iron-sulphur clusters. Upon 
reaction of iron-sulphur clusters with nitric oxide, dinitrosyl iron complexes (DNICs) 
and tetranitosyl iron complexes (also known as Roussin’s red esters – RREs) can form. 
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Figure 4.4: EPR analysis of WhiB1 and its response to nitric oxide. (A) From top to 
bottom: apo-WhiB1; anaerobically reconstituted holo-WhiB1; holo-WhiB1 treated with 
a 27-fold molar excess of Proli NONOate for ten minutes under anaerobic conditions; 
holo-WhiB1 treated with a 27-fold molar excess of Proli NONOate for two hours. 
Spectra were recorded at 20 K. (B) EPR spectra (g = ~2 region) of the nitric oxide 
treated samples in (A) measured at 77 K for quantification. For all samples, WhiB1 
concentration was 17 µM. The spectra were obtained using a continuous-wave EPR 
spectrometer with a microwave frequency of 9.68 GHz operating at a 100 kHz magnetic 
field modulation. 
85 
 
nitrosylated iron complexes, presumably tetranitrosylated iron complexes, with the 
EPR-silent form as the major species (Smith et al., 2010). 
 
4.3.3 Stoichiometry of the reaction of WhiB1 with nitric oxide 
 
To determine the stoichiometry of the reaction of WhiB1 with nitric oxide, holo-WhiB1 
was titrated against Proli NONOate under anaerobic conditions and the changes in 
absorbance monitored using UV-visible spectroscopy. Reconstituted WhiB1 (19 μM 
cluster) was analysed in a cuvette maintaining anaerobic conditions as described in 
Section 2.6.4. The reaction buffer used was 100 mM Tris (pH 7.4) containing 0.5 M 
NaCl and 10% glycerol to reduce the effect of the additions of Proli NONOate which is 
stored in sodium hydroxide. Proli NONOate was injected through the silicone seal, to 
maintain anaerobic conditions, in increasing amounts (0-90 µM). UV-visible spectra 
were obtained 10 minutes after each addition (Figure 4.5A), and a decrease in 
absorbance at 420 nm and an increase at 350-360 nm was seen, along with an isosbestic 
point at 480 nm. These features are indicative of the formation of nitrosylated iron 
sulphur clusters (Cruz-Ramos et al., 2002). The cumulative change in absorbance at 355 
nm (corresponding to nitrosylation) was calculated for each addition of Proli NONOate, 
accounting for the dilution factor, and plotted against the ratio of nitric oxide:WhiB1. 
Eight nitric oxide molecules reacted per iron-sulphur cluster of WhiB1 (Figure 4.5B), 
suggesting the formation of an octa-nitrosylated iron-sulphur centre. 
 
4.3.4 Stopped-flow kinetics of the reaction of holo-WhiB1 and nitric oxide 
 
Stopped-flow rapid rate kinetic analysis of the reaction of the [4Fe-4S] cluster of 
WhiB1 with nitric oxide was carried out as described in Section 2.6.5 and in Crack et al. 
(2011). Holo-WhiB1 (7 µM cluster) was exposed to 300 µM or 643 µM nitric oxide 
giving a nitric oxide:[4Fe-4S] ratio of ~43 and ~92 respectively. The absorbance at 
364 nm (formation of nitrosylated clusters) and 420 nm (disassembly of the [4Fe-4S] 
cluster) was measured over time and the resulting absorbance spectra are shown in 
Figure 4.6. The spectra shown are averages of at least seven runs per wavelength and 
nitric oxide concentration. The reaction of WhiB1 with nitric oxide was extremely rapid  
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Figure 4.5: Stoichiometry of the reaction of Holo-WhiB1 with nitric oxide. (A) 
Reconstituted WhiB1 (19 µM cluster) was exposed to increasing amounts of Proli 
NONOate (0-90 µM in 10 µM increments) under anaerobic conditions. UV-visible 
spectra were obtained 10 minutes after each addition. The arrows indicate the decrease 
in absorbance at 420 nm and the increase in absorbance at 355 nm as the concentration 
of nitric oxide increased. (B) The cumulative changes in absorbance at 355 nm 
(corresponding to the formation of nitrosylated WhiB1) from two representative 
titrations. The dilution associated with each addition of Proli NONOate was taken into 
account. These values were plotted against the total nitric oxide added (µM; correction 
factor applied) divided by the initial concentration of iron-sulphur cluster (µM). The 
dashed vertical lines indicate the points at which further addition of NONOate failed to 
change the absorbance at 355 nm. 
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Figure 4.6: Stopped-flow kinetics of holo-WhiB1 nitrosylation. Holo-WhiB1 (7 μM 
[4Fe-4S]) in the presence of 643 μM nitric oxide, giving a [nitric oxide]:[4Fe-4S] ratio 
of ~92, was measured at 364 nm (A) and 420 nm (B). Holo-WhiB1 (7 μM [4Fe-4S]) in 
the presence of  300 μM nitric oxide, giving a [nitric oxide]:[4Fe-4S] ratio of ~43, was 
measured at 364 nm (C) and 420 nm (D). Inserts show early events in the reaction time 
course. Crack et al. (2011). 
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and multiphasic, with reaction completion in 5 seconds for the addition of 643 µM nitric 
oxide and 10 seconds for the addition of 300 µM (Figure 4.6). 
 
4.3.5 Kinetic analysis 
 
The reaction of the [4Fe-4S] cluster of WhiB1 with nitric oxide was modelled using the 
reaction below, based on that of Sutton et al., (2004) for FNR and oxygen.  
 
 
Three distinct phases were observed at both wavelengths (364 and 420 nm), suggesting 
a three step reaction A→B→C→D. The data were fitted separately, and together, under 
pseudo-first order conditions to exponential function: y = y0 + (ymax – y0)(1 – e
[-kobs . x]
), 
by computing fits for the parameters y0, kobs and ymax (Sutton et al., 2004). Curve fitting 
was carried out by Dr Jason Crack and described in Crack et al. (2011). Each 
absorbance data set (364 nm and 420 nm) gave similar rate constants for the initial, 
rapid phase and final, slower phase of the reaction of holo-WhiB1 with nitric oxide. The 
intermediate phase however, had different characteristics at 364 nm compared to 
420 nm, indicating that these two wavelengths report different processes in the 
intermediate part of the reaction. Thus the overall reaction was modelled as a four-step 
reaction: A→B→C→D→E, where the initial and final steps (A→B and D→E) are 
detected at both wavelengths, and steps B→C and C→D are detected at 364 nm and 
420 nm respectively (Crack et al., 2011).  
 
Similar observations were made with WhiD from S. coelicolor as reported in Crack et 
al. (2011). Plots of the observed pseudo-first order rate constants (kobs) against nitric 
oxide concentration for the reaction with WhiD were linear for each step, indicating a 
first order dependence on nitric oxide (Figure 4.7, blue lines; Crack et al., 2011). Using 
this information, the data for WhiB1 at the two nitric oxide concentrations also suggests 
a linear relationship between kobs and nitric oxide concentration (Figure 4.7, red lines; 
Crack et al., 2011). The rate constants (from the linear fits in Figure 4.7) for the reaction 
of holo-WhiB1 with nitric oxide are summarised below. 
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Figure 4.7: Kinetic dependencies of the nitrosylation reaction on nitric oxide 
concentration. Multiphase kinetics were observed for the reactions of both holo-WhiB1 
and holo-WhiD with NO over a range of concentrations (under pseudofirst-order 
conditions) at both A364 nm and A420 nm. The observed rate constants (kobs) are plotted as a 
function of NO concentration. Panels A-D correspond to steps 1-4, respectively, of the 
four-step  mechanism. kobs corresponds to A364 nm  () and A420 nm () for WhiB1. 
Least-square linear fits of the data are shown (red lines), the gradient of which 
corresponds to the apparent second-order rate constant. Data for WhiD () are plotted 
for comparison with least-square linear fits (blue lines). Figure and legend adapted from 
Crack et al. (2011). 
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Reaction Step Rate constant (M
-1
s
-1
) 
A→B (4.40 ± 0.44) X 105 
B→C (1.38 ± 0.04) X 104 
C→D (8.34 ± 0.93) X 103 
D→E (0.90 ± 0.06) X 103 
 
4.3.6 Conformational changes in WhiB1 upon exposure to nitric oxide 
 
The oligomeric state of both apo- and holo-WhiB1 was analysed using gel filtration as 
described in Section 3.4.3. Holo-WhiB1 (50 μM) after treatment with 1 mM Proli 
NONOate was also analysed as described in Section 2.5.10. Holo-WhiB1 was seen as a 
monomer with a symmetrical peak (Figure 3.10) corresponding to a molecular weight of 
~12.5 kDa, when compared to a standard curve (Figure 3.9B). Holo-WhiB1 after 
treatment with Proli NONOate eluted as an asymmetrical peak, with a shoulder (Figure 
4.8). The peak corresponded to ~715 seconds and the shoulder to ~700 seconds elution 
time. When used to determine the molecular weights using the standard curve (Figure 
3.9B), the peak gave a molecular weight of ~12.5 kDa as for holo-WhiB1 (actual 
molecular weight 12.876 kDa) and the shoulder ~15.8 kDa. This data shows that 
reaction of the iron-sulphur cluster of WhiB1 with nitric oxide causes a conformational 
change in the protein structure with a subsequent change in its gel filtration elution 
profile. 
 
4.3.7 Stability of the nitrosylated form of WhiB1 
 
The reaction of holo-WhiB1 with nitric oxide leads to the formation of a nitrosylated 
iron-sulphur cluster. To determine whether this form of WhiB1 is stable or dissociates 
quickly to yield apo-WhiB1, UV-visible spectroscopy was carried out. Under anaerobic 
conditions holo-WhiB1 (4.2 μM cluster), in 25 mM Tris buffer (pH 7.4) containing 0.5 
M NaCl, 10% glycerol and 1 mM DTT, was analysed by UV-visible spectroscopy 
(Figure 4.9, red trace). It was then exposed to Proli NONOate (400 μM), yielding 
~10 μM nitrosylated form which was unchanged after 2 hours (Figure 4.9, orange 
trace). The cuvette was then uncapped and the reaction exposed to air. Spectra were 
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Figure 4.8: Gel filtration analysis of holo-WhiB1 and Proli NONOate. Holo-WhiB1 
(50 µM) was exposed to 1 mM Proli NONOate. The peak corresponding to the WhiB1 
monomer is indicated, along with the shoulder formed as a result of the conformational 
change in WhiB1 after reaction of its iron-sulphur cluster with nitric oxide.  
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Figure 4.9: Stability of the nitrosylated form of WhiB1. UV-visible spectra were 
obtained for holo-WhiB1 (4.2 µM cluster) before and after exposure to 400 µM Proli 
NONOate in anaerobic conditions and in the presence of 1 mM DTT for 2 hours. This 
provided ~10 µM nitrosylated cluster which was unchanged in this time. The reaction 
was then exposed to air and spectra obtained after 2 and 24 hours. 
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taken after 2 hours (green line) and 24 hours (blue line).  Introduction of oxygen caused 
the absorbance at 355 nm to decrease by ~20% after 2 hours and only after 24 hours 
was the nitrosylated form of WhiB1 fully degraded to apo-WhiB1. Thus the nitrosylated 
WhiB1 is a relatively stable form of the protein. 
 
4.4 Protein disulphide reductase activity of WhiB1 
 
To determine whether WhiB1 has general protein disulphide reductase activity, an 
insulin reduction assay was carried out as described in Section 2.5.12. The table below 
shows the results of the assays with increasing concentrations of apo-WhiB1, as well as 
holo-WhiB1 and nitric oxide-treated WhiB1 (exposed to 100 μM Proli NONOate) 
compared to Escherichia coli thioredoxin, a bone fide general protein disulphide 
reductase.  
 
Protein Concentration 
(μM) 
Rate 
(ΔA600 min
-2
)(x 10
-3
) 
None - 0.07 
Thioredoxin 2.5 1.30 
Apo-WhiB1 5 0.10 
Apo-WhiB1 10 0.43 
Apo-WhiB1 20 0.45 
Holo-WhiB1 5 0.07 
Nitric oxide-treated apo-WhiB1 5 0.07 
Nitric oxide-treated holo-WhiB1 5 0.02 
 
Although increased insulin reduction was observed as the concentration of apo-WhiB1 
increased, with 5 µM WhiB1 the rate of reaction was slow compared to that of a lower 
concentration of thioredoxin and were similar to that of the rate obtained where no 
protein was assayed. There was no significant reduction for holo-WhiB1 or nitric oxide-
treated samples. 
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4.5 The DNA-binding properties of WhiB1 
 
4.5.1 Apo-WhiB1 binds at its own promoter 
 
Electromobility shift assays were carried out to determine whether WhiB1 was capable 
of binding to its own promoter DNA (PwhiB1) as described in Section 2.7.3. Increasing 
concentrations of apo-WhiB1 and holo-WhiB1 (0, 5, 10, 20 and 50 μM) were incubated 
separately with ~2 nM radiolabelled PwhiB1 (Section 2.7.1) before separation of 
protein-DNA complexes from free PwhiB1 DNA. Figure 4.10 shows how apo-WhiB1, 
in the presence of a reducing agent, binds PwhiB1 (lanes 2-5). The smeared appearance 
of the EMSA at lower protein concentrations suggests that the complex is relatively 
unstable and dissociates during electrophoresis (Figure 4.10, lane 3). DNA-binding was 
inhibited by the presence of the [4Fe-4S] cluster in holo-WhiB1 (Figure 4.10, lanes 6-
9). EMSAs were carried out by Dr M. Stapleton and are reported in Smith et al. (2010). 
 
4.5.2 DNA-binding of holo-WhiB1 is restored by treatment with nitric oxide 
 
Holo-WhiB1 does not bind to the whiB1 promoter (Figure 4.10), indicating that the 
presence of the [4Fe-4S] cluster inhibits DNA-binding. Electromobility shift assays 
(Section 2.7.3) were carried out on nitric oxide-treated holo-WhiB1 with PwhiB1 to 
determine whether nitrosylation of the cluster would allow DNA-binding. Increasing 
concentrations of holo-WhiB1 (0, 5, 10, 20 and 50 μM) were treated with a 20-fold 
molar excess of Proli NONOate for 1 minute at room temperature before incubation 
with ~2 nM radiolabelled PwhiB1 (Section 2.7.1). Protein-DNA complexes were then 
separated from free PwhiB1 DNA by electrophoresis. Figure 4.11A shows how nitric 
oxide-treated holo-WhiB1 binds to the whiB1 promoter (lanes 2-5 and 7-10). In the 
absence of additional reducing agent (30 mM DTT), nitric oxide-treated holo-WhiB1 
formed a second retarded species of lower mobility (Figure 4.11A, lane 5). This species 
was absent in the presence of increased reducing agent (Figure 4.11A, lanes 9 and 10). 
Reconstitution of the cluster following nitric oxide-treatment then abolished DNA-
binding (not shown). EMSAs were performed by Dr M. Stapleton and are reported in 
Smith et al. (2010). 
  
95 
 
 
 
 
 
 
 
 
 
 
Figure 4.10: Binding of WhiB1 at the whiB1 promoter (PwhiB1) region. 
Radiolabelled PwhiB1 was incubated with increasing concentrations of apo- or holo-
WhiB1 as indicated before separation of protein-DNA complexes (PwhiB1-WhiB1) 
from free DNA (PwhiB1) by electrophoresis. Lane 1, no protein; lanes 2-5 and 6-9 
contain, 5, 10, 20 and 50 M WhiB1 respectively. The locations of PwhiB1 and 
PwhiB1-WhiB1 are indicated. EMSAs were carried out by Dr M. Stapleton (Smith et 
al., 2010). 
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Figure 4.11: Effect of nitric oxide treatment and oxidation state on DNA-binding 
by WhiB1. (A) Treatment of holo-WhiB1 with nitric oxide permits binding to 
PwhiB1. A 10-fold molar excess of Proli NONOate was added to increasing 
concentrations of holo-WhiB1. After incubation for 1 minute at room temperature, an 
aliquot was removed and DTT added to a final concentration of 30 mM. After further 
incubation for 3 minutes at room temperature, PwhiB1-WhiB1 complexes were 
separated from PwhiB1 by electrophoresis. Lanes 1 and 6, no protein; lanes 2-5 and 7-
10 contain, 5, 10, 20 and 50 M WhiB1 respectively. The locations of PwhiB1 and 
PwhiB1-WhiB1 complexes are indicated. (B) Oxidation of WhiB1 results in 
formation of a second retarded species. Radiolabelled PwhiB1 was incubated with 
apo-WhiB1 before separation of protein-DNA complexes (PwhiB1-WhiB1) from free 
DNA (PwhiB1) by electrophoresis. Lane 1, no protein; lane 2, 20 M apo-WhiB1 pre-
treated with 5 mM diamide, lane 3, 20 M apo-WhiB1 pre-treated with 1 mM DTT. 
The locations of PwhiB1 and PwhiB1-WhiB1 are indicated. EMSAs were carried out by 
Dr M. Stapleton (Smith et al., 2010). 
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4.5.3 DNA-binding is affected by the oxidation state of WhiB1 
  
As discussed in Section 4.5.2, in the absence of additional reducing agent a second 
retarded species of lower mobility was seen upon binding of nitric oxide-treated holo-
WhiB1 to PwhiB1 (Figure 4.11A, lane 5). Apo-WhiB1 was therefore also analysed to 
determine whether a similar species would be seen in its oxidised state. Apo-WhiB1 (20 
μM) was pre-treated with either the oxidising agent diamide (5 mM) or the reducing 
agent DTT (1 mM) and incubated with ~2 nM radiolabelled PwhiB1 (Section 2.7.1). 
Protein-DNA complexes were then separated from free PwhiB1 DNA by 
electrophoresis (Section 2.7.3). Figure 4.11B shows how oxidised apo-WhiB1 showed 
two retarded species compared to one for reduced apo-WhiB1 (compare lanes 2 and 3). 
EMSAs were carried out by Dr M. Stapleton and reported in Smith et al. (2010). 
 
4.5.4 DNA-binding of WhiB1 is specific 
 
The specificity of DNA-binding of WhiB1 was determined by carrying out EMSAs 
with various promoters and by competition assays. Apo-WhiB1 was unable to bind to 
rpfA, ahpC and Rv3616c promoter DNA (Smith et al., 2010; Stapleton et al., 2012). 
Competition electromobility shift assays were carried out to further demonstrate the 
specificity of DNA-binding of WhiB1 to its own promoter. Apo-WhiB1 (20 μM) was 
incubated with ~2 nM radiolabelled PwhiB1 (Section 2.7.1) and a 100-fold excess of 
unlabelled PwhiB1 or PrpfA DNA. Protein-DNA complexes were then separated from 
free DNA by electrophoresis (Section 2.7.3). Addition of unlabelled PwhiB1 inhibited 
binding of both reduced (Figure 4.12A, compare lanes 2 and 3) and oxidised (Figure 
4.12B, compare lanes 2 and 3) apo-WhiB1 to radiolabelled PwhiB1. A 100-fold excess 
of unlabelled PrpfA however, did not affect binding (Figure 4.12A and B, compare 
lanes 2 and 4). The DNA-binding ability of apo-WhiB1 is thus specific to its promoter 
(PwhiB1) in both its oxidised and reduced forms. EMSAs were carried out by Dr M. 
Stapleton and reported in Smith et al. (2010). 
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Figure 4.12: DNA-binding by WhiB1 is specific. (A) DNA-binding of apo-WhiB1 in 
reducing conditions is specific to the whiB1 promoter. Binding of 20 M apo-WhiB1 
in the presence of 1 mM DTT to radiolabelled PwhiB1 (lane 2) was challenged by the 
presence of a 100-fold excess of unlabelled PwhiB1 DNA (lane 3) or a 100-fold excess 
of unlabelled PrpfA DNA (lane 4). Lane 1 contains no protein. The locations of PwhiB1 
and PwhiB1-WhiB1 complexes are indicated  (B) DNA-binding of apo-WhiB1 in 
oxidising conditions is also specific to the whiB1 promoter. Binding of oxidised apo-
WhiB1 (20 M, pre-treated with 5 mM diamide) to radiolabelled PwhiB1 (lane 2) was 
challenged by the presence of a 100-fold excess of unlabelled PwhiB1 DNA (lane 3) or 
a 100-fold excess of unlabelled PrpfA DNA (lane 4). Lane 1 contains no protein. The 
locations of PwhiB1 and PwhiB1-WhiB1 complexes are indicated. EMSAs were carried 
out by Dr M. Stapleton (Smith et al., 2010). 
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4.5.5 DNase footprinting of WhiB1 at PwhiB1 
 
Apo-WhiB1 binds to its own promoter (PwhiB1). To identify the binding site, DNase I 
footprinting was carried out as described in Section 2.7.4. Increasing concentrations of 
apo-WhiB1 (0, 5, 10, 20 μM) were incubated with radiolabelled PwhiB1 before 
digestion with DNase I and separation of fragments by electrophoresis. A Maxam and 
Gilbert G track was prepared as described in Section 2.7.5 and run alongside the 
samples to allow sequence analysis. A distinctive DNAse I cleavage pattern was seen, 
showing a protected region located at -40 to -3 relative to the transcript start site (Figure 
4.13, region labelled W). The footprint also exhibited several hypersensitive sites, 
suggesting that apo-WhiB1 causes significant distortion of PwhiB1 upon binding 
(Figure 4.13). DNase footprinting was carried out by Dr M. Stapleton and is reported in 
Smith et al. (2010). 
 
4.6 Discussion 
 
As previously shown in Chapter 3, WhiB1 incorporates a [4Fe-4S] cluster. Iron-sulphur 
clusters are intrinsically sensitive to oxygen, and thus holo-WhiB1 was exposed to 
oxygen to determine whether the cluster reacts to form apo-WhiB1. Purification of 
WhiB1 produces protein containing either a [4Fe-4S] or [2Fe-2S] cluster or protein in 
its apo-form (Figure 3.3). Upon prolonged exposure to oxygen after purification, the 
clusters disassemble forming apo-WhiB1. This indicates that the cluster of WhiB1 is 
relatively stable. Reconstituted WhiB1, containing a [4Fe-4S] cluster (10 μM), was 
exposed to an 11-fold molar excess of oxygen and the absorbance measured in the 
presence of 1 mM DTT (Figure 4.1). After 120 minutes, there was very little change in 
absorbance at 420 nm, indicating the [4Fe-4S] cluster was still present and not sensitive 
to oxygen in this time. After ~24 hours plus, the cluster disassembled to apo-WhiB1. 
There was no sign of changes in the absorbance spectrum indicating the formation of an 
intermediate [2Fe-2S] cluster in the reaction with oxygen. It is therefore thought that the 
[2Fe-2S] cluster containing WhiB1 seen in purification is due to partial iron-
incorporation, and not a degradation product of the reaction of the [4Fe-4S] cluster of 
WhiB1 with oxygen. The slow rate of the reaction shows that the iron-sulphur cluster of 
WhiB1 is relatively stable in the presence of oxygen, in comparison to the rapid reaction 
of the iron-sulphur cluster of the known oxygen sensor, FNR of Escherichia coli (Crack 
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Figure 4.13: Binding of apo-WhiB1 at the whiB1 promoter region. (A) DNase I 
footprint of apo-WhiB1 at PwhiB1. Apo-WhiB1 was incubated with PwhiB1 before 
DNase I digestion. Hypersensitive sites associated with interaction with apo-WhiB1 are 
indicated with arrows; numbering is relative to the transcriptional start site. The location 
of apo-WhiB1 interaction (W) is indicated, as well as the -10 and -35 elements. Lane1 
1, no protein; lanes 2-4, 5, 10 and 20 μM apo-WhiB1; lanes 5, Maxam and Gilbert G 
track. (B) Nucleotide sequence of PwhiB1. Important features highlighted are; the 
transcript start site (+1, block arrow), -10 and -35 elements (underlined), the 
hypersensitive sites that characterise interaction with apo-WhiB1 (red), the location of 
the protected region (W, overlined), and two related DNA sequences within the 
protected region (blue). Footprinting was carried out by Dr M. Stapleton (Smith et al., 
2010). 
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 et al., 2004). As shown in Chapter 3 (Figure 3.7), the CD spectrum of the oxygen-
insensitive iron-sulphur cluster of WhiB1 is very different to the oxygen-sensitive iron-
sulphur cluster of FNR. This difference in cluster environment may contribute to the 
oxygen stability of the WhiB1 cluster.  
 
The reaction of other Wbl proteins with oxygen has also been analysed. WhiD from 
Streptomyces coelicolor was refolded from inclusion bodies and the [4Fe-4S] cluster 
reconstituted. Upon oxygen exposure, changes in absorption spectra were consistent 
with formation of a [2Fe-2S] cluster after 50 minutes and an apo-protein after a 
subsequent 100 minutes (Jakimowicz et al., 2005). The rate of the reaction was 
dependent on the degree of oxygen exposure and the presence of DTT, whereby the first 
stage of the reaction, the change in [4Fe-4S] to [2Fe-2S], was faster in the absence of 
DTT (Jakimowicz et al., 2005). A similar reaction profile and rate was seen for the 
reaction of holo-WhiB3 from M. tuberculosis with oxygen, with a 75% cluster loss in 
180 minutes (Singh et al., 2007). The reaction of holo-WhiB4 from M. tuberculosis and 
oxygen, again showed a similar reaction profile but with a slower rate of change over 
~84 hours (Alam et al., 2007). This reaction was carried out in the presence of DTT 
because omission of the reducing agent led to precipitation, which is similar to our 
observations for WhiB1. Although the reaction of WhiD and WhiB3 with oxygen are 
quicker than that of WhiB1, the rates of reaction are still relatively slow. The clusters of 
WhiB3, WhiB4 and WhiD all react with oxygen through a [2Fe-2S] intermediate. 
Interestingly, similar to the reaction profile for WhiB1, WhiD purified with a [4Fe-4S] 
cluster (native-WhiD) reacts with oxygen to form apo-WhiD with no [2Fe-2S] 
intermediate (Crack et al., 2009). This reaction was still faster than that for WhiB1, with 
full cluster disassembly in 120 minutes (Crack et al., 2009). The difference in the 
reaction profiles of protein refolded from inclusion bodies (WhiB3, WhiB4 and WhiD) 
compared to that of protein purified in a soluble form (WhiB1 and native-WhiD) may 
highlight that small changes in protein fold due to refolding from inclusion bodies, 
affects the environment around the cluster and subsequently its interaction with 
molecular oxygen. 
 
As the iron-sulphur cluster of WhiB1 was shown to be relatively oxygen stable, its 
sensitivity to nitric oxide was then analysed. Nitric oxide is a key component of the host 
response to M. tuberculosis infection, and to mount an effective response against it, 
bacteria must reprogram gene expression. This reprogramming of gene expression is 
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likely to involve the upregulation of nitric oxide detoxification systems. Mycobacterium 
tuberculosis is capable of detoxifying nitric oxide by its oxidation with haem-bound 
oxygen via the truncated haemoglobin trHbN, yielding nitrate ion (Couture et al., 1999; 
Ouellet et al., 2002; Pathania et al., 2002). This detoxification system is likely to be 
sufficient for detoxification of endogenous nitric oxide, produced by nitrite reduction by 
the Nar nitrate reductase system in M. tuberculosis. The Nar system is upregulated in 
hypoxic conditions to allow the reduction of nitrate to nitrite (Sohaskey and Wayne, 
2003), however nitric oxide can be produced if nitrite is then reduced. The increase in 
exogenous nitric oxide experienced by M. tuberculosis during infection, may saturate 
the detoxification systems. Nitric oxide sensing transcription factors may therefore play 
an important role in M. tuberculosis survival. There are a number of bacterial nitric 
oxide sensing regulators that serve in this role, including a number of iron-sulphur 
containing proteins. FNR, Iron-regulatory protein-1 (IRP1), NsrR, SoxR and WhiB3 are 
all examples of nitric oxide sensitive transcription factors (Cruz-Ramos et al., 2002; 
Ding and Demple, 2007; Kennedy et al., 1997; Spiro, 2007; Tucker et al., 2008; 
Wardrop et al., 2000). The reaction of nitric oxide with the iron-sulphur clusters of 
these regulators causes conformational changes which then have effects on their 
function. The iron-sulphur cluster of FNR reacts with nitric oxide to form a dinitrosyl-
iron complex (DNIC), and this form of FNR is incapable of binding DNA (Cruz-Ramos 
et al., 2002). A similar finding for the nitrosylation of the [2Fe-2S] cluster of NsrR, 
causing inactivation of the protein, is seen (Tucker et al., 2008). In contrast, reaction of 
nitric oxide with the [2Fe-2S] cluster of SoxR forming a DNIC, activates the protein 
(Ding and Demple, 2000). The apo-forms of WhiB3 and IRP1 are capable of binding 
DNA and mRNA respectively, both of their iron-sulphur clusters react with nitric oxide 
forming DNIC compounds (Kennedy et al., 1997; Singh et al., 2007). In the case of 
IRP1, exposure to nitric oxide activates mRNA binding by promoting cluster 
disassembly (Wardrop et al., 2000). Characterisation of the reaction of holo-WhiB1 
with nitric oxide detailed here showed a rapid reaction which then had an effect on 
protein function. 
 
Initial UV-visible spectroscopic tests with holo-WhiB1 and Proli NONOate, a rapid 
nitric oxide releaser, showed a change in the absorbance spectrum (Figure 4.2). The 
peak at 420 nm, corresponding to the [4Fe-4S] cluster, was replaced with a shoulder at 
350-360 nm. Absorbance at this wavelength is attributed to nitrosylated iron-sulphur 
clusters, thus the cluster of WhiB1 reacts with nitric oxide. Nitrosylated iron-sulphur 
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clusters that absorb at this wavelength can be found in two forms; dinitrosyl iron 
complexes (DNICs) and tetranitrosylated iron complexes (also known as Roussin’s red 
esters - RREs) (Figure 4.3). To determine which of these species is formed, electron 
paramagnetic spectroscopy (EPR) was carried out as the DNICs are EPR active with 
characteristic EPR spectra, whereas RREs are EPR silent. Results showed the presence 
of DNIC species after the reaction of holo-WhiB1 with nitric oxide, corresponding to 
10% of the total iron content after 10 minutes, falling to 4% after 2 hours (Figure 4.4). 
This may indicate that the remaining iron is present as RREs. Taken with the UV-
visible spectroscopic analysis, to which both dinitrosyl and tetranitrosyl iron complexes 
contribute, the EPR data suggests a mixture is present with the EPR silent RREs the 
major species. The iron-sulphur cluster of WhiB3 has been shown to be a nitric oxide 
sensitive also, forming DNIC compounds identified by EPR analysis (Singh et al., 
2007). 
 
The reaction of holo-WhiB1 with nitric oxide was further analysed to understand the 
reaction mechanism. Titrating increasing amounts of nitric oxide against holo-WhiB1 
and monitoring the change in absorbance showed 8 nitric oxide molecules reacted with 
each [4Fe-4S] cluster (Figure 4.5). Similar findings were seen for WhiD from S. 
coelicolor (Crack et al., 2011). The spectral properties of the product and the 
stoichiometry are consistent with the formation of two RREs per holo-WhiB1. 
Accordingly, using the molar absorption coefficient of tetranitrosylated clusters, 
determined by Cruz-Ramos et al. (~8500 M
-1
cm
-1
) (Cruz-Ramos et al., 2002), the 
absorbance increase at 360 nm upon the completion of the titration was equivalent to 
the formation of ~2.5 RREs (Smith et al., 2010). As discussed in Crack et al. (2011), 
DFT (Density Functional Theory) was used to calculate the possibility of two RREs 
being present after reaction of nitric oxide with the iron-sulphur clusters of WhiB1 and 
WhiD. These calculations suggested the possibility of a novel octa-nitrosylated cluster, 
[4Fe
I
4(NO)8-(S-cys)4]
0
, being formed in the protein cavity from the dimerisation of two 
RREs (Figure 4.14; Crack et al., 2011). The formation of such an octa-nitrosylated 
species would entail a rearrangement of the iron positions relative to cysteine thiols 
(Crack et al., 2011). This would lead to conformational changes, as indicated by gel 
filtration analysis for WhiB1 (Section 4.3.6), which may allow a switch in the DNA-
binding properties of Wbl proteins (Singh et al., 2007; 2009; Smith et al., 2010). The 
nitrosylated iron-sulphur cluster was a stable product under anaerobic conditions, but  
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Figure 4.14: Model depicting the proposed octa-nitrosylated cluster resulting from 
nitrosylation of the [4Fe-4S] cluster of Wbl proteins. DFT calculations suggest the 
formation of this cluster from the dimerisation of two RREs for WhiB1 and WhiD. 
Figure is adapted from Crack et al. (2011). 
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was slowly degraded upon exposure to oxygen (Figure 4.9; Section 4.3.6). Similar 
findings were seen for nitrosylated WhiD (Crack et al., 2011). 
 
Another interesting feature of the reaction of holo-WhiB1 with nitric oxide, is the speed 
of the reaction. Unlike the reaction with oxygen, the iron-sulphur cluster of WhiB1 
reacts with 8 nitric oxide molecules extremely rapidly in a complex multiphasic reaction 
(Crack et al., 2011). As discussed in Section 4.3.5, the reaction of the iron-sulphur 
cluster with nitric oxide proceeds in a four step mechanism. There is little known about 
how the protein environment can regulate the relative rates of attack of nitric oxide and 
other diatomic molecules on the specific sites of iron-sulphur clusters. The mechanism 
by which nitric oxide reacts with the iron-sulphur clusters of both WhiB1 and WhiD 
provides new insight. The first step of the reaction (A→B) was detected at both 
wavelengths (420 nm; monitoring [4Fe-4S] cluster loss and 364 nm; monitoring 
nitrosylated cluster appearance) and is first order with respect to nitric oxide. This is the 
fastest step of the reaction (Section 4.3.5) and is very likely to be the binding of one 
nitric oxide molecule to the cluster. This increases the accessibility for further nitric 
oxide-binding in steps B→C (detected at 364 nm) and C→D (detected at 420 nm) 
(Crack et al., 2011). These steps are both first order with respect to nitric oxide also, 
and it is thought that this indicates either a single nitric oxide is involved in each step, or 
that nitric oxide binding to different irons of the cluster occurs independently. 
Fluorescence titration data of the reaction of WhiD with nitric oxide suggests the 
formation of a stable intermediate with a stoichiometry of 4 nitric oxide:1 [4Fe-4S] 
cluster (Crack et al., 2011). Intermediate D therefore appears to be a tetranitrosylated 
cluster, indicating that in steps B→C and C→D, there is binding of one or two nitric 
oxide molecules. The last step of the reaction, D→E (detected at both wavelengths) was 
again first order, leading to the formation of the octa-nitrosylated cluster (Crack et al., 
2011).  
 
The findings discussed here on the reaction of nitric oxide with the iron-sulphur cluster 
of WhiB1, and those also seen for WhiD, have provided a detailed insight into the 
mechanism of the reaction (Crack et al., 2011; Smith et al., 2010). The effects of nitric 
oxide on the function of WhiB1 were then analysed. 
 
Wbl proteins have long been considered to function as DNA-binding transcription 
factors, and evidence of this has recently been obtained for WhiB1, WhiB2 and WhiB3 
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from M. tuberculosis as well as the WhiBTM4 protein from mycobacteriophage TM4 
(Rybniker et al., 2010; Singh et al., 2009; Smith et al., 2010). WhiB2 was capable of 
binding to its own promoter, as seen here for WhiB1 (Rybniker et al., 2010). WhiBTM4 
was also capable of binding to the whiB2 promoter region, suggesting WhiB2 is capable 
of regulating its own expression and is inhibited by WhiBTM4 (Rybniker et al., 2010). 
WhiB3 was shown to bind to the promoter regions of two polyketide biosynthetic genes 
(pks2 and pks3), and this was independent of the state of the iron-sulphur cluster (Singh 
et al., 2009). Recently, a number of Wbl proteins, including WhiB1, have been 
suggested to act as general protein disulphide reductases (Alam et al., 2007; 2009; Garg 
et al., 2007). Here, apo-WhiB1 was shown to have insignificant general protein 
disulphide reductase activity (Section 4.4). Similarly, protein disulphide reductase 
activity was not seen for WhiD from S. coelicolor (Crack et al., 2009). Results here 
indicate that WhiB1 is not a general protein disulphide reductase, although the 
propensity of apo-WhiB1 to form both intra- and inter-disulphide bonds (Chapter 3) 
suggests such redox chemistry is possible. It may require an as yet unidentified 
reductase and specific target proteins for reduction. In this context WhiB1 specifically 
interacts with and reduces disulphide bonds in the α(1,4)-glucan branching enzyme 
GlgB (Garg et al., 2009). Results presented here suggest WhiB1 to behave as a DNA-
binding transcription factor, interacting with its own promoter. However, it is possible 
that WhiB1 is bi-functional, acting as both a gene regulator and a specific GlgB 
reductase. 
 
The [4Fe-4S] cluster of WhiB1 reacts specifically and rapidly with nitric oxide to 
convert the protein from a non-DNA-binding protein to a form capable of binding to its 
own promoter. This suggests that WhiB1 may play a role in establishing M. tuberculosis 
infections by controlling gene expression in response to macrophage-generated or 
endogenous nitric oxide. Recent evidence has shown that whiB1 expression was not 
directly affected by exogenous nitric oxide but was highly up-regulated by cAMP 
(Larsson et al., 2012). Previous studies have shown whiB1 expression to be activated by 
intermediate levels (2.5 µM) of the cAMP receptor protein (CRP) Rv3676, and 
repressed by high levels (20 µM) of Rv3676 (Stapleton et al., 2010). In vitro 
transcription reactions with apo-WhiB1 and PwhiB1 in the absence of Rv3676 or in the 
presence of either intermediate or high concentrations of Rv3676, showed apo-WhiB1 
always repressed its own transcription. This shows the inhibition is more severe than 
that mediated by high concentrations of Rv3676, and silences any Rv3676-dependent 
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activation of whiB1 expression, at least in vitro (Smith et al., 2010). DNase I 
footprinting of apo-WhiB1 at the whiB1 promoter showed a 37 bp protected region 
at -40 to -3, relative to the transcription start site, obscuring both the -35 and -10 
elements (labelled W; Figure 4.13). This site was downstream of the Rv3676 activating 
site (centred at -58.5) and overlapped the repressing Rv3676 site (centred at -37.5) 
(Stapleton et al., 2010). The footprint was also characterised by hypersensitive sites 
which span a region too large for the binding of one apo-WhiB1 monomer, suggesting 
multiple apo-WhiB1 interactions (Figure 4.13). Based on the location of the protected 
site in the footprint, repression of transcription is likely to occur by apo-WhiB1 
blocking RNA polymerase binding. As mentioned in Section 4.1, WhiB3 interacts with 
the sigma factor SigA (Steyn et al., 2002). Therefore it is also a possibility that WhiB1 
interacts with SigA to repress whiB1 transcription by inhibiting RNA polymerase 
activity, or by preventing RNA polymerase from accessing the promoter. What is clear 
is that there is a complex interplay between at least two regulators (WhiB1 and Rv3676) 
and their cognate signals (nitric oxide and cAMP) to control the expression of the 
essential whiB1 gene. Further in vivo studies to establish the dynamics of WhiB1 and 
Rv3676 activities during infection should shed new light on this emerging regulatory 
partnership. 
 
Upon infection of macrophages, mycobacterial-derived cAMP increases promoting 
bacterial survival by interfering with host signalling pathways (Agarwal et al., 2009). 
cAMP is also important in M. tuberculosis gene regulation, affecting the regulatory 
properties of the cAMP receptor proteins Rv3676 and Rv1675c (Gazdik and 
McDonough, 2005; Rickman et al., 2005; Stapleton et al., 2010). As discussed here, 
whiB1 expression is under dual regulation of the cAMP-responsive Rv3676 protein and 
the nitric oxide-responsive WhiB1 protein. This regulation may provide a mechanism to 
integrate the transcriptional response to two signals, cAMP and nitric oxide, associated 
with infection (Figure 4.15; Smith et al., 2010). Although the detailed mechanism 
remains unknown, the data suggests that in the environment of the macrophage (high 
nitric oxide and cAMP levels) transcription of the essential transcription factor whiB1 
will be inhibited. This is consistent with entry of M. tuberculosis into the dormancy 
state. At low nitric oxide concentrations (related to the immunocompromised state), 
holo-WhiB1 is formed, de-repressing whiB1 transcription, consistent with emergence 
from dormancy (Smith et al., 2010). 
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Figure 4.15: Model depicting nitric oxide- and cAMP-mediated regulation of 
whiB1 expression. The forms of WhiB1 are represented by labelled circles, where no 
specific form is indicated this represents a mixture of oxidised and reduced apo-WhiB1 
and nitrosylated-WhiB1.  The whiB1 promoter DNA (PwhiB1), Rv3676 (labeled 
circles), nitric oxide and iron-sulphur cluster biosynthesis machinery are also indicated. 
Clockwise from bottom left, when cAMP levels are low and nitric oxide is absent, 
transcription of whiB1 occurs at basal levels.  At intermediate concentrations of cAMP, 
expression of whiB1 is activated by the M. tuberculosis CRP protein (Rv3676) binding 
at class I site to allow increased synthesis of apo-WhiB1 (Stapleton et al., 2010).  At 
high concentrations of cAMP, Rv3676 occupies tandem sites at PwhiB1 and represses 
whiB1 expression. Apo-WhiB1 protein acquires a [4Fe-4S]
2+
 resulting in the non-DNA-
binding form.  Each WhiB1 [4Fe-4S]
2+
 cluster reacts rapidly with 8 nitric oxide 
molecules to produce a mixture of DNIC and RRE complexes.  In the presence of 
oxygen, the nitrosylated form of WhiB1 slowly degrades to yield apo-WhiB1 (Figure 
4.9). DNA-binding activity has been demonstrated for reduced and oxidised apo-WhiB1 
and nitric oxide-treated WhiB1. The DNA-binding apo-WhiB1 severely represses 
whiB1 expression in vitro in the presence and absence of the M. tuberculosis CRP, 
Rv3676, by interactions at sites located upstream and downstream of the Rv3676 
binding sites.  Apo-WhiB1 can be switched off by the action of the iron-sulphur cluster 
assembly machinery to regenerate the non-DNA-binding holo-WhiB1 resulting in de-
repression of whiB1 expression and synthesis of apo-WhiB1 protein.  Figure and legend 
from Smith et al. (2010). 
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A key question arising from these observations is ‘what are the roles of the various 
forms of WhiB1?’ WhiB1 has been shown to exist in [4Fe-4S], [2Fe-2S], nitrosylated, 
reduced apo-, and oxidised apo- forms. Apo-WhiB1 and nitric oxide-treated-holo-
WhiB1 both bind to the whiB1 promoter specifically, and the binding of the apo-form is 
affected by oxidation state with two species being formed in oxidising conditions 
(Sections 4.5.1 – 4.5.4; Figures 4.10 – 4.12). It is thought that the slower migrating 
complex (Figure 4.11B) is formed by PwhiB1 and oxidised (disulphide) apo-WhiB1, 
whereas the faster migrating species is formed by PwhiB1 and reduced (dithiol) apo-
WhiB1 (Figure 4.11B) or PwhiB1 and nitrosylated-WhiB1 (Figure 4.11A). The DNA-
binding activity of WhiB1 is therefore modulated by its nitric oxide-responsive iron-
sulphur cluster and the oxidation state of the protein. Further work is now required to 
establish whether all the various forms have distinct functions, or whether they have 
overlapping activities and which of the forms present in vitro are physiologically 
relevant. 
 
To conclude, WhiB1 from M. tuberculosis is an essential protein with a [4Fe-4S] cluster 
that acts as a specific nitric oxide-sensor converting it from a non-DNA-binding protein 
to a DNA-binding protein capable of repressing its own transcription. This sensing of 
nitric oxide and the resulting switch in DNA-binding, as well as the essential nature of 
WhiB1, has implications for the control of M. tuberculosis gene expression during the 
infection process (Smith et al., 2010). 
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5.0 Structure-function relationships of WhiB1 
 
5.1 Introduction 
 
To further our understanding of WhiB1, the structure-function relationships of the 
protein were analysed using site-directed mutagenesis of several amino acids. Residues 
involved in iron-sulphur cluster coordination, those that may be potentially involved in 
modulating the cluster environment, and residues in the predicted DNA-binding region 
were altered to discover those important for WhiB1’s function as a nitric oxide-sensing 
transcription factor. 
 
Like most members of the Wbl family in the Actinomycetes, WhiB1 has four conserved 
cysteine residues (C9, 37, 40 and 46) in its N-terminal region. They are believed to act 
as the ligands for the [4Fe-4S] iron sulphur cluster (Crack et al., 2011; Smith et al., 
2010). Replacement of all four conserved cysteine residues at once in WhiB3 from 
Mycobacterium tuberculosis abolished cluster coordination (Singh et al., 2007), and the 
in vivo function of WhiD from Streptomyces coelicolor required all four cysteine 
residues (Jakimowicz et al., 2005). Interestingly, in the WhiB2 protein from 
Mycobacterium smegmatis, only three of the four cysteine residues were required for 
function in vivo. The cysteine 67 residue (equivalent to C9 in WhiB1) was not required 
for function, whereas the aspartic acid 71 residue (equivalent to D13 in WhiB1) was 
(Raghunand and Bishai, 2006b). The four cysteine residues of WhiB1 and the aspartic 
acid 13 residue were all individually altered to alanine and their role in cluster ligation 
analysed. 
 
As shown in Chapter 4, the iron-sulphur cluster of WhiB1 is stable upon exposure to 
oxygen but reacts rapidly with nitric oxide (Crack et al., 2011; Smith et al., 2010). The 
stability of the iron-sulphur cluster to oxygen is unusual, and residues potentially 
involved in aiding this feature were identified. The transcription factor FNR of 
Escherichia coli contains an oxygen-sensitive [4Fe-4S] cluster, and residues involved in 
promoting this have been analysed (Bates et al., 2000; Jervis et al., 2009). The serine 24 
to phenylalanine variant of FNR had increased oxygen stability, and structural models 
suggested that the cysteine 23 ligand is shielded by the phenylalanine side-chain thereby 
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protecting the cluster (Jervis et al., 2009). In contrast, serine at position 24 is believed to 
permit the interaction of the FNR [4Fe-4S] with oxygen. A proline residue (P41) in a 
similar position to serine 24 in WhiB1 was altered to serine to see whether this variant 
may have increased oxygen sensitivity and thus implicate proline in control of the 
cluster environment. Another residue involved in oxygen sensitivity of the iron-sulphur 
cluster of FNR is leucine 28 as shown by Bates et al. (2000). Alteration of leucine 28 to 
histidine produced a variant that was functional under aerobic conditions, i.e. the cluster 
did not undergo rapid disassembly (Bates et al., 2000). A glutamic acid residue (E45) in 
a comparable position to leucine 28 was altered to leucine to determine whether this 
would increase the oxygen sensitivity of the iron-sulphur cluster of WhiB1. 
 
As discussed in Chapter 4, apo- and NO-treated-holo-WhiB1 are capable of binding to 
whiB1 promoter DNA (Smith et al., 2010). The C-terminal region of WhiB1 is 
predicted to encode the DNA-binding domain. Sequence analysis and secondary 
structure predictions suggest the presence of a β-turn motif (58GVWGG62) followed by a 
predicted helical region (
63
EDERRALKRRNA
76
), forming part of an unconventional 
helix-turn-helix. There is very little evidence that these features of the C-terminal region 
are involved in DNA-binding, except in the Mycobacteriophage protein WhiBTM4. The 
variants L55Q, V56D, V58E (in the β-turn) and R67C (in the helix) of WhiBTM4 
showed impaired DNA-binding (Rybniker et al., 2010). Amino acid sequence alignment 
of 28 Wbl proteins using ClustalW identified two regions (
72
KRRN
75
 and 
78
TKAR
81
) 
located downstream of the β-turn that are highly conserved in the WhiB1 members. 
These positively-charged regions, along with the β-turn were targeted for site-directed 
mutagenesis to determine their role in DNA-binding, to hopefully provide new 
information on the importance of specific regions in the C-terminal domain. 
 
5.2 Site-directed mutagenesis 
 
To produce WhiB1 with the specified amino acid substitution, site-directed mutagenesis 
was carried out using the overexpression plasmid pGS2164 encoding His-WhiB1 as the 
template and primers designed to alter the amino acid in question (Sections 2.4.7 and 
2.4.10). The resulting plasmids were sequenced by Source Bioscience and those with 
the correct substitutions were transferred to BL21 (DE3) and used for the analysis 
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described in this chapter. Tables 2.1 and 2.2 detail all of the strains and plasmids 
containing the required amino acid alteration respectively.  
 
5.3 Analysis of the four cysteine residues involved in cluster-binding 
 
5.3.1 Iron-sulphur cluster incorporation of the four cysteine variants 
 
The four cysteine residues (C9, C37, C40 and C46) were individually altered to alanine 
to determine their role in cluster-binding. Each of the four proteins were overproduced 
and purified as described for wild-type WhiB1 (Sections 3.2.1 and 3.2.2). Wild-type 
WhiB1 purified with some colour, as previously shown (Figure 3.3) whereas the four 
variants were colourless after purification. The cysteine variant proteins (C9A, C37A, 
C40A and C46A) as well as wild-type WhiB1 (all 30 μM) were then anaerobically 
incubated overnight with the components for iron-sulphur cluster incorporation as 
described previously (Section 3.3.1). The wild-type WhiB1 turned straw-yellow, 
indicative of it binding a [4Fe-4S] cluster, whereas C9A, C37A, C40A and C46A 
showed little change in colour (Figure 5.1A). All proteins were then separated from 
unincorporated reconstitution components using heparin chromatography (Section 
3.3.2). The four cysteine variants were colourless compared to wild-type WhiB1 (Figure 
5.1B). This indicates their inability to incorporate an iron-sulphur cluster. 
 
To confirm the absence of iron-sulphur clusters in the four cysteine variants, UV-visible 
spectroscopy was carried out on them alongside wild-type apo- and holo-WhiB1 
(Section 2.6.4). Holo-WhiB1 (4.5 μM) showed an absorbance spectrum with a 
characteristic peak at 420 nm, indicative of a [4Fe-4S] cluster (Figure 5.2). The four 
cysteine variants (C9A, 2.5 μM; C37A, 3.7 μM; C40A, 3.6 μM; C46A, 3.6 μM) showed 
no peak at 420 nm and had spectra which resembled that of apo-WhiB1 (2.3 μM) 
(Figure 5.2). The A420 nm:A280 nm ratios were 0.35, wild-type holo-WhiB1; 0.06, C9A; 
0.06, C37A; 0.04, C40A; 0.09, C46A; and 0.02 wild-type apo-WhiB1. All samples were 
analysed in 25 mM Tris (pH 7.4) containing 0.5 M NaCl and 10 % glycerol. These data, 
taken together show that all four cysteine residues are required for cluster ligation. 
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Figure 5.1: Photographs depicting the reconstitution reaction of WhiB1. The 
four cysteine mutants of WhiB1, alongside the wild-type, were incubated with 
the reconstitution components overnight under anaerobic conditions and 
photographed (A). Each reaction was filtered and purified using heparin 
Sepharose to isolate the protein from un-incorporated reactants and photographed 
(B). 
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Figure 5.2 UV-visible spectroscopic analysis of wild-type WhiB1 and the four 
cysteine mutants. Wild-type (WT) WhiB1 and the four cysteine variants were 
anaerobically incubated with the components for reconstitution of the iron-sulphur 
clusters. The samples were purified by heparin chromatography and spectra obtained for 
the resulting proteins; WT (4.5 μM), C9A (2.5 μM), C37A (3.7 μM), C40A (3.6 μM), 
C46A (3.6 μM). Apo-WhiB1 (2.3 μM) was also shown for comparison. 
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5.3.2 DNA-binding properties of the four cysteine variants 
 
As shown in Section 4.4.1 and (Smith et al., 2010), the apo-form of WhiB1 is capable 
of binding the whiB1 promoter DNA whereas the holo-form cannot. It was therefore 
expected that the cysteine variants would retain the ability to bind DNA, providing that 
they were correctly folded. Electromobility shift assays (Section 2.7.3) were carried out 
to test this hypothesis. Increasing concentrations (0, 1, 2, 5, 10 and 15 μM) of wild-type 
apo-WhiB1, C9A, C37A, C40A and C46A were incubated with ~3 ng of radiolabelled 
PwhiB1 (Section 2.7.1) before separation of protein-DNA complexes from free PwhiB1. 
Figure 5.3 shows how each of the cysteine variants binds PwhiB1 in the same manner as 
wild type apo-WhiB1 (compare top panel to middle and bottom panels). This shows that 
the cysteine residues, although essential for cluster ligation, are not required for DNA-
binding. 
 
5.4 Analysis of the WhiB1-D13A variant 
 
5.4.1 Iron-sulphur cluster characterisation of WhiB1-D13A 
 
As mentioned above, the iron-sulphur cluster of WhiB2 from M. smegmatis is thought 
to be ligated by three cysteine residues and a conserved aspartate residue (D71) 
(Raghunand and Bishai, 2006b). The conserved aspartate 13 residue in WhiB1 was 
therefore altered to an alanine and the resulting protein analysed. The D13A variant of 
WhiB1 was overproduced and purified as described for wild-type WhiB1 (Sections 
3.2.1 and 3.2.2). The resulting protein (72 μM) was anaerobically incubated with the 
components for iron-sulphur cluster reconstitution overnight (Section 3.3.1). The D13A 
sample was straw-yellow in colour indicating that it had acquired a [4Fe-4S] cluster. It 
was then purified by heparin chromatography (Section 3.3.2) before analysis using UV-
visible spectroscopy. An absorbance spectrum was obtained for D13A (18.75 μM) in 25 
mM Tris (pH 7.4) containing 0.5 M NaCl, 10 % glycerol and 1 mM DTT (Figure 5.4A). 
An absorbance peak at 420 nm, indicative of a [4Fe-4S] cluster, was observed 
resembling the absorbance spectrum of wild-type holo-WhiB1. Exposure to 110 μM 
oxygen caused little change in absorbance at 420 nm over 24 hours (Figure 5.4A). In 
contrast, exposure of 20 μM D13A (in 25 mM Tris (pH 7.4) containing 0.5 M NaCl, 
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Figure 5.3: DNA-binding properties of the four cysteine mutants of WhiB1. 
Radiolabelled PwhiB1 was incubated with increasing concentrations of the indicated 
WhiB1 proteins before separation of protein-DNA complexes (PwhiB1-WhiB1) from 
free DNA (PwhiB1) by electrophoresis. Lanes 1, no protein; lanes 2-6 contain, 1, 2, 5, 
10 and 15 M WhiB1 respectively. The locations of PwhiB1 and PwhiB1-WhiB1 
complexes are indicated. 
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Figure 5.4: UV-Visible spectroscopy of the D13A variant of WhiB1. (A) WhiB1-
D13A (18.75 μM) incorporates a [4Fe-4S] cluster (red line).  The cluster was stable 
under 110 μM oxygen for up to 24 hours (orange and blue lines). (B) WhiB1-D13A 
reacts with nitric oxide.  Reconstituted protein (20 μM; red line) was exposed to Proli 
NONOate (228 μM; blue line). 
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10 % glycerol and 1 mM DTT) to 228 μM Proli NONOate (~20 fold molar excess of 
nitric oxide) caused a change in the absorbance spectrum. An increase at 350-360 nm 
could be seen, due to the formation of nitrosylated iron-sulphur clusters (Figure 5.4B). 
This reaction was extremely rapid (almost complete within one minute at 25°C) and 
showed the same characteristics as the reaction of wild-type holo-WhiB1 to nitric oxide. 
It was concluded that the D13A variant therefore coordinates an oxygen-insensitive but 
nitric oxide-sensitive [4Fe-4S] cluster, in a similar manner to wild-type WhiB1. This 
shows that aspartic acid 13 does not have a role in cluster binding, and corroborates the 
findings that the iron-sulphur cluster of WhiB1 is ligated by the four cysteine residues. 
 
5.4.2 DNA-binding properties of WhiB1-D13A 
 
As shown, the D13A variant had no effect on cluster acquisition. Due to the location of 
this residue being in the N-terminal domain, it was not expected to have an effect on 
DNA-binding by the apo-form to PwhiB1. An electromobility shift assay (Section 2.7.3) 
was carried out to determine whether the D13A variant could bind PwhiB1. Increasing 
concentrations (0, 0.5, 1, 2, 4, 8 and 16 μM) of apo-WhiB1-D13A were incubated with 
~3 ng of radiolabelled PwhiB1 (Section 2.7.1) before separation of protein-DNA 
complexes from free PwhiB1. Figure 5.5 shows how the D13A variant binds the whiB1 
promoter in the same manner as wild-type apo-WhiB1 (Figure 5.3, top panel). These 
findings further confirm that the D13A variant of WhiB1 has properties similar to those 
of wild-type WhiB1. 
 
5.5 Analysis of the P41S and E45L WhiB1 variants 
 
The WhiB1 proline 41 residue was altered to serine to determine whether this variant 
would become more oxygen sensitive, based on the findings that alteration of a serine in 
a similar position to phenylalanine in FNR decreases its oxygen sensitivity (Jervis et al., 
2009). The P41S variant was overproduced as described for wild-type (Section 3.2.1). 
Following cell breakage using the French pressure method (Section 2.5.4), the protein 
was found almost exclusively in the insoluble fraction. Attempts to purify WhiB1-P41S 
from the soluble cell-free extract using its histidine tag provided negligible amounts of 
protein (Section 2.5.5). The protein was then recovered from the insoluble fraction by 
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Figure 5.5: DNA-binding properties of WhiB1-D13A. Radiolabelled PwhiB1 was 
incubated with increasing concentrations of WhiB1-D13A before separation of protein-
DNA complexes (PwhiB1-WhiB1) from free DNA (PwhiB1) by electrophoresis. Lane 
1, no protein; lanes 2-7 contain, 0.5, 1, 2, 4, 8 and 16 M WhiB1 respectively. The 
locations of PwhiB1 and PwhiB1-WhiB1 complexes are indicated. 
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agitation in 6 M guanidine hydrochloride overnight at 4°C before centrifugation 
(Section 2.5.6). The soluble fraction, containing the P41S variant, was then applied to a 
HiTrap
TM
 chelating column using the refolding programme to attempt to obtain 
functional protein (Section 2.5.6). Levels of pure refolded WhiB1-P41S were very low 
(~1 mg from 5 litres culture). Attempts to reconstitute the iron-sulphur cluster were 
unsuccessful, possibly due to low protein concentration, or mis-folding. It was 
concluded that this single amino acid residue is essential for maintaining the structural 
integrity of WhiB1 and further analysis was not carried out. 
 
The glutamic acid 45 residue was altered to leucine to determine whether this change 
would promote oxygen sensitivity. This residue was chosen, because alteration of 
leucine to histidine in a similar position in FNR decreased the oxygen sensitivity of the 
cluster (Bates et al., 2000). As discussed for the P41S mutant, after overproduction and 
cell breakage the E45L was found almost exclusively in the insoluble fraction. Upon 
solubilisation with 6 M guanidine hydrochloride and refolding (Section 2.5.6), ~1.5 mg 
of E45L was obtained from 5 litres culture. Attempts to reconstitute the iron-sulphur 
cluster of this variant were also unsuccessful. It was again concluded that this single 
amino acid residue is essential for maintaining the structural integrity of WhiB1 and 
further analysis was not carried out. 
 
Due to the inability to achieve soluble and correctly folded P41S and E45L, the protein 
containing a P41S:E45L double alteration was not analysed. 
 
5.6 Analysis of the GVWGG β-turn region 
 
5.6.1 DNA-binding properties of the β-turn variants 
 
As discussed above, the GVWGG motif encoding a predicted β-turn is highly conserved 
in the Wbl family of proteins. These residues were all individually altered to glutamic 
acids residues as well as the serine immediately before the first glycine, as the 
equivalent residue in WhiBTM4 was shown to be involved in DNA-binding (Rybniker 
et al., 2010). The S57E, G58E, V59E, W60E, G61E and G62E variants were all 
overexpressed and purified as described for wild-type WhiB1 (Sections 3.2.1 and 3.2.2). 
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They were then used in electromobility shift assays to determine their DNA-binding 
properties (Section 2.7.3). Increasing amounts of each variant (0, 2.5, 5, 7.5 and 10 μM 
for all then 12.5 μM for V59E and 12.5 and 15 μM for S57E, W60E, G61E and G62E) 
were incubated with ~3 ng radiolabelled PwhiB1 (Section 2.7.1) before separation of 
protein-DNA complexes from unbound PwhiB1. The replacement of the S57, V59 and 
W60 residues with glutamic acid did not significantly impair the ability of the WhiB1 to 
bind PwhiB1 (Figure 5.6). Replacement of the three glycine residues (G58, G61 and 
G62) with glutamic acid however, inhibited DNA-binding to the whiB1 promoter. This 
suggests that the structural integrity of the predicted β-turn is in part due to the glycine 
residues and is crucial for DNA-binding. 
 
5.6.2 Iron-sulphur cluster coordination of selected β-turn variants 
 
To confirm that the lack of DNA-binding in the glycine variants was due to the essential 
nature of these residues and not due to disruption of the overall fold of the protein, the 
G61E and G62E variants were analysed for their ability to incorporate an iron-sulphur 
cluster. G61E (128 μM) and G62E (66.8 μM) were anaerobically incubated overnight 
with the components for iron-sulphur cluster reconstitution (Section 3.3.1). The 
resulting protein samples were analysed using UV-visible spectroscopy. The absorption 
spectra for both G61E and G62E showed a peak at 420 nm, indicative of the presence of 
a [4Fe-4S] cluster (Figure 5.7). This indicates that the inability of the glycine residue 
variants to bind DNA is not due to the overall disruption of the protein fold. 
 
5.7 Analysis of conserved regions in the DNA-binding domain 
 
5.7.1 DNA-binding properties of variants 
 
As noted above, two highly conserved regions in the C-terminal domain of WhiB1 
proteins were identified: 
72
KRRN
75
 and 
78
TKAR
81
. The positively-charged lysine and 
arginine residues in the first region were individually altered to glutamic acid residues 
for analysis of the DNA-binding abilities of the resulting proteins. The positive lysine 
and arginine residues in the second region, as well as arginine 77, were also altered to  
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Figure 5.6: DNA-binding properties of variants in the β-turn of WhiB1. 
Radiolabelled PwhiB1 was incubated with increasing concentrations of the indicated 
WhiB1 proteins before separation of protein-DNA complexes (PwhiB1-WhiB1) from 
free DNA (PwhiB1) by electrophoresis. Lanes 1, no protein; lanes 2-7 contain, 2.5, 5, 
7.5, 10, 12.5 and 15 M WhiB1 respectively. The locations of PwhiB1 and PwhiB1-
WhiB1 complexes are indicated. 
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Figure 5.7: The WhiB1 G61E and G62E variants incorporate an iron-sulphur 
cluster. G61E (128 μM) and G62E (66.8 μM) were incubated anaerobically with the 
components for iron-sulphur cluster reconstitution. UV-visible spectroscopy shows a 
peak at 420 nm for both variants, indicating the presence of a [4Fe-4S] cluster. 
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glutamic acids. The latter residue is heavily conserved throughout the Wbl proteins used 
in the sequence alignment and thus was also analysed. Each of the variants was used in 
electromobility shift assays to determine their ability to bind PwhiB1 (Section 2.7.3). 
Increasing concentrations of protein (0, 2.5, 5, 7.5 and 10 μM for all; 12.5 and 15 μM 
for all apart from K72E) were incubated with ~3 ng of radiolabelled PwhiB1 (Section 
2.7.1) before separation of protein-DNA complexes from unbound PwhiB1. The 
alteration of all these positively-charged residues to negatively-charged glutamic acid 
abolished DNA-binding (Figure 5.8). This suggests that the positive nature of these 
conserved regions is essential for DNA-binding. 
 
5.7.2 Iron-sulphur cluster coordination of selected variants 
 
To confirm that the inability of the non-DNA-binding variants was due to their essential 
nature rather than disruption to overall protein fold, the capability of R74E, R77E and 
K79E to incorporate an iron-sulphur cluster was determined. These three variants were 
purified in the holo-form as could be seen from the characteristic straw-yellow colour of 
the fractions. Spectra were obtained using UV-visible spectroscopy (Figure 5.9). A peak 
at 420 nm can be seen for all three variants, indicative of the presence of a [4Fe-4S] 
cluster (13 μM R74E, 14 μM R77E and 11 μM K79E cluster concentration). This shows 
that these amino acids are essential for binding to the whiB1 promoter but alteration of 
them does not affect the overall protein fold.    
 
5.8 Discussion 
 
WhiB1 is an essential iron-sulphur cluster protein. Upon exposure to nitric oxide, it 
switches from a non-DNA-binding holo-from to a DNA-binding nitrosylated 
transcription factor with the apo-form also capable of binding DNA (Crack et al., 2011; 
Smith et al., 2010; Stapleton et al., 2012). Other members of the Wbl family of the 
Actinomycetes have also been recognised as transcription factors with functions 
determined by nitric oxide (Rybniker et al., 2010; Singh et al., 2007). There has been 
little published on the structure-function relationships of this family of proteins, and this 
site-directed mutagenesis study has provided new insights into WhiB1 (Smith et al., 
2012). 
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Figure 5.8: DNA-binding properties of variants in the C-terminal region of WhiB1. 
Radiolabelled PwhiB1 was incubated with increasing concentrations of the indicated 
WhiB1 proteins before separation of protein-DNA complexes (PwhiB1-WhiB1) from 
free DNA (PwhiB1) by electrophoresis. Lanes 1, no protein; lanes 2-7 contain, 2.5, 5, 
7.5, 10, 12.5 and 15 M WhiB1 respectively. The location of PwhiB1 is indicated. 
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Figure 5.9: The WhiB1 R74E, R77E and K79E variants incorporate an iron-
sulphur cluster. The three variants shown were purified from the cell-free extract with 
a characteristic straw-yellow colour. UV-visible spectroscopy showed a peak at 420 nm, 
indicating the presence of a [4Fe-4S] cluster. 
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WhiB1 has four highly conserved cysteine residues, which are common ligands for 
iron-sulphur cluster coordination. The alteration of each residue individually rendered 
WhiB1 incapable of incorporating an iron-sulphur cluster, showing the essential nature 
of each (Figures 5.1 and 5.2). This corresponds to similar information on WhiD from S. 
coelicolor, whereby individual alteration of the four cysteine residues to alanine 
prevented in vivo activity (Jakimowicz et al., 2005). Singh et al. also showed that 
simultaneous mutation of all cysteine residues in M. tuberculosis WhiB3 led to the 
inability to coordinate an iron-sulphur cluster (Singh et al., 2003). In contrast, the C36S 
and C45S variants of the Mycobacteriophage WhiBTM4 protein had some ability to 
bind an iron-sulphur cluster, although they had increased oxygen sensitivity (Rybniker 
et al., 2010). The cysteine residues of WhiB4 from M. tuberculosis have all been 
implicated in iron-sulphur cluster binding, although each variant protein retained some 
ability to coordinate a cluster albeit with reduced capacity in comparison to wild-type 
(Alam et al., 2007). The two cysteine residues in the CXXC motif (C59 and C62) 
showed the biggest reduction in cluster binding (Alam et al., 2007). This information 
shows the importance of the cysteine residues of WhiB1 is similar to that of WhiD from 
S. coelicolor. The aspartic acid residue (D13) was not important in cluster ligation for 
WhiB1 (Figure 5.4), unlike the corresponding aspartic acid 71 residue of WhiB2 in M. 
smegmatis. The D71 residue was shown to act as the fourth ligand for the iron-sulphur 
cluster of WhiB2, with replacement of cysteine 67 having no effect on protein function 
(Raghunand and Bishai, 2006b). Similarly, the [4Fe-4S] cluster of FNR from Bacillus 
subtilis is ligated by three of its six cysteine residues (C227, C230 and C235) and the 
aspartic acid 141 residue (Gruner et al., 2011; Reents et al., 2006).  The WhiB1 iron-
sulphur cluster is stable in the presence of oxygen but reacts rapidly with nitric oxide, 
and these properties were not affected by replacement of the conserved aspartic acid 
(D13) residue with alanine (Figure 5.4). The environment surrounding the iron-sulphur 
cluster, modulated by the amino-acid side chains, is likely to be responsible for 
controlling the cluster’s sensitivity. The two residues targeted to determine this, proline 
41 and glutamic acid 45, are likely to be essential for general protein fold as soluble 
correctly folded protein was unobtainable. Further targeted mutagenesis of surrounding 
amino acids is necessary to try to understand the cluster’s environment. The four 
cysteine variants, and the aspartic acid variant, showed DNA-binding capabilities 
similar to that of wild type (Figures 5.3 and 5.5). This was expected as it is the C-
terminal domain of Wbl proteins that is believed to be involved in DNA-binding, as 
opposed to the N-terminal domain. 
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The C-terminal domain of the Wbl proteins has long been considered to be responsible 
for DNA-binding (den Hengst and Buttner, 2008). There have however been few 
attempts to define the molecular requirements for DNA-binding by Wbl proteins. Three 
proteins with C-terminal truncations of the M. smegmatis protein WhiB2 were produced 
with differing activities (Raghunand and Bishai, 2006b). A truncation lacking twelve 
amino acids (corresponding to the second helix of the helix-turn-helix motif) showed 
similar activity to wild-type. Truncations lacking the turn-helix and the helix-turn-helix 
showed partial activity and no activity respectively (Raghunand and Bishai, 2006b). 
This shows the importance of the predicted C-terminal helix-turn-helix in function, but 
does not show specific residues involved in DNA-binding. Electromobility shift assays 
carried out on loss of function mutants in WhiBTM4 indicated that amino acid 
substitutions directly before and in the C-terminal β-turn (L55Q, V56D and V58E) 
inhibited DNA-binding (Rybniker et al., 2010). As shown for WhiB1, replacement of 
the three glycine residues (G58E, G61E and G62E) in the GVWGG β-turn motif 
inhibited DNA-binding (Figure 5.6). These two independent studies indicate that the 
structural integrity of the β-turn is necessary for DNA-binding in WhiB1 and 
WhiB4TM4. A fourth WhiBTM4 variant encoding a replacement of arginine 67 in the 
predicted helix with cysteine also caused impaired DNA-binding (Rybniker et al., 
2010). Therefore two conserved positively-charged motifs (KRRN and TKAR) found in 
WhiB1 proteins in the helix downstream of the β-turn, as well as a conserved arginine 
residue found in other Wbl proteins, were targeted for mutagenesis. The positively 
charged residues were altered to glutamic acid and all the resulting proteins were 
incapable of binding to the whiB1 promoter (Figure 5.8). This mutagenesis analysis, as 
well as that carried out on WhiBTM4, highlights the essential nature of the structural 
integrity of the β-turn and the positive charge of the helical region in DNA-binding. It is 
worth noting that these findings specifically affect DNA-binding and are not due to 
problems in overall protein fold as the variants were capable of incorporating an iron-
sulphur cluster (Figures 5.7 and 5.9). 
 
To conclude, the experiments described in this chapter to understand the structure-
function relationships of WhiB1 have shown at least three C-terminal motifs are 
essential for DNA-binding and that the interaction with DNA is inhibited by the 
presence of a [4Fe-4S] cluster ligated by cysteine residues 9, 37, 40 and 46.  
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6.0 Interaction of WhiB1 and Rv1675c with other promoters 
 
6.1 Introduction 
 
As shown in Chapter 4, apo-WhiB1 can bind at its own promoter (PwhiB1). This 
binding is specific and modulated by the presence and state of the iron-sulphur cluster, 
whereby holo-WhiB1 is incapable of DNA-binding but apo- and nitrosylated-WhiB1 
are. Here, work has been carried out to determine whether WhiB1 can interact with 
other promoters, namely that for the essential chaperonin gene groEL2 (Sassetti et al., 
2003). 
 
Expression of whiB1 is regulated by Rv3676c, a cAMP receptor protein (Rickman et 
al., 2005). Mycobacterium tuberculosis possesses a second cAMP receptor protein, 
Rv1675c (Cmr – cAMP and macrophage regulator) (McCue et al., 2000). Rv1675c has 
not been fully characterised, and was therefore the subject of further study here. 
Rv1675c has been identified as a cAMP-responsive transcription factor, regulating four 
cAMP-induced genes (Gazdik and McDonough, 2005; Gazdik et al., 2009). Of these 
four genes, Rv1675c bound the promoters of mdh (encoding a malate dehydrogenase), 
groEL2 and Rv1265 (a gene of unknown function) suggesting direct regulation (Gazdik 
et al., 2009). Here, we aim to confirm its ability to bind the groEL2 promoter, and to 
characterise the DNA-binding properties of Rv1675c with a selection of other 
promoters. A number of genes were identified to be potentially regulated by Rv1675c 
by DNA microarrays (Debbie Hunt, unpublished data). Four genes were selected for 
analysis here; Rv2007c, fdxA encoding a ferredoxin; Rv2032, an acr-coregulated gene of 
unknown function; Rv3133c, dosR encoding the regulator of the 2-component DosRS 
system; Rv3134c, encoding a gene of unknown function that may play a role in the 
phosphorelay of the DosRS system. All of the genes are predicted to be in the DosRS 
regulon and by completing DNA-binding experiments with the promoters for these four 
genes, it was hoped to determine whether Rv1675c can interact with them all 
individually or whether the regulatory effect is through interaction with dosR.  Thus, the 
work presented in this chapter aims to understand the larger regulatory role of WhiB1 in 
response to the important signalling molecules, nitric oxide and cAMP. 
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6.2 Interaction of WhiB1 with the groEL2 promoter region 
 
Electromobility shift assays were carried out to determine whether WhiB1 could bind to 
the promoter of groEL2 as described in Section 2.7.3. Increasing concentrations of apo-
WhiB1 (0, 0.25, 5, 10, 20 and 40 µM) were incubated separately with ~1.6 nm 
radiolabelled PgroEL2 (Section 2.7.1) before separation of protein-DNA complexes 
from free DNA by electrophoresis. Figure 6.1A shows how apo-WhiB1 binds PgroEL2 
(lanes 4-6). As discussed in Chapter 4, holo-WhiB1 is incapable of binding to whiB1 
promoter DNA (Figure 4.10). This observation can also be seen for holo-WhiB1 and 
PgroEL2 (Figure 6.1B). The binding of apo-WhiB1 to the groEL2 promoter is specific, 
as shown for binding to PwhiB1, as addition of unlabelled PrpfA in competition EMSAs 
did not affect binding (Stapleton et al., 2012). As previously discussed in Chapter 4, 
WhiB1 was unable to bind to the rpfA, ahpC and Rv3616c promoters, further indicating 
that DNA-binding of WhiB1 is specific to PwhiB1 and PgroEL2 (Smith et al., 2010; 
Stapleton et al., 2012). EMSAs were carried out by Dr Melanie Stapleton (Stapleton et 
al., 2012). 
 
6.3 Characterisation of Rv1675c 
 
6.3.1 Optimisation of Rv1675c overproduction 
 
Electrically competent cells of Escherichia coli BL21 λ(DE3) were transformed with 
pGS2103, encoding recombinant His-Rv1675c. 
 
Trials to discover the best conditions for overproduction of His-Rv1675c were 
completed in 10 ml cultures. To first determine the optimum time for induction, 100 µl 
of an overnight culture was added to a 10 ml volume of LB containing kanamycin. The 
culture was grown at 37 °C with shaking (250 rpm) until an OD600 of ~0.8 was reached. 
IPTG was added to a final concentration of 30 µg/ml and the culture returned to 37 °C 
with shaking. Whole cell samples were taken before induction and at 60, 90, 120, 150, 
180 and 210 minutes post induction for analysis by SDS-PAGE as described in Section 
2.5.2 (Figure 6.2A). There was a prominent polypeptide at ~30.5 kDa in all post- 
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Figure 6.1: DNA-binding properties of WhiB1 at the groEL2 promoter region 
(PgroEL2). (A) WhiB1 binds PgroEL2. Radiolabelled PgroEL2 was incubated with 
increasing concentrations of WhiB1 before separation of protein-DNA complexes 
(PgroEL2-WhiB1) from free DNA (PgroEL2) by electrophoresis. Lanes 1, no protein; 
lanes 2-6 contain 2.5, 5, 10, 20 and 40 M apo-WhiB1 respectively. The locations of 
PgroEL2-WhiB1 and PgroEL2 are indicated. (B) Holo-WhiB1 does not bind 
PgroEL2. Radiolabelled PgroEL2 was incubated with apo-WhiB1 or holo-WhiB1 
before separation of protein-DNA complexes (PgroEL2-WhiB1) from free DNA 
(PgroEL2) by electrophoresis. Lane 1, no protein; lane 2, 20 M apo-WhiB1; lane 3, 20 
M holo-WhiB1. The locations of PgroEL2 and PgroEL2-Rv1675c are indicated. 
EMSAs were carried out by Dr Melanie Stapleton and are reported in Stapleton et al., 
2012. 
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Figure 6.2: Optimisation of overexpression of recombinant Rv1675c in BL21 
λ(DE3). (A) Comparison of different induction times. Lane 1, Precision plus protein 
standards (molecular weights indicated in kDa); Lane 2, Cell extract before IPTG 
induction; Lanes 3-8, Cell extracts with 30 g/ml IPTG induction for 60, 90, 120, 150, 
180 and 210 minutes. (B) Comparison of different IPTG concentrations. Lane 1, 
Precision plus protein standards (molecular weights indicated in kDa); Lane 2, Cell 
extract before IPTG induction; Lanes 3-7, Cell extracts after 120 minutes induction with 
30, 60, 120, 240 and 480 g/ml IPTG. (C) Comparison of different induction 
temperatures. Lane 1, Precision plus protein standards (molecular weights indicated in 
kDa); Lane 2, Cell extract before IPTG induction; Lanes 3-5, Cell extracts after 120 
g/ml IPTG induction for 2 hours at 25, 30 and 37 C. The location of the Rv1675c 
polypeptide is indicated. 
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induction fractions, corresponding to His-Rv1675c. There was little difference in 
relative abundance of His-Rv1675c as judged by SDS-PAGE, and 2 hours was chosen 
as it offered a good level of overproduction. Secondly, the ideal concentration of IPTG 
to use was determined. Growth was carried out as above and cultures were then induced 
with 30, 60, 120, 240 and 480 µg/ml of IPTG for 2 hours. Whole cell samples were 
taken for SDS-PAGE analysis (Figure 6.2B). The final concentration of 120 µg/ml of 
IPTG was chosen as it offered good overproduction, but all IPTG concentrations were 
effective. The use of different induction temperatures was the final condition tested in 
optimising His-RV1675c overproduction. Growth was again carried out as described 
above and cultures were then induced with 120 µg/ml IPTG and moved to 25, 30 or 
37 °C for 2 hours. Whole cell samples were taken and analysed using SDS-PAGE 
(Figure 6.2C). There was good overproduction of Rv1675c at 25 °C, which was chosen 
as it was hoped that the lower temperature would assist protein folding and solubility. 
 
Upon finding the optimum overproduction conditions (induction with 120 µg/ml IPTG 
for 2 hours at 25 °C), Rv1675c was purified by affinity chromatography.  
 
6.3.2 Purification of His-Rv1675c overproduction 
 
Cell pellets from the overproduction of Rv1675c (1-5 litres of culture) (Section 2.5.3) 
were resuspended in binding buffer (10 ml) and lysed in a French pressure cell 
according to the method detailed in Section 2.5.4. After clarification of the cell-free 
pellet from the insoluble pellet, SDS-PAGE analysis showed Rv1675c to be in the 
soluble fraction (data not shown). This was subsequently used for affinity purification 
as described in Section 2.5.5. Figure 6.3A shows the elution profile from the HiTrap 
chelating column. Three peaks were seen on the elution profile for Rv1675c 
purification, and fractions corresponding to the peaks were analysed by SDS-PAGE 
(Figure 6.2B). The first two contained off-target proteins, but the third corresponded to 
Rv1675c, confirmed by the presence of a species on SDS-PAGE at ~30.5 kDa (Figure 
6.3B). The purification shown in Figure 6.3 was achieved using a 1 ml nickel affinity 
column. This provided a good level of Rv1675c from the soluble fraction (~11 mg from 
1 litre of culture). The conditions described in Section 6.3.1 for overproduction, and this 
method of purification, have thus provided a successful way of purifying Rv1675c using 
its histidine tag to be used in DNA-binding experiments. 
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Figure 6.3: (A) Elution profile from HiTrap chelating chromatography of cell-free 
extract containing His-Rv1675c. Supernatant (10 ml) was applied to a Hi-Trap 
chelating column (1 ml) and fractionated with a linear gradient of imidazole (0-1 M). 
The traces show protein (A280: blue line) and imidazole gradient (red line). The expected 
location of the Rv1675c is indicated. (B) Histidine-tagged purification of His-
Rv1675c. Coomassie Blue-stained SDS-PAGE gel: Lane 1, Precision plus protein 
standards (molecular weights indicated in kDa); Lanes 2-13, Fractions collected after 
application of the imidazole gradient corresponding to the three peaks seen in Figure 
6.2A. 
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6.3.3 DNA-binding of Rv1675c at the groEL2 promoter region 
 
Rv1675c has previously been shown to bind the groEL2 promoter region (Gazdik et al., 
2009). To corroborate these findings, electromobility shift assays were carried out with 
Rv1675c and PgroEL2 as described in Section 2.7.3. Increasing concentrations (0, 0.5, 
1, 2, 4, 8 and 16 µM) of Rv1675c were incubated with ~3 ng of radiolabelled PgroEL2 
(section 2.7.1), with or without 2 mM cAMP, before separation of protein-DNA 
complexes from free DNA. Figure 6.4 shows Rv1675c binds the PgroEL2 DNA in the 
presence and absence of cAMP (lanes 5-7 and 12-14). These data are consistent with the 
finding of Gazdik et al. (2009). 
 
6.3.4 DNA-binding of Rv1675c at selected promoter regions 
 
Electromobility shift assays (Section 2.7.3) were carried out with Rv1675c and the four 
promoters discussed in Section 6.1. Increasing concentrations (0, 0.5, 1, 2, 4, 8 and 
16 µM) of Rv1675c were incubated with ~3 ng of the desired radiolabelled promoter 
DNA (PRv2007c, PRv2032, PRv3133c or PRv3134c) (Section 2.7.1), before separation 
of protein-DNA complexes from free DNA. Figure 6.5 shows the DNA-binding ability 
of Rv1675c to these promoters. Rv1675c is unable to bind PRv2007c and PRv2032 
(Figure 6.5 A and B) but does bind PRv3133c and PRv3134c (Figure 6.5 C and D, lanes 
5-7). 
 
6.4 Discussion 
 
As discussed in Chapter 4, WhiB1 has been shown to be a nitric oxide-responsive 
transcription factor capable of binding to its own promoter (PwhiB1) and repressing its 
transcription (Smith et al., 2010). The work in this chapter has identified a second gene 
regulated by WhiB1, groEL2. Mycobacterium tuberculosis has two chaperonin genes; 
groEL1 (Rv3417c), which is dispensable and located downstream of whiB3 (Rv3416), 
encoding a member of the Wbl family of proteins, and the essential groEL2 (Rv0440) 
(Sassetti et al., 2003). Chaperonin proteins function in the sequestration and re-folding 
of mis-folded proteins in a chamber formed from two stacked heptameric rings of  
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Figure 6.4: Binding of Rv1675c at the groEL2 promoter (PgroEL2) is independent 
of cAMP. Radiolabelled PgroEL2 was incubated with increasing concentrations of 
Rv1675c, with or without cAMP as indicated, before separation of protein-DNA 
complexes (PgroEL2-Rv1675c) from free DNA (PgroEL2) by electrophoresis. Lanes 1 
and 8, no protein; lanes 2-7 and 9-14 contain, 0.5, 1, 2, 4, 8 and 16 M Rv1675c 
respectively. The locations of PgroEL2 and PgroEL2-Rv1675c are indicated. 
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Figure 6.5: DNA-binding properties of Rv1675c with different promoters. 
Radiolabelled PRv2007c (A), PRv2032 (B), P3133c (C) or P3134c (D) was incubated 
with increasing concentrations of Rv1675c before separation of protein-DNA 
complexes from free DNA by electrophoresis. Lanes 1, no protein; lanes 2-7 contain, 
0.5, 1, 2, 4, 8 and 16 M Rv1675c respectively. The location of free DNA (PRv2007c, 
PRv2032, P3133c or P3134c) and protein-DNA complexes (PRv3133c-Rv1675c or 
PRv3134c-Rv1675c) are indicated. 
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GroEL capped by GroES. Refolding can then occur in a process requiring ATP 
hydrolysis (Lund, 2009). GroEL2 from M. tuberculosis however, does not form such a 
structure but is dimeric and lacks ATPase activity (Qamra and Mande, 2004). GroEL2 
from M. tuberculosis has been shown to be highly antigenic whereby monocytes having 
phagocytosed mycobacteria are known to present GroEL2 on their cell surface to 
T lymphocytes (Friedland et al., 1993). Cytotoxic CD4
+
 cells may then lyse the GroEL2 
expressing monocytes (Ottenhoff et al., 1988). GroEL2 has also been shown to 
stimulate the release of cytokines interleukin-10 and tumour necrosis factor-α from 
monocytes in a CD14-independent manner (Friedland et al., 1993; Lethwaite et al., 
2001). Thus GroEL2, unlike other chaperonins, has a role in modulating the immune 
environment. 
 
Here, it is shown that apo-WhiB1 binds the groEL2 promoter region (Figure 6.1A) and 
that this binding is specific (Section 6.2; Stapleton et al., 2012). As shown for binding at 
the whiB1 promoter (Chapter 4; Smith et al., 2010), binding at PgroEL2 saturated over a 
narrow range of apo-WhiB1 concentrations, consistent with cooperative interactions 
with the DNA. This implies the presence of more than one apo-WhiB1 binding site. The 
entire of the Rv0439c-Rv0440 intergenic region was required for DNA binding by apo- 
and nitrosylated-WhiB1 binding, indicating its importance in forming a stable 
nucleoprotein complex and the likelihood of there being at least two binding sites for 
WhiB1 (Stapleton et al., 2012). DNase I footprinting identified only one locus of apo-
WhiB1 binding at PgroEL2, overlapping the -35 element, similar to that for binding at 
PwhiB1 (Stapleton et al., 2012; Smith et al; 2010). In vitro transcription assays showed 
apo-WhiB1 represses transcription of groEL2, which taken with the footprinting data, 
suggests that repression is by promoter occlusion (Stapleton et al., 2012; Figure 6.6). 
Due to the essential nature of the GroEL2 chaperonin, down-regulation of groEL2 
expression by WhiB1 in the presence of nitric oxide should therefore inhibit growth of 
M. tuberculosis. This may assist with entry into the dormant state. Furthermore, 
GroEL2 is highly antigenic and repression of its transcription by WhiB1 in the presence 
of nitric oxide, an important signal associated with infection, may aid in evasion of the 
immune response and promote the entrance into dormancy. 
 
Regulation of groEL2 expression has been attributed to a number of other regulatory 
pathways. Expression was increased upon heat shock in a process involving the 
repressor protein HrcA, and lowered in response to Mg(II)-starvation (Stewart et al.,  
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Figure 6.6: Model depicting the complex regulation of groEL2 expression. 
Expression of groEL2 is increased upon heat shock and decreased during Mg(II) 
starvation (Stewart et al., 2002; Walters et al., 2006). These effects on expression are 
indirect. Expression of groEL2 is directly repressed by WhiB1 in response to nitric 
oxide in vitro. Rv1675c directly activates groEL2 expression in vitro and this effect is 
independent of cAMP. An as of yet unidentified regulator may mediate the effect of 
cAMP on Rv1675c.  
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2002; Walters et al., 2006). The important signalling molecule cAMP has also been 
shown to have an effect on the regulation of expression of groEL2. Addition of 
exogeneous cAMP to Mycobacterium bovis BCG cultures increased the expression of a 
number of genes including groEL2. This effect was more pronounced under low oxygen 
conditions, suggesting a possible role for cAMP regulation during host infection 
(Gazdik and McDonough, 2005). This is further supported by experiments showing 
groEL2 transcription was increased after 24 hour macrophage infection (Li et al., 2001). 
Rv1675c, a member of the cAMP receptor protein family, has also been shown to 
regulate groEL2 expression whereby in a Rv1675c mutant strain of M. bovis BCG, 
expression of groEL2 was reduced two hours into macrophage infection (Gazdik et al., 
2009). Direct binding of Rv1675c to the groEL2 promoter in vitro was also seen 
(Gazdik et al., 2009). This direct binding has been confirmed here, and was shown to be 
unaffected by cAMP (Section 6.3.3; Figure 6.4). In vitro transcription reactions showed 
that Rv1675c activates groEL2 transcription and this occurs in the absence of cAMP, 
suggesting that Rv1675c does not directly mediate the cAMP effect on groEL2 
expression (Stapleton et al., 2012; Figure 6.6). 
 
Expression of the other known target of WhiB1, whiB1, also responds to cAMP via the 
cAMP receptor protein CRP (Rv3676) (Rickman et al., 2005; Stapleton et al., 2010). 
Expression of whiB1 has recently been shown to be 11-fold upregulated in the presence 
of cAMP (Larsson et al., 2012). Activation by cAMP-CRP is however inhibited by apo-
WhiB1, thus WhiB1 negatively autoregulates its own expression (Smith et al., 2010; 
Stapleton et al., 2010). It is therefore possible that the cAMP-mediated effects on 
groEL2 expression observed in vivo (Gazdik and McDonough, 2005) arise, at least in 
part, from the CRP-mediated regulation of whiB1.  
 
Work here has shown that both the known WhiB1 targets, whiB1 and groEL2, are 
linked to cAMP signalling. cAMP is an important signalling molecule in M. 
tuberculosis gene regulation (Gazdik and McDonough, 2005; Rickman et al., 2009; 
Stapleton et al., 2010) and upon infection of macrophages, mycobacterial cAMP has 
been shown to promote bacterial survival by subverting host signalling pathways 
(Agarwal et al., 2009). The interaction between cAMP-responsive regulators and the 
nitric oxide-responsive WhiB1 protein may provide a mechanism to integrate the 
transcriptional response to two important signals associated with infection. The 
interplay of these regulators, as well as their effects on the expression of the essential 
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chaperonin GroEL2 can be further analysed to get a better understanding of gene 
regulation in M. tuberculosis infection. 
 
Recent DNA microarray data have shown Rv1675c to negatively regulate a number of 
other genes, all of which are found in the DosRS regulon (D. Hunt, unpublished data). It 
was of interest to establish whether Rv1675c directly regulates these genes. As seen in 
Figure 6.5 (panels A and B), Rv1675c did not show direct binding to Rv2007c (fdxA 
encoding a ferredoxin) or Rv2032 (an acr-coregulated gene of unknown function). It did 
however bind to Rv3133c, encoding the regulator DosR of the 2-component DosRS 
system (Figure 6.5C). Interestingly, it also bound Rv3134c, which encodes a gene of 
unknown function but may play a role in the phosphorelay of the DosRS system (Figure 
6.5D). It appears likely that Rv1675c regulates the set of genes seen in the microarray 
data via the DosRS regulon. It could do this by binding to the promoter of dosR and   
Rv3134c. Further DNA-binding experiments with other genes controlled by the DosRS 
regulon, as well as the genes encoding the DosRS system will provide further 
information on the role of Rv1675c in its regulation. DNase I footprinting and in vitro 
transcription reactions will also provide a better insight into the breadth of Rv1675c 
influence on M. tuberculosis gene expression and the interplay with other regulators. 
The DosRS regulon is involved in the programming of the dormancy state of M. 
tuberculosis, responding to the important infection signals of nitric oxide and hypoxia 
(Voskuil et al., 2003). Non-toxic concentrations of nitric oxide induce a 48-gene 
regulon, via the response regulator DosR to inhibit aerobic respiration and slow 
replication of cells (Voskuil et al., 2003). The regulon is controlled by a 3-component 
regulatory-system with two sensor kinases, DosS (redox sensor) and DosT (hypoxia 
sensor), which bind nitric oxide, carbon monoxide and oxygen (Kumar et al., 2007) and 
the DosR regulator. As well as the control by these important signalling gases, there are 
multiple regulatory sequences upstream of Rv3134c, which is directly upstream of dosR 
(Leistikow et al., 2010). This suggests complex regulation by a number of different 
regulators, including Rv1675c shown here. 
 
Work here has identified the importance of the NO-responsive transcription factor 
WhiB1 and the cAMP-responsive Rv1675c in regulating the essential chaperonin 
groEL2 (Figure 6.6) and the role of Rv1675c in regulating the dormancy regulon. These 
two regulators, in response to the important infection signals of NO and cAMP, may be 
essential in regulating the dormancy programming of M. tuberculosis and thus play a 
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role in the infection process. Work to further understand their roles in regulating these 
genes, as well as their combined interactions, may provide important insights into the 
complex process of dormancy. 
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7.0 Discussion 
 
The work presented here has identified WhiB1 as an iron-sulphur cluster binding 
transcription factor, requiring all four cysteine residues for cluster incorporation (Smith 
et al., 2010; 2012). The iron-sulphur cluster reacts rapidly with nitric oxide, probably 
forming an octa-nitrosylated cluster in a multiphasic reaction (Crack et al., 2011). 
Reaction of holo-WhiB1 with nitric oxide, converts WhiB1 from a non-DNA binding 
form to a form capable of binding both the whiB1 and groEL2 promoters (Smith et al., 
2010; Stapleton et al., 2012). Apo-WhiB1, both oxidised and reduced, also bound these 
promoter DNAs. WhiB1 is capable of repressing its own transcription in vitro, and that 
of groEL2 also. Thus it is concluded that the iron-sulphur cluster of WhiB1 is a sensor 
of nitric oxide, and that exposure to nitric oxide converts holo-WhiB1 from a non-
DNA-binding form into a form capable of regulating transcription (Crack et al., 2011; 
Smith et al., 2010; Stapleton et al., 2012). 
 
The work described here and elsewhere raises a new set of questions about the role of 
WhiB1 in the infection process of M. tuberculosis. The whiB1 gene has been identified 
as essential for M. tuberculosis survival (Smith et al., 2010), thus one of the most 
important questions is ‘why?’. Is WhiB1 itself essential or does it regulate a subset of 
genes which are themselves essential? The reason for the essential nature of whiB1 is 
not established, but one possibility is that sufficient nitric oxide is present under the 
conditions tested to activate whiB1, possibly regulating genes essential in nitric oxide 
detoxification. It has been shown here that apo-WhiB1, both oxidised and reduced, as 
well as nitric oxide-treated holo-WhiB1 are capable of DNA binding and transcriptional 
repression in vitro. If axenic cultures do not produce sufficient nitric oxide to activate 
WhiB1, then its essentiality implies that the holo-form of WhiB1 may regulate as yet 
unidentified essential gene(s). The transcription factor IscR for example, regulates 
distinct groups of genes in its [2Fe-2S] holo- form and apo-form (Nesbit et al., 2009). 
The alternative forms of WhiB1 may specifically regulate overlapping sets of genes, 
which could explain its essential nature. 
 
The role of WhiB1 in the global transcriptional network also remains to be fully 
understood. As discussed in detail in Chapter 4, there is a complex interplay between 
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the cAMP receptor protein, CRP
MT
 (Rv3676) and WhiB1 in controlling whiB1 
expression. Thus dual regulation of whiB1 expression by the cAMP-responsive CRP
MT
 
and the nitric oxide responsive WhiB1 protein provides a mechanism for integrating 
two important infection-associated signals, suggesting that in the environment of the 
macrophage (high nitric oxide and cAMP levels) transcription of the essential 
transcription factor whiB1 will be inhibited. This is consistent with entry into the 
dormant state. At low nitric oxide concentrations (related to the immunocompromised 
state), holo-WhiB1 is formed, de-repressing whiB1 transcription, consistent with 
emergence from dormancy (Smith et al., 2010). The WhiB1 protein may also coordinate 
the response to hypoxia, due to the presence of its iron-sulphur cluster thereby 
incorporating a third signal associated with infection into the network. Although the 
cluster appears stable in the presence of molecular oxygen, it may respond to reactive 
oxygen species such as superoxide and hydrogen peroxide that are more abundant in an 
aerobic environment. In low oxygen and nitric oxide levels, associated with the hypoxic 
granuloma and emergence from dormancy, holo-WhiB1 may activate genes for survival 
and then de-repress its own transcription to aid in emergence. Figure 7.1 shows WhiB1 
at the centre of transcriptional regulation in response to various signals and regulators. 
The diagram shows several key regulators discussed in Chapter 1 and the signals they 
respond to, in order to alter gene expression. WhiB1, and the other WhiB proteins 
(except WhiB5 as it is not known what it responds to) are shown to respond at some 
level to the three infection signals of hypoxia/nutrient starvation, oxidative/nitric oxide 
stress, and cAMP. The differences in their responses to these signals indicate a different 
role for each of the proteins, but all may regulate a different subset of genes to promote 
different stages of the infection; from phagocytosis by macrophages (WhiB1, 3, 6 and 
7), to entry into dormancy (WhiB1, 2, 3 and 4), and then emergence from the dormant 
state (WhiB1). These proteins, along with the regulators involved in dormancy 
(DosR/S/T, PhoPR, EHR) and cAMP signalling (CRP
MT
 – Rv3676 and Cmr – 
Rv1675c), are all necessary for the complex gene regulation necessary for tuberculosis 
pathogenesis. The data presented in Chapter 6, showing how Cmr (Rv1675c) binds 
upstream of the Rv3134c gene that is located directly upstream of the DosR regulator, 
and upstream of the gene encoding the DosR regulator itself (Rv3133c), may highlight a 
link between the response to cAMP and hypoxia. In vitro transcription assays to 
determine whether Cmr can activate or repress these Dos genes, will help provide 
further information on the integration of cAMP and hypoxia signalling. Understanding 
the interplay between all these regulators will provide fresh insight on how  
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Figure 7.1: Linking the transcriptional regulators of M. tuberculosis and their 
signals. Mycobacterium tuberculosis undergoes extensive changes in gene expression 
during infection, with a number of transcriptional regulators responding to the different 
environments experienced. A selection of transcriptional regulators and their signals are 
shown here, to illustrate the complex network employed by M. tuberculosis to succeed 
as a pathogen. 
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M.tuberculosis enters and emerges from the persistent state, including the role of 
WhiB1 in this process. 
 
In conclusion, and as discussed in Chapter 4, the essential nature of whiB1 and the 
change in DNA-binding ability in response to nitric oxide has implications in the 
control of M. tuberculosis gene expression in the host environment (Smith et al., 2010). 
Although high concentrations of nitric oxide kill M. tuberculosis (Darwin et al., 2003), 
lower concentrations have been shown to promote entry into the persistent state 
(Voskuil et al., 2003). Nitric oxide sensing and the reprogramming of gene expression 
by WhiB1 could therefore contribute to developmental adaptations by M. tuberculosis 
in response to host-generated nitric oxide during infection. WhiB1 is therefore a 
potential target for new and more efficient treatment of tuberculosis.  
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